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Abstract
According to data from the World Health Organization (WHO), 17.7 million peo-
ple were estimated to have died of cardiovascular diseases (CVDs) in 2015. That
represents 31% of all global deaths, making these diseases the leading cause of
death worldwide. The heart is a complex system that works due to the interaction
of a large number of elements at different temporal and spatial scales. The main
function of the heart is to pump blood throughout the body, with this mechani-
cal action being triggered by electrical impulses. Issues arising in the electrical or
mechanical actions of the heart at any of the involved temporal and spatial scales
can lead to cardiac malfunctioning. Mathematical modeling and simulation of the
heart’s electrical activity (so-called cardiac electrophysiology) and signal process-
ing of bioelectrical signals provide an ideal framework to join the information from
clinical and experimental studies with the understanding of the mechanisms un-
derlying them. Due to the high number of factors involved in the development and
validation of cardiac computational electrophysiological models and the intricate
interrelationships between them, novel methodologies that help control the design,
update and validation of new models become of great advantage. These method-
ologies can target from the definition of ionic gating in the simulated cells to the
propagation of the electrical impulse in multi-scale models. This thesis aims to
improve the existing knowledge on heart’s electrophysiology by developing novel
techniques to develop and validate cardiac computational models, with evaluation
of the effects of the modeled events by considering interactions between model
components and by simulating a range of spatio-temporal scales.
In chapter 2, a new paradigm was introduced to develop a novel human ven-
tricular cell model, the CRLP model, by departing from a previously published
model and incorporating novel experimental measurements of potassium currents
and reformulating the L-type calcium current. The introduced paradigm was based
on the analysis of the model’s ability to replicate a set of well-established electro-
physiological markers and on a sensitivity analysis of those markers to variations
in model parameters. A major advantage of the proposed paradigm was the possi-
bility to identify model parameter values that do not directly depend on individual
current measurements or concentrations and which are commonly set in an ad hoc
xi
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manner. The developed CRLP model was validated, and its improved capacity
to investigate arrhythmia-related properties, as compared to the cell model it was
based on, was corroborated.
In chapter 3, the CRLP model developed in chapter 2 was updated to in-
troduce the formulation of intracellular potassium ([K+]i) dynamics. This is an
important characteristic for investigation of ventricular arrhythmias arising under
conditions of hyperkalemia, one of the components of myocardial ischemia. Di-
rect introduction of [K+]i dynamics into the model generated an imbalance in the
potassium currents leading to a drift in [K+]i. To correct for such an imbalance,
an optimization framework was proposed that allowed estimating the ionic cur-
rent conductances of the CRLP model while guaranteeing physiologically plausible
values of selected electrophysiological properties, some of them highly relevant for
investigation of ventricular arrhythmias.
As mentioned above, when proposing a new model, or when updating an exist-
ing model, consistency between simulated and experimental data should be verified
by considering all involved effects and scales. The closer the experimental condi-
tions are reproduced in the computer simulations, the more robust the process of
model development and validation can be. In chapter 4, in silico simulation of
experimental protocols was proposed to analyze: how interactions between model
components affect the development and validation of mathematical ion channel
models; and how propagation affects action potential (AP)-based markers sim-
ulated in isolated cells and in tissue preparations, with identification of the ionic
contributors in each case. The CRLP model, developed in chapter 2 and updated in
chapter 3, presented a rather atypical shape at the end of the depolarization phase
of the AP (phase 1). In silico simulations of experimental protocols described in
chapter 4 and the optimization methodology introduced in chapter 3 were used to
improve the AP shape while validating the adjusted model at ionic, cell and tissue
scales.
In chapter 6 all the initial formulations and subsequent updates of the CRLP
model proposed in previous chapters were integrated and the ionic conductances of
the integrated model were readjusted to improve replication of experimental elec-
trophysiological measures. All the methodologies introduced throughout the thesis
were used to build a novel human ventricular AP model. For model validation, a
range of available experimental data at different scales and aimed at evaluating dif-
ferent electrophysiological properties was considered. Conditions underlying each
of the experimental studies were replicated as faithfully as possible. Results simu-
lated with the final version of the CRLP model were in all cases compared with all
available experimental evidences and with the most recent human ventricular cell
models published in the literature.
Chapter 7 summarizes the main conclusions of the thesis and presents new lines
of research that could be undertaken in future studies.
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Resumen y conclusiones
De acuerdo a los datos de la Organización Mundial de la Salud, se estima que 17,7
millones de personas murieron de enfermedades cardiacas en 2015, lo que supone el
31% de las muertes, haciendo de estas patologías la primera causa de muerte en el
mundo. El corazón es un sistema complejo que trabaja gracias a la interacción de
un gran número de elementos en diferentes escalas espaciales y temporales. La fun-
ción principal del corazón es bombear sangre en todo el cuerpo, siendo esta acción
mecánica activada por la estimulación eléctrica. La aparición de problemas en el
funcionamiento eléctrico o mecánico del corazón en cualquiera de las escalas involu-
cradas, temporal o espacial, puede dar lugar a un mal funcionamiento cardiaco. El
modelado matemático y la simulación de la actividad eléctrica del corazón (denomi-
nada electrofisiología cardiaca) y el procesado de señales bioeléctricas proporcionan
un marco ideal para unir la información clínica y los estudios experimentales con
la comprensión de los mecanismos que subyacen a estos problemas. Debido al gran
número de factores que se deben tener en cuenta a la hora de desarrollar y validar
un modelo computacional de electrofisiología cardiaca, asi como las complejas in-
teracciones que existen entre ellos, hacen que nuevas metodologías que facilitan la
concepción, la actualización y la validación de nuevos modelos sean de gran valor.
Estas metodologías pueden enfocarse sea en la definición de las compuertas iónicas
de los modelos, como en la propagación del impulso eléctrico en modelos multi-
escala. Esta tesis pretende mejorar el conocimiento existente sobre electrofisiología
cardiaca proponiendo nuevas técnicas para desarrollar y validar modelos computa-
cionales cardiacos, a través de la evaluación de los efectos de los eventos modelados
mediante la consideración de las interacciones entre los diferentes componentes del
modelo y la simulación de un rango de escalas espacio-temporales.
En el capítulo 2, se introdujo un nuevo paradigma para desarrollar un nuevo
modelo de potencial de acción de cardiomiocito humano, el modelo CRLP, par-
tiendo de un modelo previamente publicado e incorporando nuevas mediciones
experimentales de corrientes de potasio y reformulando la corriente de calcio tipo
L. El paradigma introducido se basó en el análisis de la capacidad del modelo
para replicar un conjunto de marcadores electrofisiológicos bien establecidos y en
un análisis de sensibilidad de esos marcadores a las variaciones en los parámetros
xiii
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del modelo. Una de las ventajas del paradigma propuesto fue la posibilidad de
identificar parámetros del modelo que no dependen directamente de las mediciones
individuales de corrientes o concentraciones y que comúnmente se establecen ad
hoc. El modelo CRLP se validó y se midió su rendimiento en la capacidad para
predecir marcadores relacionados con la arritmia ventricular en comparación con
el modelo cellular en el que se había basado.
En el capítulo 3, se actualizó el modelo CRLP desarrollado en el capítulo 2 para
introducir la formulación de la dinámica de potasio intracelular ([K+]i). Esta es
una característica importante para la investigación de arritmias ventriculares que
surgen en condiciones de hiperpotasemia, uno de los componentes de la isquemia
de miocardio. La introducción directa de la dinámica de [K+]i en el modelo gen-
eró un desequilibrio en las corrientes de potasio que condugeron a una deriva en
[K+]i. Para corregir tal desequilibrio, se propuso un algoritmo de optimización
que permitía estimar las conductancias de las corrientes iónicas del modelo CRLP
al tiempo que garantizaba valores fisiológicamente plausibles de una selección de
propiedades electrofisiológicas, algunas de ellas muy relevantes en el estudio de
arritmias ventriculares.
Como se mencionó anteriormente, al proponer un nuevo modelo o al actualizar
un modelo existente, la coherencia entre los datos simulados y experimentales debe
verificarse considerando todos los efectos y escalas involucradas. Cuanto mejor se
reproduzcan las condiciones experimentales en las simulaciones, más robusto será
el proceso de desarrollo y validación del modelo. En el capítulo 4, se propuso la
simulación de protocolos experimentales in silico para analizar cómo las interac-
ciones entre los componentes del modelo afectan el desarrollo y la validación de
los modelos matemáticos de canales iónicos; y cómo la propagación afecta los mar-
cadores basados en el potencial de acción cuando son simulados en células aisladas
o en preparaciones tisulares, identificando cómo contribuye cada corriente iónica
en cada caso.
El modelo CRLP, desarrollado en el capítulo 2 y actualizado en el capítulo 3,
presentaba una forma más bien atípica al final de la fase de despolarización del
potencial de acción (fase 1). La simulación in silico de los protocolos experimen-
tales descritos en el capítulo 4 y la metodología de optimización presentada en el
capítulo 3 se utilizaron para mejorar la forma del potencial de acción al tiempo que
validaba el modelo ajustado a escalas iónicas, celulares y de tejido.
En el capítulo 6 se integraron todas las formulaciones iniciales y actualiza-
ciones subsiguientes del modelo CRLP propuestas en los capítulos anteriores y se
reajustaron las conductancias iónicas del modelo para mejorar el comportamiento
del modelo con respecto a medidas electrofisiológicas experimentales. Todas las
metodologías introducidas a lo largo de la tesis se utilizaron para obtener un nuevo
modelo de potencial de acción ventricular humano. Para la validación del mod-
elo, se consideró un rango de datos experimentales disponibles a diferentes escalas
y destinados a evaluar diferentes propiedades electrofisiológicas. Las condiciones
subyacentes a cada uno de los estudios experimentales se replicaron tan fielmente
como fue posible. Los resultados simulados con la versión final del modelo CRLP se
compararon en todos los casos con todas las evidencias experimentales disponibles
UniversidadZaragoza
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y con los modelos de células ventriculares humanas más recientes publicados en la
literatura.
El capítulo 7 resume las principales conclusiones de la tesis y presenta nuevas
líneas de investigación que podrían emprenderse en futuros estudios. En conclusión,
diferentes técnicas para mejorar el desarrollo y la validación de modelos electrofi-
siológicos cardíacos han sido propuestos y analizados en esta tesis. Basándose en
el aumento de potencia computacional, se han considerado nuevas estrategias para
reducir el número de hipótesis y/o supuestos al construir un modelo de potencial de
acción de cardiomiocito ventricular. La aplicación de un algoritmo de optimización
junto con la simulación in silico de los protocolos experimentales han ayudado a
encontrar un modelo que represente mejor los resultados experimentales de los
marcadores electrofisiológicos de riesgo arrítmico.
JesúsCarro
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Chapter 1
Introduction
1.1 Motivation
According to data of the World Health Organization, an estimated 17.7 million
people died of cardiovascular diseases (CVDs) in 2015. That represents 31% of all
global deaths, making these diseases the leading cause of death worldwide. CVDs
are caused by different disorders of the heart and blood vessels, which include coro-
nary heart disease (heart attacks), cerebrovascular disease (stroke), raised blood
pressure (hypertension), peripheral artery disease. It is also important to note that
CVDs are the leading noncommunicable disease (NCD). In 2011, 36 million people
died from an NCD, with half caused by CVDs [14]. For this reason, it is necessary
to improve the current techniques to detect, diagnose, and prevent CVDs.
In particular, within the group of CVDs, one of the most important causes
of sudden death is cardiac arrhythmia, when the heart beats with an abnormal
rhythm: too quickly, too slowly, or erratically. Types of arrhythmia include: atrial
fibrillation, bradycardia, conduction disorders, premature contraction, tachycar-
dia, and ventricular fibrillation. Typically, a cardiac arrhythmia is caused by an
abnormal behavior of the heart’s natural pacemaker, a problem in the conduction
system to contract the heart, or because another part of the heart starts working
as the pacemaker. These pathological situations preclude the heart carrying out
its main function: to pump deoxygenated blood to the lungs and oxygenated blood
to the rest of the body.
The heart is a complex system that works through the interaction of different
elements at different scales, in which its main function is performed by a mechan-
ical action that is electrically controlled. Mathematical modeling and simulation
of the heart’s electrical activity (so-called cardiac electrophysiology) and signal
processing of bioelectrical signals provide an ideal framework for joining the in-
formation from clinical and experimental studies with the understanding of the
mechanisms underlying them. Tools capable of testing different hypotheses and
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predicting potential abnormalities in the heart’s behavior can be produced within
such a framework, and, in a relatively near future, they may be used in clinical
practice as complementary instruments to help in the prevention of cardiac dis-
eases and in the improvement of their diagnosis and therapy. In particular, for the
study of ventricular arrhythmias, the utilization of an in silico model of the heart
could improve understanding of the heart function, how different pathologies are
developed, and how they are expressed. Nevertheless, it remains essential to have
an action potential (AP) model able to reproduce experimentally and clinically
observed arrhythmic behaviors at the cell and tissue levels. This would allow sim-
ulation of the electrical activity of the heart from cell to body surface. Then, a total
in silico reconstruction of the most well known bioelectrical signal, the electrocar-
diogram (ECG), could be used for investigating the mechanisms and manifestations
of ventricular arrhythmias at different scales.
Due to the number of factors to be considered during the development of a
model, the interrelationships between them, and the need to preserve the improve-
ments obtained by previous models, it is necessary to develop novel methodologies
that help control the design, modification, and validation of new models. These
new methodologies should help control all elements of the model during its de-
velopment, from the definition of the ionic gates to the combination in multiscale
models, and to consider the implication of any definition or modification in the
simulation of the entire heart.
In the following sections, a general introduction is presented on how the heart
works (mainly from an electrical point of view), how the behavior of the heart is
affected by disease or by pathological conditions and how mathematical models
can be used to study the heart in physiological and pathological conditions. Subse-
quently, a description is provided on the electrical conduction system of the heart
and on the range of involved spatio-temporal scales. Next, the evolution of cardiac
electrophysiological models and the main components of a model of human ven-
tricular cells are analyzed. Finally, the Grandi-Pasqualini-Bers (GPB) model of
human ventricular cells [15], used as a starting point for this thesis, is studied. The
chapter end with the main objectives and a short outline of the different studies
described in this thesis.
1.2 Electrical and Mechanical Activity of the Heart
The heart is a volumetric pump that beats at 75 beats per minute and moves more
than five liters of blood. It consists of four chambers, the left and right ventricles,
and the left and right atria (see Figure 1.1). Deoxygenated blood enters the heart
through the right atrium, and, from there, flows through the tricuspid valve to the
right ventricle and is pumped to the lungs. Oxygenated blood returns from the
lungs through the left atrium, then, flows to the left ventricle through the mitral
valve. Once, the blood is in the left ventricle, it is pumped through the aortic
valve to the systemic circulation. Under normal conditions, all of these phases are
timed and synchronized, and this permits the blood to circulate and to transport
oxygen and other nutrients throughout the body. This mechanism works because
UniversidadZaragoza
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Figure 1.1: The anatomy of the heart and associated vessels, and orientation of
cardiac muscle fibers. Figure from [16].
of the electromechanical coupling of the cardiac cells, and to a complex system that
propagates the electrical signals to obtain a coordinated contraction of the heart.
1.2.1 Excitability of cardiac cells
Cardiac muscle cells (or cardiomyocytes) are excitable cells, that is, when a stimu-
lation current pulse depolarizes the resting membrane of a cardiomyocyte beyond
the threshold voltage, then an action potential (AP) is generated. During an AP,
the membrane potential (the potential at the inner surface relative to that at the
outer surface of the membrane), rises rapidly at the beginning (depolarization).
This first depolarization phase is followed by a small decrease in the action poten-
tial (dome) to then enter the third phase (plateau) where the membrane potential
is held at a high voltage for few milliseconds prior to enter the repolarization (the
fourth phase), in which the membrane potential recovers its resting value (the fifth
and last phase).
The membrane potential is caused by the difference of concentration between
the ions in the intracellular and extracellular compartments. The three main ions
present in the cardiomyocytes are sodium (Na+), potassium (K+) and calcium
(Ca2+). When an external stimulus is applied, an initial upstroke is generated by
the inward flux of sodium ions through the corresponding sodium channels. After
the first phase, the sodium channels close and the transient outward potassium
current is activated and attempts to return the cell to its resting state. The outward
potassium current is compensated by and inward calcium ion flux and therefore
slow down the decrease in the potential during the plateau phase. Calcium channels
begin closing while slow potassium currents begin acting until the cell recovers its
initial resting state. In cardiac muscle, the activation of one cell can propagate to
the neighbor cells, and, as a result, the activation generates complex wavefronts
that propagate through the cardiac tissue.
JesúsCarro
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1.2.2 Electromechanical coupling
When the membrane of the myocyte is depolarized, the channels that allow the
passage of calcium ions through them are open. Most of these ions enter through
the L-type calcium channel to a subspace called the dyadic space, which is formed
by the T-tubule (an extension of the cell membrane) and the close proximity of
the sarcoplasmic reticulum (the internal store for calcium). When calcium enters,
the concentration in the dyadic space elevates and it triggers the opening of the
ryanodine receptors in the sarcoplasmic reticulum. This launches a process known
as calcium-induced calcium release, during which, the calcium input into the cell
is amplified with the calcium present in the sarcoplasmic reticulum (SR). Free cal-
cium present in the cytosol binds to troponin and calmodulin favoring myofilament
contraction. The joint action of many cardiac cells contracting in an orderly way
in a small period of time causes the blood to be pumped by the heart.
1.2.3 Propagation of the electrical signal throughout the heart
As explained in the previous sections, the cardiac tissue is electrically excitable and
its excitation propagates through the tissue. In addition, when a cardiac tissue is
excited, it contracts because of the electromechanical coupling described previously.
These two phenomena are fundamental for the correct functioning of the heart,
but its proper operation also depends on the regulation and synchronization of the
different cardiac chambers.
The pacemaker of the heart is the sinoatrial (SA) node which is located in the
right atrium at the superior vena cava. It consists of specialized self-excitatory
muscle cells that are self-activated at the rate of about 70 beats per minute. From
the sinus node, activation propagates throughout the atria, but it cannot propagate
directly to the ventricle because a barrier of fibrous tissue is present. To do this, the
activation propagates first through the atrioventricular (AV) node, which is located
at the boundary between the atria and ventricles and which delays the excitation
of the ventricular tissue due to a very low conduction velocity (CV): 2-5 cm/s (e.g.
the CV of the atria is between 80 and 100 cm/s) [16]. Activation wavefront takes
an estimated 75 ms to cross the AV node. Because of this, the atria contract and
pump the blood to the ventricles when they are still relaxed.
Once the activation traverses the AV node, it travels through a common bundle,
called the bundle of His which later separates into two bundle branches: the right
and left bundle branches. Finally, these branches ramify into the Purkinje fibers
that are connected to the ventricular walls and, through them, the activation is
spread in the ventricle from many different locations. The ventricles, which have
the blood coming from the atria, contract with the propagation of the electrical
activation and pump the blood to the lungs and the rest of the body.
Figure 1.2 illustrates the isochronic surface of the activation in the ventricles.
The image is from [16] with data from [17].
Different AP shapes can be found at the various types of cardiac cells in the
heart. Figure 1.3 illustrates them with a delay similar to the one that is normally
found in a healthy heart.
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Figure 1.2: Isochronic surfaces of the ventricular activation. Image from [16] with
data from [17].
Figure 1.3: Different waveforms for each of the specialized cells found in the heart
are shown. The latency shown approximates that normally found in the healthy
heart. Image from [16].
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Figure 1.4: Electrode positions in the standard 12-lead ECG. Image created by
Nicholas Patche, Boston Medical Center (CC BY-SA 4.0).
1.2.4 The electrocardiogram
The ECG is a tool that can be used to assess the electrical and muscular activities
of the heart. It records the electric potential on the surface of the thorax that has
been generated by the electrical activity of cardiac cells. To measure it, electrodes
can be placed on the thorax that will record various electric signals depending on
their positions. Figure 1.4 illustrates, the standard 12-lead ECG is presented.
As depicted in Figure 1.3, the depolarization and repolarization of the cardiac
cells is represented in the following parts of the ECG:
 The atrial depolarization generates the P-wave.
 The ventricular depolarization corresponds to the QRS-complex that hides
the atrial repolarization.
 The ventricular repolarization corresponds to the T-wave.
The use of the ECG is widespread in clinical practice because it is a non-invasive
test that provides significant information about cardiac electrical events. One of
the limitations of the ECG is that it offers simultaneous information in different
spatio-temporal scales. The main limitation of this measurement is that, in many
cases, some information could be masked by other events in the heart or by the
effect of the propagation. In-silico models of the electrical activity of the heart is
a powerful tool to solve this limitation, and to help in the better understanding
of the ECG, because this technique permits simultaneous observation of what is
happening in each of the involved scale.
1.2.5 Acute myocardial ischemia
In previous sections, heart’s behavior under physiological conditions and its pri-
mary function of pumping blood to the body have been described. However, many
pathologies and diseases can lead to cardiac malfunctioning. From the electrical
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point of view, when an alteration of the normal conditions generates an abnormal
propagation of the electrical waves from the SA node to the rest of the heart, due
to the electromechanical coupling the heart would not be able to contract prop-
erly, and consequently, would not be able to pump blood to the rest of the body.
The arrhythmias are among the most important causes of sudden death. They
can be generated by two main mechanisms: abnormal automaticity and abnormal
conduction.
Injured or damaged tissue can conduct slowly or act as an obstacle (no con-
ducting tissue) causing an abnormal anatomical conduction. Conversely, abnormal
behavior of myocardial cells associated with channelopathies or the influence of cer-
tain drugs can generate an abnormal automaticity. This could cause heart beats
that originate not in the SA node (ectopic beats) but ones that can degenerate into
different types of arrhythmias grouped into two large families: supra ventricular
arrhythmias and ventricular arrhythmias. Supra ventricular arrhythmias are asso-
ciated with arrhythmic behaviour of the upper part of the heart (the atria). On the
contrary, ventricular arrhythmias are associated with the lower part of the heart,
and are of two types –ventricular tachycardia or ventricular fibrillation– [18, 19].
Many pathological conditions can result in a ventricular tachycardia or fibrillation,
but one of the most important perpetrators is ventricular ischemia caused by the
obstruction of one of the main coronary arteries. When the flow of blood is par-
tially interrupted by this blockage, the flow of oxygen and glucose to the muscle
cells and the washout are also interrupted within the affected region [20]. This
situation generates mainly three effects: a reduction in oxygen (hypoxia), an in-
creasing of the extracellular potassium (hyperkalemia), and an acidification of the
tissue (acidosis). Under these effects, the AP suffers significant alterations: the
excitability of the cell and the conduction velocity in the tissue are reduced, and
the effective refractive period (ERP) is increased [20, 21]. In addition, all of these
changes appear with a high degree of heterogeneity which makes it an important
pro-arrhythmic substrate.
Although the pro-arrhythmic mechanisms under acute ischemia have been ex-
tensively investigated, they are not yet fully understood. Many studies have at-
tempted to shed some light on this phenomenon, primarily using animal models
instead of human ventricles, as for example Janse et al. in porcine [22] and canine
subjects [21]. Experimental studies demonstrated that, this heterogeneity (mainly
in the border between the ischemic and the healthy zones) leads to the establish-
ment of reentries around the ischemic zone [21, 23]. When these phenomena appear
under ischemic conditions, they could separate the rhythm of the heart from the
one marked by the SA node and cause it to beat in a disorderly fashion.
Myocardial ischemia is clinically recognized when a ST-segment depression is
detected in the ECG [24, 25]. However, the mechanisms behind this depression
remain under discussion and other techniques are being explored to attempt to
increase the detection capacity. Due to the complexity of the problem and to the
different scales involved, computer simulations of three dimensional human hearts
have been used to study this pathology to better understand the mechanisms of
reentry formations and maintenance under myocardial ischemia.
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1.3 Modeling the Electrical Activity of the Heart
Cardiac electrophyisiological models can be used to simulate the electrical behavior
of one myocyte, a fiber of cardiac cells, a tissue, or the entire heart. This wide range
of possibilities enables their use in many different situations and for many purposes.
The primary reasons to use these models can be summarized in the following ideas:
 Reduce animal experimentation: The development and validation of medical
drugs require different phases. One is the experimental validation of the drug:
before testing the drug in humans, it can first be tested in animal models.
 Increase electrophyisiological cardiac knowledge: One of the limitations of the
in vivo or in vitro experiments is that only a few variables can be measured at
the same time during the experiment. The in silico simulation of the electrical
activity of the cardiac cells permits simultaneous study of all parameters of
interest, improving understanding of the mechanisms behind a normal or a
pathological behavior of the cell. Given that models are limited by their
imperfections or the lack of knowledge of some parts of the cell, their proper
use must include awareness of the model limitations, consideration during
the research process, and careful use.
 Assist the decision-making process: Once a patient has been diagnosed, it is
important to consider his specific characteristics to determine the most effec-
tive treatment. The dosage of a medical drug and the area of a tachycardic
heart to be ablated are among the many example situations in which the
simulation of the patient’s heart could result in a more accurate treatment.
1.3.1 First electrophysiological model of an excitable cell
The first action-reaction electrophysiological model was proposed by Alan L. Hodgkin
and Andrew F. Huxley and their colleagues at Cambridge [26]. This model was
possible because of their measurements of the electrical activity of the squid giant
fiber with the voltage clamp technique. With the results of the measurements,
they proposed a model in which the cell was described as an electrical circuit in
which ionic currents pass through the ionic channels that act as resistances, and
the membrane work as a capacitor. The electrical activity of the squid giant fiber
was described using four currents: one of sodium (INa), another of potassium (IK),
a small leakage current (Il), that represents the current carried by other ions, and
the capacitive current. Each of these currents uses its own path or channel in the
cell, and for this reason, this model is called the parallel conductance model or the
chord conductance model [27]. In the original formulation of the Hodgkin-Huxley
(HH) model a current from the outside to the inside was represented by a positive
current, but in this thesis the current notation that represents a current from the
inside to the outside as a positive one is used [16] (see Figure 1.5).
Two forces move the ions into or out of the cell: diffusion and electrostatic
attraction. For a type of ion, when these two forces are equals in magnitude but
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Figure 1.5: The equivalent circuit of the Hodgkin-Huxley model. The voltage
sources show the polarity of the positive value. The calculated Nernst voltages
of sodium, potassium, and chloride designate the value of corresponding voltage
sources. Image from [16].
opposite, this ion is in equilibrium. The equilibrium voltage of an ion is called the
Nernst potential and is defined as follows [28]:
VK =   R  T
zk  F log

[k]i
[k]o

(1.1)
where VK is Nernst potential for the ion k, R is the gas constant, T is the
absolute temperature, zk is the valence of the ion k, F is the Faraday’s constant,
[k]i is the intracellular concentration of the ion k, and [k]o is the extracellular
concentration of the ion k.
The diffusion force is modeled as a voltage source in the HH model using the
Nernst potential, and the ion permeability of the membrane for the different ions
is modeled with a conductance per unit area (based on Ohm’s law) as follows:
GK =
Ik
Vm   VK (1.2)
where GK is the membrane conductance per unit area for the ion k, Ik is the electric
current carried by the ion k per unit area, VK is the Nernst voltage for the ion k,
and Vm is the membrane voltage.
Hodgkin and Huxley assumed that each type of ion passes only through a
specific channel for it; they also supposed that the opening and closing of the
channels are controlled by electrically charged particles. The probability that one
of this particles is in an open state depends on the membrane voltage. So, they
JesúsCarro
12 New Methodologies for the Developmentand Validation of Electrophysiological Models
defined the ionic conductance for each channel as the product between the maximal
conductance of the channel (a constant value) and the fraction of particles in open
state, but, as is explained in [16], they did not make any assumptions on the
chemical or anatomical nature of these particles.
They modeled mathematically the fraction of them in an open state with ordi-
nary differential equations as follows:
dg
dt
= g  (1  g)  g  g (1.3)
where g is the transfer rate coefficient for particles from closed to open state, g is
the transfer rate coefficient for particles from open to closed state, g is the fraction
of particles in the open state and (1   g) is the fraction of particles in the closed
state.
Using the previous equation the steady-state values of the fraction of them in
an open state and the constant time they need to reach the steady-state can be
obtained:
gss =
g
g + g
(1.4)
g =
1
g + g
(1.5)
During a voltage-clamp experiment, the fraction of particles in an open state
will follow this expression:
g(t) = gss + (gss   g0)  e 
t
g (1.6)
where g0 is the fraction of particles in an open state at the beginning of the exper-
iment.
According to the definition proposed by Hodgkin and Huxley, each channel can
have more than one type of particles and can need more than one particle in open
state to permit to the ions to pass through itself. For example, in the HH model,
the potassium channels are formed by four particles of type n, and the sodium
ones are formed by three of type m and one of type h. The potassium and sodium
conductances in the HH model are defined as follows:
GK = GK,max  n4 (1.7)
GNa = GNa,max m3  h (1.8)
where GK;max and GNa;max are the maximal conductances of the potassium and
sodium channel respectively.
The particles of type n and m are particles of activation. Under the resting
potential they are not in the open states and when the voltage increases, the
fraction of particles in the open state increases (see Figure 1.6 and Figure 1.7).
On the contrary, the h particles are deactivation ones. When the voltage tend to
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Figure 1.6: Voltage dependence of the particles in the potassium channels of the
HH model. (A)Variation of transfer rate coefficients n and n, (B) Variation of
n and n4 as functions of membrane voltage. Image from [16].
Figure 1.7: Voltage dependence of the particles in the sodium channels of the HH
model. (A) m and m, (B) h and h, (C) m and h, and (D) m3 h as a function
of membrane voltage. Image from [16].
JesúsCarro
14 New Methodologies for the Developmentand Validation of Electrophysiological Models
minus infinity all the particles are in the open state but when the voltage increases,
the fraction of particles in the open state is reduced (see Figure 1.7).
The total transmembrane current density in the HH model is the sum of the
capacitive and ionic currents as follows:
Im = Cm  dVm
dt
+ (Vm   VNa) GNa + (Vm   VK) GK + (Vm   VK) GL (1.9)
where Im is the membrane current per unit area; Cm is the membrane capacitance
per unit area; Vm is the membrane voltage; VNa, VK and VK are the Nernst potential
for sodium, potassium and leakage ions respectively; and GNa, GK and GL are the
sodium, potassium, and leakage conductance per unit area respectively.
When the cell is in an open circuit, there cannot be axial current since there
is no potential gradient in the axial direction. Under this situation, the previous
equation can be expressed as follows:
dVm
dt
=   1
Cm
 ((Vm   VNa) GNa + (Vm   VK) GK + (Vm   VK) GL) (1.10)
1.3.2 Evolution of electrophysiological models for cardiac cells
While the Hodgkin and Huxley equations were empirically derived, their formalism
continues to be used, and most of the electrophysiological models developed after
Hodgkin and Huxley (nerve models, cardiac models, and neuronal models, for
example) follow the formalism they proposed.
Ten years after the HH model, Denis Noble proposed the first model of car-
diac cell in which he adapted the HH model to represent the electrophysiological
behavior of a Purkinje cell [29]. The first cardiac electrophysiological models were
developed to explain the main differences between the heart cells and the ner-
vous cells: the AP duration [30]. Soon, these models became more complex by
incorporating the different ionic currents that were being discovered. Initially, the
potassium current was separated into two new currents: IK1 and IK2 [31–33]. Later,
Sanguinetti and Jurkiewicz discovered that the IK2 current was made up of two
components: IKr and IKs [34]. However, it was not until 1964 that voltage-clamp
experiments allowed the discovery of the calcium current [35]. Step by step, other
elements were incorporated to the models as the sodium-calcium exchanger (Incx)
and the homeostasis of the intracellular concentrations [36].
Similarly, the models were adapted to different cell types: ventricle [37], atrium
[38]; and different species: rabbit [38, 39], guinea pig [40, 41], dog [42, 43], and
human [44–47], for example.
One of the possibilities of cellular action potential models is that they can be
incorporated into cellular network models to simulate cardiac tissue [48–51] and
study the behavior of the entire organ under pathological situations or before the
effect of drugs.
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1.3.3 Human ventricular electrophysiological models: main ionic currents
An electrophysiological cardiac model describes the membrane potential of a car-
diac cell and is composed of different currents that pass through the cell membrane.
As described for the HH model, these currents are generated by the passage of ions
through different channels, exchangers, and pumps that connect the intracellular
and the extracellular media. Each current is formulated mathematically to rep-
resent the various effects that occur in the channels (for example, activation and
inactivation of ion channels) and these models also include the balance between
the intracellular and extracellular ionic concentrations, and between the different
compartments of the miocyte. In the cases of the human ventricular models, the
most important ions for the modeling of the AP are: sodium (Na+), potassium
(K+), and calcium (Ca2+). While there are many differences between the existing
human ventricular cell models, the main currents are present in all of them. In the
following subsections, the principal ones are described.
Sodium current
The fast sodium current (INa) is the main sodium current in human ventricular
cells. There exists also the late sodium current (INaL) but this current plays a
relevant role only under pathological conditions (for example, LQT3 or HF [52]).
INa is mainly modeled following the formalism proposed by Hodgkin and Huxley,
with three activation gates of type m and two inactivation gates (j and h).
Potassium currents
Four potassium currents are mostly present in the human ventricular cell mod-
els. Three correspond to voltage-gated ion channels (Kv), whereas the fourth is
an inward rectifying current. Kv channels are the most diverse super-family of
ion channels and have a significant impact on AP shape and duration. These dif-
ferences are related to the cell type and function, but also to differences among
various species [52]. These differences make it important to use data from human
cardiomyocytes for the characterization of these currents.
Transient outward potassium current (Ito): This voltage gated current acti-
vates and inactivates rapidly during the depolarization phase of the action po-
tential. It can be divided into two components (Ito;f and Ito;s).Both components
activate rapidly following membrane depolarization. On the contrary, Ito;f inacti-
vates rapidly whereas Ito;s inactivates slowly (compared to Ito;f ). While not all of
the models divide the current into two components, all define it with two voltage-
dependent gates (one for activation and another one for inactivation). The major
difference between models lies in how they model the differences between the ven-
tricular cell types: by varying the conductance, by modifying the proportion of the
fast and the slow component, or both together.
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Rapidly activation potassium current (IKr): This current activates rapidly upon
depolarization [53]. The activation occurs faster than inactivation (act > 100ms,
inact < 20ms) [52]. In all of the recent human ventricular cell models, this current
is modeled with two voltage-dependent gates (one for activation and another for
inactivation) and uses the Nernst potential following the HH formalism.
Slowly activation potassium current (IKs): This slow component of the total
potassium current is much smaller than IKr and plays an less significant role in
the APD [54]. When this current is blocked, and in the absence of sympathetic
stimulation, the role played by IKs is quite small. However, when the ventricular
muscle repolarization reserve is attenuated, the role of this current in limiting AP
prolongation becomes significant [55]. This current is generally modeled using the
Nernst potential and with two voltage-dependent activation gates. In most parts
of the models, the two voltage-dependent gates are the same.
Inward rectifier potassium current (IK1): This current is present in all ventricular
and atrial myocytes and plays a major role in the action potential repolarization
[56]. It is usually modeled with one voltage-dependent and time-independent gate,
and the formulation used for this gate also makes use of the Nernst potential
following the HH formalism.
Calcium current
The L-type calcium current (ICaL) is the principal current for the entry of calcium in
the cardiac cells and it is typically modeled using the Goldman-Hodgkin-Katz equa-
tion. This current plays an important role during the plateau phase of the action
potential, in the action potential duration, and in the shape of the repolarization.
The L-type calcium channels are frequently modeled by a voltage-dependent
activation gate (d), by one or more voltage-dependent inactivation gates (f , f2),
and by calcium-dependent inactivation gates.
Pumps and exchangers
The previous currents modeled the behavior of ionic channels, through which the
ions pass without needing energy expenditure. However, there are also currents in
the cell caused by the movement of ions against gradient that require consuming
ATP (pumps), or by using the force of ions that pass in the direction of the gradient
(exchangers). Two of these types of currents are present in most human ventric-
ular cell models: the sodium-potassium pump current and the sodium-calcium
exchanger current.
Sodium-potassium pump(INaK): The sodium-potassium pump current is the prin-
cipal mechanism for active ion transport across the membrane of excitable cells
[57]. In addition, it plays an important role in regulating cardiac electrophysiology
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under physiological and pathological conditions. Two schemes have become pre-
dominant for modeling this current: the first one proposed by Di Francesco and
Noble in their seminal work [36], and the second one corresponding to it [58]. The
DiFrancesco–Noble formulation is mostly present in the majority of the models for
the specialized conduction system (sinoatrial node and Purkinje fiber models), and,
on the contrary, the Luo–Rudy formulation results predominate in mathematical
models of atrial and ventricular cardiac myocytes.
Sodium-calcium exchanger current (Incx): The sodium-calcium exchanger plays
an important role in the regulation of intracellular calcium concentration ([Ca2+]i).
This exchanger regulates muscle relaxation in cardiac myocytes [59]. This current is
usually modeled following the formulation proposed by Mullins [60] and simplified
by DiFrancesco and Noble [36]. In this formulation, the sodium calcium exchanger
current is modeled as a time-independent current, with the value of the current
being dependent on the intracellular and the extracellular concentration of Na+
and Ca2+ ions, and on the membrane potential.
1.3.4 Human ventricular electrophysiological models: recent developments
In recent years a number of mathematical models of electrical and ionic homeostasis
in human ventricular myocytes have been proposed. One of the most extensively
used models is that proposed by ten Tusscher-Panfilov (TP06) [51], which is an
improved version of the ten Tusscher-Nobel-Nobel-Panfilov (TNNP04) model [46],
in which the calcium dynamics, the slow delayed rectifier potassium current (IKs)
and the L-type calcium current (ICaL) were reformulated. Both the TNNP04 and
the TP06 models are based on experimental human data for most of the main ionic
currents. One of the major advantages of the TP06 model over previous human
ventricular models is that it accurately reproduces restitution of the AP duration
(APD). Conversely, the TP06 model presents the major shortcomings of being
insensitive to changes in certain ionic current densities [61] and of inadequately
representing rate dependence of intracellular calcium levels [12].
Another relevant model of human ventricular cells was proposed by Iyer et al.
(IMW04) [45]. This model provides a detailed description of calcium homeostasis
and reproduces diverse aspects of the excitation-contraction coupling (ECC). How-
ever, important limitations have been reported for this model, including the fact
that it is extremely sensitive to variations in the sodium potassium pump (INaK)
and to the inward rectifier potassium (IK1) current densities [61]. It also produces
quite long APs and relatively flat restitution curves in tissue [62]. In addition, the
most relevant ionic currents in the IMW04 model are described using Markovian
chains, with the consequent increase in complexity (more than 60 state variables),
which imposes serious restrictions on the size of the time step required for stabil-
ity and increases the overall computational time when using this model in tissue
simulations [62].
At the beginning of this thesis, a new model of human ventricular AP was pro-
posed by Grandi et al. (GPB) [15]. The development of this model departs from
JesúsCarro
18 New Methodologies for the Developmentand Validation of Electrophysiological Models
the rabbit ECC model proposed by Shannon et al. [63], which includes the sub-
sarcolemmal and junctional compartments in the formulation of the currents and
provides a detailed description of calcium handling. The GPB model includes new
definitions of ionic current densities and kinetics according to recent experimen-
tal data on human myocytes. This model is defined for two types of cells, namely
endocardial and epicardial. These two cell types differ only by the maximal conduc-
tivity of the fast and slow components of the transient outward potassium current
(Ito). The GPB model improves the AP response to frequency changes and of-
fers a better performance against blockades of potassium currents (IK1, IKs and the
rapid delayed rectifier potassium current IKr) with respect to the TP06 model. The
major drawback of the GPB model is that it does not adequately reproduce S1S2
restitution properties nor APD rate adaptation dynamics. These drawbacks can be
attributed to the fact that the GPB model was developed from a rabbit ventricular
model, and the characteristics of S1S2 restitution and APD rate adaptation are
notably different in the two species.
Parallel to the development of this thesis, O’Hara et al. proposed the O’Hara-
Rudy-dynamic (ORd) model [64]. This new ventricular cell model is based on
the most extended data set of healthy human cells. Data from more than 100
healthy human hearts were used to examine the steady state rate dependence, and
restitution of the ventricular AP. The model was also studied under the effect of
drugs that selectively block different channels (for example, mexiletine, ryanodine,
nisoldipine, and E-4031). As it will be discussed later, the complexity of this
model is greater than that of previous models. The major drawback of the ORd
model is the rate dependence of the intracellular calcium ([Ca2+]i): While under
physiological conditions [Ca2+]i increases about a 30% with frequency, in the ORd
model it increases about 300%.
In 2015, Himeno et al. proposed a new human ventricular cell model [65]. As
opposed to the previously described models, the Himeno et al. model included
a description of excitation-contraction. The model comparison performed in the
present study was restricted to purely electrophysiological models.
Table 1.1 presents a summary with the main differences among the four models
described above, i.e. TP06, IMW04, GPB and ORd.
1.3.5 The Grandi-Pasqualini-Bers model
When this thesis was started, the most detailed and recent human ventricular
cell model published in the literature was the GPB model. Since the objective of
the thesis was to computational modeling and simulation for the investigation of
ventricular arrhythmias under ischemic conditions, the GPB model was taken as a
starting point. After performing an in-depth evaluation on the ability of this model
to represent experimental behavior in relation to a number of electrophysiological
properties, the necessity to update the GPB model for the study of arrhythmias was
identified. In this thesis different methodologies for the development and validation
of an electrophysiological cardiac model are introduced and applied to update the
GPB model. In this section a detailed description of the GPB model is presented.
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TP06 IMW04 GPB ORd
] State
variables
20 67 38 41
Computation
time
Short Very long Long Long
Cell types Endo, mid,
epi
Epi Endo, epi Endo, mid,
epi
Steady-state
AP properties
Physiological
APD values,
very low trian-
gulation
Physiological
APD values
and triangula-
tion
Physiological
APD values
and triangula-
tion
Short APD
values, but
physiological
triangulation
Steady-state
calcium levels
Low diastolic
and systolic
values
Low diastolic
and systolic
values
Very low di-
astolic and
systolic values
Low diastolic
and systolic
values
APD90 adap-
tation to
abrupt heart
rate changes
Very fast Very slow Rabbit char-
acteristics
Physiological
behavior
Sodium and
calcium rate
dependence
Very sensitive
to increasing
stimulation
frequency
Physiological
behavior
Physiological
behavior
Very sensitive
to increasing
stimulation
frequency
APD sen-
sitivity to
variations
in ionic cur-
rent densities
Lowly sensi-
tive to INaK ,
INa,Ca, IKs, IK1,
ICaL, IKr and
INa
Highly sen-
sitive to INaK
and IK1
Lowly sensi-
tive to IKr and
highly sensi-
tive to IK1
Lowly sensi-
tive to IK1,
ICaL and INa,Ca,
and highly
sensitive to IKr
Table 1.1: Differences between human ventricular cell models. Data are obtained
from [12, 61, 62, 64] and from simulations performed in this thesis.
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The GPB model describes the AP of endocardial and epicardial human my-
ocytes. For both cell types the total transmembrane ionic current, Iion, is given
by:
Iion = INatot + ICltot + ICatot + IKtot ;
where each of the individual currents denotes the current generated by the passage
of sodium, chlorine, calcium, and potassium ions, respectively, through the cell
membrane.
Sodium current. Following the approach of Shannon et al. [63], the sodium
current was divided into two components: i) a subsarcolemmal component, and
ii) a junctional component, which correspond to the cell compartments where the
current is generated. Both components are formed by the same subcurrents:
INatotjunc = INajunc + INa,bkjunc + 3  Incxjunc + 3  INaKjunc + ICaNajunc
INatotsl = INasl + INa,bksl + 3  Incxsl + 3  INaKsl + ICaNasl
INatot = INatotjunc + INatotsl
where INa is the fast sodium current, INa,bk is the background sodium current, Incx
is the current of the sodium-calcium exchanger, INaK is the current of the sodium-
potassium pump, and ICaNa is the sodium current through the L-type calcium chan-
nels.
Chlorine current. The chlorine current, which is not present in other previous
model as in TP06 or TP04. In the GPB models this current is described by:
ICltot = IClCa + ICl,bk
where IClCa is the calcium-activated chlorine current, and ICl,bk is the background
chlorine current.
Calcium current. The calcium current, as in the case of the sodium current,
has two components, junctional and subsarcolemmal:
ICatotjunc = ICajunc + ICa,bkjunc + IpCajunc   2  Incxjunc
ICatotsl = ICasl + ICa,bksl + IpCasl   2  Incxsl
ICatot = ICatotjunc + ICatotsl
where ICa is the calcium current through the L-type calcium channels, ICa,bk is the
background calcium current, IpCa is the sarcolemmal calcium pump current, and
Incx is the current of the sodium-calcium exchanger.
Potassium current. The potassium current is defined as follows:
IKtot = Ito + IKr + IKs + IK1   2  INaK + ICaK + IKp
where Ito is the transient outward potassium current (decomposed into a fast
and a slow component), IKr is the rapidly activating potassium current, IKs is
the slowly activating potassium current (decomposed into junctional and subsar-
colemmal components), IK1 is the inward rectifier potassium current, INaK is the
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current of the sodium-potassium pump (decomposed into junctional and subsar-
colemmal components), ICaK is the potassium current through the L-type calcium
channels (decomposed into junctional and subsarcolemmal components), and IKp
is the plateau potassium current. In the GPB model, differentiation between en-
docardial and epicardial cells is set by assigning different contributions to the fast
and slow Ito components.
1.3.6 Acute ischemia models
Over the past 20 years, cardiac ischemia has been studied using mathematical
modeling and computer simulations. These techniques have become a useful tool
in analyzing the electrophysiology of the myocardial arrhythmias [66]. In one of the
first works by Ferrero et al. [67], the authors studied how the metabolic changes
produced by the ischemia in the cell affect the electrophysiological behavior of the
cardiac tissue. This study was limited by the utilization of two dimensional tissues
and this limitation was also present in further studies [68]. Following these results,
different works have extended this concept, accounting for heterogeneity caused by
ischemia [69], realistic fiber orientation and transmural heterogeneity [70, 71], and
how reduced repolarization increases arrhythmic risk in the heterogeneous substrate
caused by acute myocardial ischemia [72].
At the cell level, AP under myocardial ischemia is modeled adding the three
main effects to the electrophysiological cardiac models: hyperkalemia, hypoxia and
acidosis. The hyperkalemia is simulated by increasing the extracellular potassium
to levels around 10 mM as it has been experimentally reported [73]. The hypoxia is
simulated by adding the ATP-sensitivity [K+]i current (IKATP), a current discovered
by Noma [74]. When distribution of oxygen is reduced, the cell is not able to
generate ATP from ADP. Due to this situation, ATP concentration is reduced
in the cell and IKATP channels open. Finally, acidosis is usually modeled by a
reduction of the ionic conductances of the INa and the ICaL currents according to
the experimental results of [67, 75]. While all three of these effects are present
during a cardiac ischemia, the hyperkalemia plays the most important role.
For the simulation of the ischemia, different scales need to be considered when
the myocardial it is studied because some of the electrophysiological consequences
of ventricular ischemia must be analyzed in tissue or in the entire organ. For ex-
ample, how the effective refractory period increase or how the conduction velocity
decreases under ischemic conditions must be studied at least in a fiber of ventricu-
lar myocytes. Another example is the study of reentrant patterns and vulnerable
windows in acutely-ischemic ventricle which must be analyzed on the organ level.
In this case, an ischemic region is placed in a bi-ventricle model with fiber orien-
tation, and, according to the experimental findings from Coronel et al. [73], the
ischemic region is composed of a normal zone (NZ), transitional border zones (BZ),
and the central zone (CZ) of ischemia. The BZ corresponds to a linear variation in
electrophysiological properties between the NZ and the CZ as shown in experiments
[73]. For this simulations, an important parameter in the simulation of ventricular
ischemia is the washed zone (not affected by ischemia) in the endocardium as a re-
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sult of the interaction between the blood inside of the ventricle and the endocardial
tissue [23].
In this complex scenario, the AP model represents the corner stone. A good
AP model that is able of reproducing the cardiac behavior under arrhythmias is a
key element for the in silico cardiac modeling.
1.4 Objectives and Outline of the Thesis
1.4.1 Aim of the thesis
The main objective of this thesis is the proposal of novel methodologies to im-
prove development and validation of cardiac computational models. In particular,
this thesis focused on building a human ventricular cell model able to represent
experimental evidences regarding a range of electrophysiological properties, which
included well-established markers of arrhythmic risk. The developed model could
then be used to investigate ventricular arrhythmias and, in particular, those arising
under conditions of hyperkalemia, a component of myocardial ischemia.
As described at the beginning of this general introduction, mathematical model-
ing and simulation of cardiac electrical activity provides an ideal framework where
to join clinical data and experimental observations to gain understanding of car-
diac electrophysiology and underlying mechanisms. The use of cardiac modeling
and simulation in combination with other techniques, such as signal processing of
cardiac electrical signals, can be a powerful tool to aid in the prevention of cardiac
arrhythmias as well as in the improvement of their diagnosis and therapy.
To this end, it is very important to have cardiac computational models able
to reproduce available clinical and experimental evidences. Cardiac action poten-
tial models are a key element in the development of whole-heart in silico models.
The more faithfully the action potential model represents experimental behavior,
the more useful it will be for investigation of cardiac electrical activity and the
generation of cardiac arrhythmias.
1.4.2 Specific objectives
The general objectives of this thesis are:
 To develop new methodologies for the development and validation of elec-
trophysiological models: During the development of a cardiac model, many
simplifications are required to be able to isolate parts of the model and to ad-
just the parameters of this part to the experimentally measured values. The
increase in computational capacity permits consideration of more elements
in the development process and could help reduce these simplifications. In
particular, the following situations have been considered in this thesis:
– Considering the entire model of an ionic channel when the parameters
of the channel are adjusted: The usual process to model the behavior
of an ionic channel involves in the measurement of different elements of
the model considering them independent of each other because of the
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experimental protocol used for the measurement. While in many cases
this approximation could be valid, with the increasing complexity of
the models, the interaction between the different elements of the model
also increases. For this reason, it is necessary to consider the possible
interactions of the different elements of the model in the experimental
measurements.
– Considering simultaneously all of the ionic conductances when the model
is adjusted: One of the most important parts in the development of a
cardiac model is the selection of the value for the ionic conductances.
This action is notably difficult because ionic conductances cannot be
measured directly. To select each value, they are usually considered
independently to adjust some electrophysiological properties. One of
the limitations of using this adjustment technique of one-at-a-time is
that the interactions or the cross effects are neglected. For this reason,
one of the objectives of this thesis is to develop techniques that allow
selecting the cardiac ionic conductances by modifying them at the same
time and considering all of the interactions or the cross effects.
– Considering the differences between the simulations in isolated cell and
in tissue to fit as closely as possible to the experiments: Due to the
sensitivity of some ionic currents to the process of cell isolation, the
experiments in cardiac cells are usually performed using small pieces
of tissue. Nevertheless, due to computational reasons, most of the ad-
justments in cardiac models are performed using simulations at the cell
level. One of the objectives of this thesis is to study how this simplifica-
tion could affect the development of a cardiac model and how it could
be overcome.
 To apply all of these methodologies for the development of a human ventric-
ular action potential model: In recent years, several models of the human
ventricular action potential have been proposed, because of the increase in
available data. However, while the available data increases the models are
limited in representing certain physiological situations. The objective of this
thesis is to incorporate the new technique to the modification of a human ven-
tricular AP model to try to approximate its behavior, as much as possible,
to what has been observed experimentally.
1.4.3 Outline of the thesis
The thesis is organized as follows:
 Chapter 2 describes an initial analysis of the GPB model and a first update of
it. The GPB model was analyzed for the purpose of investigating ventricular
arrhythmias occurring in the context of hyperkalemia, a component of my-
ocardial ischemia. After evaluating the model, the necessity to modify it to
solve issues related to different electrophysiological properties, like APD rate
adaptation to abrupt frequency changes among others, was identified. The
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update of the GPB model, denoted as the CRLP model, was first presented
at the CinC Conference, while a full analysis of the updated model, including
evaluation of its performance under hyperkalaemic conditions, was published
in a scientific journal:
– J. Carro, J. F. Rodríguez Matas, P. Laguna, E. Pueyo. Analysis and
Improvement of a Human Ventricular Cell Model for Investigation of
Cardiac Arrhythmias. XXXVII International Conference on Computers
in Cardiology, Belfast (UK), pp. 817 - 820 (Sep, 2010).
– J. Carro, J. F. Rodríguez, P. Laguna, E. Pueyo. A Human Ventric-
ular Cell Model for Investigation of Cardiac Arrhythmias under Hy-
perkalaemic Conditions. Phil Trans A, n. 639, pp. 4205 - 4232 (Nov,
2011).
 Chapter 3 presents an algorithm to adjust the ionic conductances of a car-
diac computational model by considering electrophysiological markers as con-
straints. The need for such an algorithm came from the fact that, after eval-
uation of the CRLP model developed in chapter 2, additional characteristics
were determined to be necessary for investigation of cardiac arrhythmias.
Specifically, in this chapter intracellular potassium dynamics were introduced
into the CRLP model developed in chapter 2 to investigate arrhythmias aris-
ing in the context of hyperkalemic conditions. To avoid the imbalance in
the total potassium current, a new algorithm was proposed to adjust ionic
current conductances of the updated computational model in such a way that
representation of experimentally measured electrophysiological markers is ei-
ther improved or at least maintained with respect to the model before the
update. The initial results of this chapter were presented at a scientific con-
ference. The final algorithm with illustration of its application to the study
of conditions involving large changes in potassium concentration has been
accepted to be published in an international journal:
– J. Carro, J. F. Rodríguez Matas, and E. Pueyo, A Response Surface
Optimization approach to adjust ionic current conductances of cardiac
electrophysiological models, in Gordon Research Conference in Cardiac
Arrhythmia Mechanisms, Lucca, Italy, 2015.
– J. Carro, E. Pueyo, J. F. Rodríguez. A response surface optimization
approach to adjust ionic current conductances of cardiac electrophysi-
ological models. Application to the study of potassium level changes.
PLOS One (Accepted).
 In Chapter 4, limitations in the development and validation of electrophysio-
logical models caused by the differences between the experimental protocols
and the simulations are analyzed. In the previous chapters of this thesis,
for the development and validation of the new versions of the model avail-
able experimental measures were readily used to adjust model parameters or
to compare with simulation results. To evaluate whether this is a suitable
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approximation, two scenarios involving scales ranging from ion channels to
tissue were studied. This study allowed us to determine when it is possible to
use them directly and when more complicated simulations are required. The
results of this chapter at the ionic level were presented at an international
conference, and the complete study evaluating both scenarios was published
in a scientific journal:
– J. Carro, J. F. Rodríguez-Matas, V. Monasterio, and E. Pueyo. Limi-
tations in electrophysiological model development and validation caused
by differences between simulations and experimental protocols. Progress
in Biophysics and Molecular Biology, vol 129, pp. 53 - 64, (Oct, 2017).
– J. Carro, J. F. Rodríguez Matas, E. Pueyo. In Silico Simulations of
Experimental Protocols for Cardiac Modeling. XXXVI Annual Inter-
national Conference of the IEEE Engineering in Medicine and Biology
Society, Chicago (USA), pp. 5695 - 5698 (Aug, 2014).
 In Chapter 5, a modification of the calcium current is proposed to improve
the shape of the AP before the plateau phase. Based on the results obtained
in Chapter 4, rather than directly comparing experimental and model char-
acterizations, in silico simulation of the experimental protocol was used to
adjust the new version of the model. To do that, the algorithm proposed in
Chapter 3 was adapted to update model expressions at the ionic level. In
addition, a new validation process considering the entire cell was described.
The obtained results were presented at two international conferences:
– J. Carro, J. F. Rodríguez Matas, and E. Pueyo, A Methodology to
Improve Human Ventricular Models for the Investigation of Cardiac
Arrhythmias, in 61st Annual Meeting of the Biophysical Society, New
Orleans, USA, 2017.
– J. Carro, J. F. Rodríguez Matas, and E. Pueyo, Multiscale Methods
for Definition of Ionic Variables in Electrophysiological Models, in Eu-
ropean Medical and Biological Engineering Conference (EMBEC) Tam-
pere, Finland, 2017.
 Chapter 6 presents the final update of the model. All the modifications to
the CRLP model proposed in chapter 2, as described in Chapters 3 and 5,
were considered and the optimization algorithm proposed in Chapter 3 was
used to adjust ionic current conductances and calcium handling character-
istics. In this chapter the optimization function was redefined and a large
number of experimental datasets recorded from healthy human ventricular
cells or tissues were used. Based on the results obtained in Chapter 4, only
those electrophysiological markers whose values are comparable when eval-
uated in simulated single cells and tissues were considered, as some of the
experimental data had been recorded in tissue and simulations were run in
cells. Additional electrophysiological markers were used for validation pur-
poses by comparing experimental data with tissue simulation results. The
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results of this chapter are part of a paper that is in preparation and will be
submitted to an international journal.
 Finally, Chapter 7 presents the most important conclusions of the thesis and
discusses possible future research lines.
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Chapter 2
A New Paradigm for
Electrophysiological
Model Development
2.1 Introduction
Despite the fact that the human ventricular AP models currently available in the
literature are able to reproduce certain electrophysiological properties observed ex-
perimentally, they fail in representing other relevant aspects, as pointed out in
Chapter1. To obtain a model suitable for the study of human ventricular electro-
physiology, with a focus on the investigation of ventricular arrhythmias, in this
chapter a human ventricular AP model was developed departing from the GPB
model. The methodology proposed for model development was based on the compu-
tation of well-established electrophysiological markers and the results of a sensitiv-
ity analysis of the modulation of those markers by variations in the characteristics
of major ionic currents. Using that methodology key limitations of the GPB model
were unraveled and inadequacies in the definitions of specific ionic current charac-
teristics were identified. Based on those findings, gating kinetics of the ICaL current
were reformulated by introducing both fast and slow voltage-dependent inactivation
gates [51], maximal INaK was reduced to best match experimental APD90 rate adap-
tation data, and the IK1 current was redefined by accounting for recent experimental
data published in the literature [76]. The new developed model, herein denoted by
CRLP, was tested and compared with the original GPB model and with the widely
used TP06 model. Model comparison was based on twelve cellular electrophysi-
ological markers computed using five different stimulation protocols, as in [12].
Our results show that the introduced modifications brought most markers into the
physiological range, and considerably improved others with respect to the GPB and
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TP06 models. In addition, the CRLP model was tested by simulating hyperkalemic
conditions in tissue. Under those conditions, potassium starts to pour out of is-
chemic myocardial cells causing depolarization of the myocardium at rest, slowing
conduction and decreasing excitability. Recovery of excitability is known to out-
last repolarization, a phenomenon termed post-repolarization refractoriness. Our
results show that under hyperkalemia APD90 progressively decreased with the level
of extracellular potassium, [K+]o, whereas the effective refractory period (ERP)
increased after a threshold in the level of [K+]o was surpassed. Conduction veloc-
ity (CV) decreased with [K+]o and conduction was blocked above [K+]o = 10:4
mM. Additionally, APD90 alternans appeared for [K+]o > 9:8 mM. These results
suggest that the model is suitable to represent areas of inhomogeneities of resting
potential and dispersion in recovery of excitability corresponding to different hy-
perkalemic levels within the tissue. Those areas of inhomogeneities could provide
a setting for unidirectional block that could become the substrate for arrhythmias
in ischemic hearts.
2.2 Methods
Electrophysiological markers were used in this study to guide the modifications
applied onto the GPB model to generate the proposed CRLP model. Specifically,
markers related to S1S2 restitution and APD90 rate adaptation dynamics were
identified as not being adequately reproduced by the GPB model and appropriate
modifications were performed. Those and other markers were also used to evaluate
the performance of the CRLP model and to compare it with that of the TP06 and
GPB models.
In the following subsections, the cellular electrophysiological markers used in
this study are presented, and the protocols used to compute them are described.
2.2.1 Selected markers
 APD90: APD was traditionally considered as the main preclinical marker of
drug cardiotoxicity. APD prolongation was linked to long QT syndrome and
increased risk of developing Torsades de Pointes [77, 78]. APD90 was used in
this study to denote AP duration at 90% repolarization (Figure 2.1.a)).
 Triangulation: This marker quantifies the shape of the final part of the AP
and was calculated as the difference between APD at 50% and 90% repolar-
ization (Figure 2.1.a)). Low triangulation values indicate square APs, while
high values indicate triangular APs. Triangulation was proposed as a marker
of pro-arrhythmia [77], with long APD90 values without triangular APs con-
sidered as anti-arrhythmic, and triangular APs considered as pro-arrhythmic
in general.
 Systolic and diastolic intracellular calcium ([Ca2+]i) levels: Calcium transient
properties evaluated at different frequencies was reported as risk markers
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[79, 80]. In this study, diastolic (level at rest) and systolic (level at peak)
calcium transient levels were evaluated at 0.5 Hz and 1 Hz (Figure 2.1.b)).
 Time constants of APD90 adaptation to abrupt changes in CL: Adaptation
of ventricular repolarization duration to abrupt changes in cycle length (CL)
was proposed as an arrhythmic risk marker [81]. In this study, the dynamics
of APD90 adaptation to abrupt changes in CL were fitted by two exponentials
with associated time constants fast and slow (Figure 2.1.c)), following the
methodology proposed in [13].
 Maximum slope of APD90 restitution curves: The maximum slope of the
APD90 restitution (APDR) curve was suggested as an arrhythmic risk marker
[82, 83]. The APDR curve describes the relationship between APD90 and the
diastolic interval (DI) (Figures 2.1.d)-e)). In this study APDR was evaluated
using the S1S2 and the dynamic protocols (see Section 2.2.2).
 Rate dependence of Na+ and Ca2+ concentrations: The importance of in-
tracellular sodium, [Na+]i, and intracellular calcium, [Ca2+]i, dynamics in
arrhythmogenesis was extensively reported [84, 85]. In this study, systolic
[Na+]i and [Ca2+]i levels were evaluated for increasing stimulation frequen-
cies (Figure 2.1.f)).
2.2.2 Stimulation Protocols
Five stimulation protocols were applied to evaluate the electrophysiological markers
presented in section 2.2.
 Steady-state protocol: A train of 3,000 stimulation pulses was delivered and
steady-state was guaranteed to be reached. Simulations were carried out
using two different CL values (1,000 and 2,000 ms). The evaluated markers
were: APD90 at 1 Hz, Triangulation at 1 Hz, Systolic [Ca2+]i at 0.5 and 1
Hz, and Diastolic [Ca2+]i at 0.5 and 1 Hz (Figures 2.1.a) and 2.1.b)).
 Abrupt changes in CL protocol: The cell was stimulated with a CL of 1,000
ms for 8 minutes, then with a CL of 600 ms for additional 8 minutes and
finally with a CL of 1,000 ms for 8 minutes (Figure 2.1.c)). The APD90
dynamics after the first abrupt CL change were fitted by two exponentials
with time constants fast and slow. APD90 adaptation dynamics after the
second abrupt CL change provided very similar results to those obtained for
the first CL change, in accordance with [12, 13], and were not reported.
 S1S2 protocol: A train of 10 basic stimulations (S1) was applied to the cell
or tissue at a CL of 1,000 ms followed by an extra stimulus (S2) delivered at
coupling intervals (CI) ranging from 1,000 to 250 ms in variable steps (100 ms
for DI>300 ms, 5 ms for 150<DI<300 ms, and 1 ms for 5<DI<150 ms). The
S1S2 restitution curve was obtained by plotting the APD90 corresponding to
the extra stimulus versus the previous DI for each of the tested CI values
(Figure 2.1.d)).
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Figure 2.1: Graphical description (using simulation results) of the markers of
arrhythmic risk used in this study: a) Steady-state AP properties (APD90, AP
triangulation); b) Steady-state [Ca2+]i properties (systolic ‘sys’ and diastolic ‘dia’
values); c) APD90 daptation to abrupt changes in CL (from 1,000 ms to 600 ms
and again to 1,000 ms), characterized by time constants fast and slow; d) APDR
curve computed using the S1S2 protocol; e) APDR curve computed using the
dynamic protocol; f) Normalized rate dependence of systolic concentrations, with
normalization performed with respect to the lowest tested frequency, i.e. 0.25 Hz.
For a better understanding of the protocols used to compute the markers shown in
panels a)-f), see the description provided in section 2.2.2.
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 Dynamic protocol: In this protocol 100 stimulations were applied at a given
CL, with the CL ranging from 1,000 to 50 ms. The APDR curve was obtained
by plotting the steady-state APD90 (corresponding to the 100th stimulus of
each CL) versus the corresponding steady-state DI (Figure 2.1.e)).
 Rate dependence protocol: The systolic values of both [Na+]i and [Ca2+]i
concentrations were measured at different frequencies (0.25, 0.5, 1, 1.5, 2, 2.5
and 3 Hz) and normalized to the level of the minimum frequency. For each
frequency, the cell was stimulated during 10 minutes to reach steady-state
and [Na+]i and [Ca2+]i were measured at the end of the 10-minute period.
The maximum normalized concentration value was computed and used as a
marker (Figure 2.1.f)).
2.2.3 The CRLP Model
Taking the GPB model as a starting point, the CRLP model was built by re-
formulating two ionic currents (ICaL and IK1) and redefining a number of model
parameters, including GNa (maximum INa conductance) and GNaK (maximal INaK
value). Those changes were motivated by the possibility of improving the per-
formance exhibited by the GPB model on two particular aspects: i) the shape
and maximum slope of the S1S2 APD90 restitution curve, and ii) the response of
the APD90 to abrupt changes in heart rate (see below). The failure of the GPB
model in reproducing experimental data on those two aspects could be attributed
to an inheritance from the Shannon rabbit ventricular model from which the GPB
model was developed. In this regard, the development of the CRLP model from
the GPB model was made by considering human data only [61]. The following
paragraphs describe the introduced modifications, as well as the data and criteria
used in the development process. A full description of the CRLP model can be
found in Appendix B.
To keep as much consistency as possible with the original GPB model, the
CRLP model was developed for the same type of myocardial cells as the GPB
model, namely endocardial and epicardial. Differences between the two cell types
were based on the definition of the Ito fast and slow components, in the same way
as previously described for the GPB model.
L-Type Calcium Current (ICaL). To obtain an APD90 adaptation response to
abrupt changes in CL in better concordance with experimental data, the L-type
calcium current was reformulated. The voltage-dependent inactivation gate f of the
GPB model was replaced with the product of a fast, f , and a slow, f2, inactivation
gates, as in [51]. The new equations for the ICaL current in the CRLP model were:
ICajunc = FjuncCaL  ICaj  d  f  f2 
 
1  fCaBj

ICasl = FslCaL  ICasl  d  f  f2  (1  fCaBsl)
ICaNajunc = FjuncCaL  INaj  d  f  f2 
 
1  fCaBj

ICaNasl = FslCaL  INasl  d  f  f2  (1  fCaBsl)
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ICaK =
IK  d  f  f2 

FjuncCaL 
 
1  fCaBj

+ FslCaL  (1  fCaBsl)

ICa = ICajunc + ICasl
ICaNa = ICaNajunc + ICaNasl
ICaL = ICa + ICaK + ICaNa
As indicated in [61], the replacement of one current component by another
one is not a simple task. Splitting the f gate in the GPB model into two new
gates required the readjustment of the time constants f2 associated with the slow
voltage-dependent inactivation gate f2 and the time constant d associated with
the activation gate d in order to obtain a meaningful ICaL current-voltage curve
(splitting the f gate without readjusting the time constants would have led to a
current-voltage curve having two relative minima).
Readjustment of f2 was based on available experimental data [2, 4–7]. Fig-
ure 2.2.a) depicts f and f2 along with experimental data [2, 4–7]. Since the
experimental data does not cover the entire voltage range, the readjustment was
performed by best fitting the tail of the f2 curve while obtaining a current-voltage
curve within the range of experimental data. The other voltage-dependent inacti-
vation time constant, f , was kept as in [51]. The equations describing f and f2
were:
fss =
1
1 + e
Vm+20
7
f = 1102:5  e (
Vm+27
15 )
2
f =
200
1 + e
13 Vm
10
f =
180
1 + e
Vm+30
10
+ 20
f = f + f + f
df
dt =
fss   f
f
f2ss =
0:67
1 + e
Vm+35
7
+ 0:33
f2 = 300  e
 (Vm+25)2
170
f2 =
31
1 + e
25 Vm
10
f2 =
16
1 + e
Vm+30
10
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f2 = f2 + f2 + f2
df2
dt =
f2ss   f2
f2
where Vm denotes transmembrane voltage.
Readjustment of d was based on the description provided in [51]:
dss =
1
1 + e
 (Vm+5)
6
d =
1:4
1 + e
 35 Vm
13
+ 0:25
d =
1:4
1 + e
Vm+5
5
d =
1
1 + e
50 Vm
20
d = d  d + d
dd
dt =
dss   d
d
The definitions of the calcium-dependent inactivation gates, fCaBj and fCaBsl ,
were taken as in the GPB model:
dfCaBj
dt = 1:7  Caj 
 
1  fCaBj
  11:9  10 3  fCaBj
dfCaBsl
dt = 1:7  Casl  (1  fCaBsl)  11:9  10
 3  fCaBsl
Additionally, based on the results of the sensitivity of APD90 to variations in
the maximal ICaL conductivity and the actual APD90 value in the GPB model
(see below, Tables 2.1 and 2.2), the relative permeabilities of the L-type calcium
channels were set to:
pCa = 1:9887  10 4 cm/s
pK = 5:4675  10 8 cm/s
pNa = 3:0375  10 9 cm/s
ICaj =
pCa  Vm  Frdy  FoRT 
 
Caj  e2VmFoRT   Cao

e2VmFoRT   1
ICasl =
pCa  Vm  Frdy  FoRT 
 
Casl  e2VmFoRT   Cao

e2VmFoRT   1
INaj =
pNa  Vm  Frdy  FoRT 
 
Naj  eVmFoRT  Nao

eVmFoRT   1
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INasl =
pNa  Vm  Frdy  FoRT 
 
Nasl  eVmFoRT  Nao

eVmFoRT   1
IK =
pK  Vm  Frdy  FoRT 
 
Ki  eVmFoRT  Ko

eVmFoRT   1
where Frdy is Faraday’s constant, FoRT is the ratio between Faraday’s constant
and the product of the gas constant and the absolute temperature, Ikm is the
maximal current for ion k in the compartmentm, and pk is the relative permeability
of ion k.
The current-voltage curve obtained with the new definition of the ICaL current
was compared with experimental data [1–3] and with the original definition of
the GPB model. Figure 2.2.b) shows the different current-voltage curves, where
it can be observed that the new definition of ICaL was in good agreement with
available experimental data [1–3], with the additional benefit of contributing to
physiological model response in terms of S1S2 APD90 restitution and APD90 rate
adaptation dynamics.
Inward Rectifier K Current (IK1). The IK1 current was redefined using recent
experimental data from human ventricular cells published in the literature [76].
The new definition for IK1 was as follows:
aK1 =
4:094
1:0 + e0:1217(Vm EK 49:934)
bK1 =
15:720  e0:0674(Vm EK 3:257) + e0:0618(Vm EK 594:31)
1:0 + e 0:1629(Vm EK+14:207)
K1ss =
aK1
aK1 + bK1
IK1 = 0:5715 
r
[K+]o
5:4
K1ss  (Vm   EK)
where EK is the [K+] reversal potential. Figure 2.2.c) shows the modified IK1
current compared with the experimental data from [76] and with IK1 from the
GPB model.
Na/K Pump Current (INaK). In order to improve the APD90 adaptation re-
sponse to abrupt changes in CL, maximal INaK was reduced by 45% with respect
to its value in the GPB model. That reduction was set based on the results of the
sensitivity analysis for the slow marker that is described above.
[K+]i and GNa. A more physiological value for [K+]i of 138 mM was used in our
model. Considering this value for [K+]i made the model more excitable as com-
pared to the original GPB model because of the increased availability of sodium
channels. Therefore, in order to obtain physiological values for the maximal up-
stroke velocity, dV /dt, in tissue, the maximum conductance of the sodium current,
GNa, was reduced to 18:864 mS/F. This modification led to a maximal upstroke
velocity of 228 mV/ms in the simulated one-dimensional (1D) tissue (see below),
which was in good agreement with the experimental results reported in [8].
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Figure 2.2: Characteristics of ICaL and IK1 in simulations and experiments: a)
Simulated ICaL voltage-dependent inactivation time constants i as a function of
voltage, where i 2 ff; f2g. Experimental data, represented by markers, were taken
from [2, 4–7]; b) ICaL current density versus voltage, with experimental data taken
from [1–3]; c) IK1 current density versus voltage with experimental data taken from
[76]. To compare simulated and experimental data under the same conditions,
[K+]i = 138 mM and [K+]o = 4 mM were used for the curves shown in panel c),
with [K+]i denoting the intracellular potassium concentration.
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Numerical methods and implementation
The cell membrane was modeled as an electrical circuit [26]. Mathematically, the
transmembrane voltage Vm was described by the following ordinary differential
equation:
Cm
dVm
dt =   (Iion   Istim) ; (2.1)
where t is time, Iion is the sum of all transmembrane ionic currents, Istim is the
externally applied stimulation current and Cm is the cell capacitance per unit
surface area.
Propagation of the electrical activity in a 1D fiber was described by the following
parabolic reaction-diffusion equation [86]:
Cm
@Vm
@t
=   (Iion   Istim) + @
@x


@V
@x

; (2.2)
where  is the diffusion coefficient of the tissue and x denotes the coordinate along
the fiber.
Physical units in the model were as follows: time t was given in milliseconds,
transmembrane potential Vm in millivolts, current densities in picoamperes per
picofarad and ionic concentrations in millimoles per liter.
The GPB and CRLP models were implemented in Fortran based on the original
codes provided by Eleonora Grandi. The TP06 model was also implemented in
Fortran from the original C codes available at Kirsten ten Tusscher’s web page:
www-binf.bio.uu.nl/khwjtuss.
Cells and tissue were stimulated with square transmembrane current pulses
twice the diastolic threshold in amplitude and 1-ms duration. For single cell sim-
ulations, forward Euler with a time step t = 0:002 ms was used to integrate the
system of ordinary differential equations governing the cellular electrical behavior.
For the 1D simulations, a homogeneous 4-cm long fiber composed of epicardial
cells was considered. A semi-implicit operator-splitting scheme [87] was used to
solve equation 2.2 with a space discretization of x = 0:1 mm and a time step
of t = 0:002 ms. A value of  = 0:0013 cm2/ms was used, corresponding to
a maximum CV of 74 cm/s, which is in agreement with experimentally reported
CV values [88]. The cell capacitance was set to Cm = 1 F/cm2. Five positions
within the fiber were selected for further analysis in each simulation. Those posi-
tions were located at 1.5, 1.75, 2, 2.25 and 2.5 cm from the stimulation end of the
cable. Reported APD90 and CV values were computed as mean values over those
positions. In all cases, the Rush and Larsen integration scheme [89] was used to
integrate the Hodgkin-Huxley type equations for the gating variables of the various
time-dependent currents (m, h, and j for INa; xtof , xtos , ytof and ytos for Ito; xkr
for IKr; xks for IKs and d, f and f2 for ICaL).
To test the sensitivity of the numerical solution to the time and space dis-
cretization indicated above, simulations were performed using a time increment of
0:5 s and a spatial discretization of 0:05 mm. Differences of less than 0.2% for
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the steady-state markers computed in isolated cells were obtained when compared
with the default time and space steps used in this study. In tissue, CV and APD90
varied by less than 1.5% and 0.02%, respectively. Also, other stimulus durations
(from 1 to 3 ms) and amplitudes (from 1.5 to 2 times the diastolic threshold) were
tested and were confirmed to provide very similar results (differences in terms of
APD90, maximal upstroke velocity as well as CV in tissue were in all cases below
0.2%, 1.6% and 0.8%, respectively).
2.2.4 Conducted Simulations
Sensitivity Analysis
A sensitivity analysis was performed to the original GPB model following the
methodology described in [12]. The aim was to elucidate how different ionic current
properties modulate the investigated electrophysiological markers. In the sensitiv-
ity analysis, each parameter was varied at a time by 30%. Also, variations of
15% were considered to assess markers’ response to different degrees of variation.
These percentages are in agreement with variability levels reported in experiments
performed in human ventricular tissue [2, 76, 90–94].
The parameters considered in the sensitivity analysis were:
 GCaL: Maximal conductance of the L-Type Calcium Current (ICaL).
 f : Time constant of the fast voltage-dependent inactivation gate (f) of the
ICaL current.
 f2 : Time constant of the slow voltage-dependent inactivation gate (f2) of
the ICaL current.
 GKr : Maximal conductance of the rapidly activating potassium current (IKr).
 GKs : Maximal conductance of the slowly activating potassium current (IKs).
 xs : Time constant of the activation gate (xKs) of the IKs current.
 GK1 : Maximal conductance of the inward rectifier potassium current (IK1).
 GNaK : Maximal value of the sodium-potassium pump current (INaK).
 Gncx : Maximal value of the sodium-calcium exchanger current (Incx).
 Gto : Maximal conductance of the transient outward potassium current (Ito).
For each marker c and parameter p, the percentage of change (Dc;p;a) and
sensitivity (Sc;p;a) were calculated as follows [12]:
Dc;p;a =
Cp;a   Ccontrol
Ccontrol
 100
Sc;p;a =
Dc;p;a  Dc;p; a
2a
 100
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where Cp;a is the value of marker c when the parameter p is varied by the percent-
age a, and Ccontrol is the value of marker c under control conditions. As shown
above, sensitivity (Sc;p;a) was calculated as the ratio of the difference between the
percentage of change (Dc;p;a   Dc;p; a) and the interval of change (2a). In this
study we used this definition particularized for a = 30%:
Sc;p;30 =
Dc;p;+30  Dc;p; 30
0:6
Larger percentages of variation (60% and 90%) in model parameters were
additionally investigated to confirm the validity of the sensitivity analysis results
under more severe ionic alterations.
Potassium Current Blocks
The following cases of total and partial potassium current blocks were simulated:
 IKs: To simulate the effect of 1 M of HMR-1556, IKs was completely blocked.
 IKr: To simulate the effect of 50 nM of dofetilide, IKr was completely blocked.
 IK1: To simulate the effect of 10 M of BaCl2, IK1 was reduced by 50%.
Restitution in Tissue
CV and APD90 restitution were additionally investigated in tissue by applying the
S1S2 protocol described in 2.2.2, with the only difference that the extra stimulus
(S2) was in this case decreased in steps of 5 ms.
Hyperkalemic Conditions
Hyperkalemic conditions were simulated by increasing [K+]o from 4 mM to 15
mM. For each [K+]o value, the diastolic threshold used to compute the stimulus
amplitude was determined as follows: the model was first stabilized until the prod-
uct of the gates h  j reached 99% of the steady-state value hss  jss. Stimulation
current pulses of variable amplitude were applied at one end of the cable and the
diastolic threshold was defined as the minimum amplitude required for an AP to
propagate along the fiber. With the model initialized at 1 Hz steady-state, ERP
was determined by stimulating the tissue with a train of 10 basic stimulations (S1)
delivered at a CL of 1,000 ms, followed by an extra stimulus (S2) delivered at
different times taken in 1 ms steps. Steady-state CV and APD90 were measured
after the last S1 stimulus.
2.3 Results
2.3.1 Results for Control Conditions
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Figure 2.3: APs computed with the TP06, GPB and CRLP models for isolated
cells and 1D tissue at CL = 1000 ms. a) TP06 cellular AP; b) GPB cellular AP;
c) CRLP cellular AP; d) TP06 tissue AP; e) GPB tissue AP; f) CRLP tissue AP.
APs in Cell and Tissue
Figure 2.3 presents APs computed from the TP06, GPB and CRLP models for an
isolated epicardial cell and for an epicardial cell coupled in tissue. In all cases APs
correspond to steady-state pacing at CL = 1000 ms. As can be appreciated from
the figure, the AP duration was of the same order in the three models. However,
the AP shape was notably more triangular for the GPB and CRLP models as
compared to the TP06 model, which presented a flatter plateau phase. Also, phase
1 of the AP substantially differed from one model to another, particulary when
comparing TP06 with the other two models. Those differences were to some extent
attenuated when comparing APs measured in tissue. It is also clear from the
figure that maximal upstroke velocity was considerably reduced for tissue APs as
compared to cell APs. While for the GPB and CRLP models maximum voltage
occurred at the upstroke peak in both cell and tissue, for the TP06 model the
maximum voltage at the plateau was even larger than at the upstroke peak in
tissue AP, as previously noted in [62] for the TNNP04 model from which the TP06
model was developed.
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Sensitivity Analysis
The results of the sensitivity analysis applied to the epicardial version of the GPB
model are presented in Table 2.1. This table shows the dependence of a large num-
ber of electrophysiological markers on the ICaL current. Not only markers related
to systolic and diastolic [Ca2+]i levels, but also APD90 and S1S2 restitution slope
were mostly sensitive to variations in ICaL. Also, Table 2.1 shows the importance of
the IK1 current for AP triangulation. INaK was determinant for [Na+]i rate depen-
dence as well as for the time constant of the slow phase of APD90 rate adaptation.
Note that APD90 rate adaptation dynamics computed from the GPB model did
not present a characteristic biphasic behavior as reported in experimental studies
[95], but adaptation was completed in only one slow phase. For that reason the
marker fast described in subsection 2.2 is not shown in Table 2.1. Finally, Incx
was relevant for [Ca2+]i rate dependence. Table 2.1 together with the analysis
presented in the following subsection were the road map to carry out the various
model improvements proposed in this work, which were described in subsection 2.2.
To confirm that the results of the sensitivity analysis presented in Table 2.1 were
not dependent on the limit (30%) considered for parameter variations, simulations
were performed considering larger percentages of variations of up to 90%. Despite
the fact that in some cases a highly nonlinear modulation of specific electrophys-
iological markers by certain ionic mechanisms was observed (e.g. triangulation
modulation by GK1, systolic [Ca2+]i modulation by GCaL or slow modulation by
GNaK), results corroborated the mechanisms identified as determinant for the in-
vestigated markers in the sensitivity analysis.
Electrophysiological markers
Table 2.2 shows the values of the computed markers for the epicardial versions
of the three models analyzed in this study (TP06, GPB and CRLP). Simulation
results were compared against a variety of experimental data taken from [2, 8–
10, 79, 95–98].
Results indicated that the GPB model performed better than the TP06 model
with respect to the following markers: AP triangulation, steady-state systolic and
diastolic [Ca2+]i levels at 0.5 Hz and rate dependence of [Na+]i and [Ca2+]i. Those
markers are illustrated for the three analyzed models in Figure 2.4.a), 2.4.b),
2.4.f) and 2.4.g). However, according to other analyzed markers, the GPB model
rendered worse performance than the TP06 model, as was the case for the S1S2
restitution curve and the APD90 adaptation to abrupt changes in CL. Regarding
the APD90 adaptation, two phases of APD90 rate adaptation were experimentally
reported in [95]: a first phase with a short time constant and a second phase
with a longer time constant. As described above, the APD90 rate response in
the GPB model did not present the first fast phase (Figure 2.4.c)). For the S1S2
restitution curves (Figure 2.4.d)), the TP06 model was in better agreement with
the experimental data of [95, 98] than the GPB model.
For the CRLP model, seven out of the twelve analyzed markers were within
physiological range and other three markers were closer to the physiological range
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Table 2.1: Results of the sensitivity analysis applied to the GPB model. The blue
scale indicates relative sensitivity for each marker. White color indicates maximum
relative sensitivity and dark blue color indicates that property and parameter are
independent. Percentages in the white boxes indicate the absolute sensitivity of
the property. A minus sign in a box indicates that marker and model parameter
vary inversely. ‘Sys’ stands for systolic and ‘Dia’ stands for diastolic.
as compared to the GPB and TP06 models. As for systolic and diastolic [Ca2+]i
levels at 1 Hz, TP06 outperforms CRLP. A significant change in the shape of the
S1S2 restitution curve was observed for the CRLP model as compared to the GPB
model (Figure 2.4.d)). The behavior shown by the CRLP model was in agreement
with experimental data [95].
Potassium Current Blocks
Table 2.3 summarizes the effect of potassium current blocks on epicardial APs com-
puted using the three tested models. Results are given as percentage of variation
of the APD90 value with respect to control conditions. In those cases where more
than one current was blocked, the variation refers to the APD90 value obtained
when only the first current was blocked. Experimental values are taken from [54].
It is clear from Table 2.3 that the GPB model performs better than the TP06
model regarding current blocks. The CRLP model performs similar to the GPB
model. Figure 2.5 illustrates the effect of current blocks on the AP shape for the
GPB and CRLP models.
Restitution in Fiber
Figure 2.6 shows CV and APD90 restitution curves computed by applying the
S1S2 protocol to the simulated 1D fiber. Regarding CV restitution, the three
models present similar behaviors, with only notable differences (>5 cm/s) observed
between the TP06 model and the other two models (GPB and CRLP) in the final
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marker TP06 GPB CRLP Physiol.
APD90 (ms) 301.2 285.0 305.6 271-366
Triangulation (ms) 28.4 51.5 78 44-112
Sys [Ca2+]i 1 Hz (M) 0.886 0.383 0.602 1.59-2.01
Sys [Ca2+]i 0.5 Hz (M) 0.199 0.345 0.523 0.71-1.68
Dia [Ca2+]i 1 HZ (M) 0.104 0.089 0.097 0.20-0.33
Dia [Ca2+]i 0.5 Hz (M) 0.068 0.085 0.091 0.14-0.32
SmaxS1S2 (—) 1.3 0.2 1.0 0.79-4.25
SmaxDYN (—) 1.0 1.1 0.9 —
fast (s) 13.3 — 10.2 —
slow (s) 124.8 56.3 105.6 70-110
Max. sys. [Ca2+]i (%) 1157 178 147 130-170
Max. sys. [Na+]i (%) 217 132 134 145
Table 2.2: markers of arrhythmic risk for the TP06, GPB and CRLP human mod-
els. Black color indicates within physiological range. Dark gray color indicates out
of physiological range but better than previous models. Light gray color indicates
out of physiological range. Experimental data are from [2, 8–10, 79, 95–98].
Current Ref. TP06 GPB CRLP Exper.
IKs 0% Control 74.9 0.7 0.6 < 2.8
IKr 0% Control 15.9 18.6 14.1 444
IKr 0% IKr block — 1.4 0.8 9IKs 0%
IK1 50% Control 3.6 11.5 14.6 4.81.5
IKr 0% IKr block 8.9 15.6 21.1 33IK1 50%
Table 2.3: Percentages of variation in APD90 caused by blocking different potas-
sium currents. Black color indicates within physiological range. Dark gray color
indicates out of physiological range but better than previous models. Light gray
color indicates out of physiological range.
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Figure 2.4: markers of arrhythmic risk from TP06, GPB and CRLP models: a)
Steady-state AP for CL = 1000 ms; b) Steady-state Ca transient for CL = 1000
ms. c) APD90 rate adaptation to abrupt changes in CL (from 1000 ms to 600 ms);
d) S1S2 restitution curve; e) Dynamic restitution curve; f) Normalized [Ca2+]i
rate dependence; g) Normalized [Na+]i rate dependence. For panels f) and g)
normalization is performed with respect to the lowest tested frequency, i.e. 0.25
Hz.
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Figure 2.5: Effect of blocking potassium currents for the GPB and CRLP models:
a) Effect of completely blocking IKr and IKs currents in the GPB model; b) Effect of
completely blocking IKr and partially blocking IK1 in the GPB model; c) Effect of
completely blocking IKr and IKs currents in the CRLP model; d) Effect of completely
blocking IKr and partially blocking IK1 in the CRLP model.
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Figure 2.6: CV and APD90 restitution curves for the TP06, GPB and CRLP
models in a simulated 1D fiber.
part of the curve, i.e. for DI values above 200 ms. Regarding APD90 restitution,
both the TP06 and CRLP model present steep restitution curves, with high slope
(close to 1) only for a narrow DI interval in the case of the CRLP model and for a
much wider DI range in the case of the TP06 model (with slope values above 1).
The GPB model shows a relatively flat APD90 restitution curve. Those results are
in good correspondence with the observations from restitution curves measured in
isolated cells (Figure 2.4.d)).
2.3.2 Results for Hyperkalemic Conditions
AP properties
Figures 2.7.a) and 2.7.c) show a comparison of the AP shape computed in single
cell and tissue for different levels of [K+]o using the CRLP model. Figures 2.7.b)
and 2.7.d) show the effect of varying [K+]o on the resting potential in single cell
and tissue. As expected, hyperkalemia shortens the APD90 and leads to elevated
resting potential, in both cells and tissue.
From Figure 2.7.c) it is also clear that for high [K+]o levels, the AP shape
varies between even and odd beats, thus leading to the occurrence of AP alternans.
Further analysis on the alternating AP behavior and the [K+]o threshold for its
occurrence can be found below.
Conduction Velocity
Figure 2.8.a) shows CV as a function of [K+]o computed from the simulated 1D
fiber using the CRLP model. As expected, hyperkalemia leads to a decrease in
CV. However, “supernormal conduction” is not observed for [K+]o levels below
physiological values (5:4 mM) as has been observed in other studies [99, 100]. Our
results also show that conduction block occurs for [K+]o > 10:4.
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Figure 2.7: Simulated hyperkalemia in cell and tissue using the CRLP model. a)
AP shape for varying [K+]o in isolated cells; b) Resting potential for varying [K+]o
in isolated cells; c) AP shape for varying [K+]o in 1D fiber; d) Resting potential
for varying [K+]o in 1D fiber.
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Figure 2.8: Behavior of the CRLP model under hyperkalemic conditions in a 1D
fiber: a) CV versus [K+]o; b) dependence of ERP and APD90 with [K+]o; c)
example of alternans for [K+]o = 10:0 mM, each color representing a different
position in the fiber; d) value of different currents normalized to the maximal value
of each one in the same example as the previous results.
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Action Potential Duration and Effective Refractory Period
Figure 2.8.b) shows ERP and APD90 of the last basic (S1) beat for different [K+]o
values computed in the simulated 1D fiber using the CRLP model. Results show
that hyperkalemia causes postrepolarization refractoriness. The difference between
ERP and APD90 remains almost constant for [K+]o  6 mM, with this difference
increasing rapidly for [K+]o > 6 mM. For [K+]o > 9:8 mM, alternans appear
in the tissue, causing the ERP and APD90 curves to branch out (Figure 2.8.b)).
This characteristic of the ERP and APD90 curves has not been reported in other
human ventricular simulation studies of the literature, but is in agreement with
experimental results in other species and with clinical data [101–103]. We tested
the same hyperkalemic conditions in simulated TP06 and GPB 1D fibers and we
could not observe branching out of the ERP or APD90 curves after increasing [K+]o
up to 15 mM.
Figure 2.8.c) depicts AP propagation in the simulated CRLP 1D fiber for
[K+]o = 10 mM. Alternans were observed for all computed positions within the
fiber. Figure 2.8.d) shows ICaL, INa and [Ca2+]i, each normalized to its maxi-
mum value, for the same time period shown in Figure 2.8.c). Results indicate that
conduction relies on INa even for the highly depressed APs. For the long APs,
the AP upstroke is divided into two components, the first one characterized by a
steep upstroke and supported by INa, and the second one supported by ICaL, in
agreement with the results reported in [67].
2.4 Discussion and conclusions
In this chapter a new human ventricular cell model, the CRLP model, was de-
veloped based on the recently proposed GPB model. The CRLP model combines
recent experimental measurements of potassium currents and reformulates the L-
type calcium current by introducing fast and slow voltage-dependent inactivation
gates, similar to the formulation proposed in the TP06 model. That new formu-
lation led to ICaL dynamics that were in good agreement with experimental data
and, more notably, allowed the CRLP model to accurately reproduce S1S2 restitu-
tion and APD90 rate adaptation characteristics. All the modifications were made
with the aim of retaining the advantages that the GPB model has over previous
models, such as the TP06 model, while improving the performance on other electro-
physiological aspects. The novelty of this study was that model development was
not based only on the incorporation of new data from experiments on individual
ionic currents or concentrations. More importantly, the development was driven
by a new paradigm consisting in analyzing the ability of the model to replicate a
set of well-established electrophysiological markers and on a sensitivity analysis of
those markers to variations in model parameters. The proposed model development
framework allows assessing model performance under a variety of conditions, either
physiological or pathological. This provides useful information for the adjustment
of different model parameters that do not directly depend on individual current
measurements or concentrations, and which would be otherwise set in an ad hoc
UniversidadZaragoza
2. A New Paradigm for Electrophysiological Model Development 49
manner.
2.4.1 New model characteristics
The introduction of fast and slow ICaL inactivation gates in the CRLP model led
to a more physiological APD90 rate adaptation response to abrupt changes in CL
as compared to the GPB model. However, by doing so, a larger ICaL current was
obtained for the CRLP model, which led to the reformulation of IK1 and read-
justments of other parameters to keep APD90 within physiological values. The
resulting APD90 value for the CRLP model was closer to the APD90 value of the
TP06 model, without significantly altering the AP triangulation of the GPB model,
which was well within the reported physiological range. The other modifications
introduced into the CRLP model rendered most of the investigated markers to be
within the physiological range or otherwise closer to the physiological range as com-
pared to the GPB and TP06 models. In this regard, only for systolic and diastolic
[Ca2+]i levels at 1 Hz the TP06 model outperformed CRLP. In addition, the CRLP
model showed improved performance with respect to the GPB model regarding the
S1S2 restitution, not only by bringing the maximum S1S2 restitution slope within
the physiological range, but also by providing a shape for the restitution curve in
good agreement with experimental measurements [95].
Even though the model modifications introduced in this work significantly im-
proved the performance of the CRLP model over the GPB model in reproducing
experimental data related to a number of electrophysiological markers, they have
minimally affected the behavior of the model against potassium current blocks. In
this regard, the CRLP model still provides results in very good agreement with
available experimental data regarding AP response to IKr, IKs and IK1 blocks [54].
2.4.2 Simulation of hyperkalemic conditions
Simulations under hyperkalemic conditions showed that APD90 progressively de-
creased with the level of [K+]o, whereas ERP increased after a threshold in [K+]o
was reached ([K+]o  6 mM). CV decreased with hyperkalemia and conduction
was blocked above [K+]o = 10:4 mM. These results suggest that the longer ERP
values and the occurrence of conduction block above [K+]o = 10:4 mM in the
central zone of acutely ischemic tissue could cause areas of conduction block that
could set a substrate for reentrant arrhythmias. Additionally, alternans were ob-
served in ERP and APD90 for [K+]o > 9:8 mM. These results are in agreement
with experimental studies where alternans were observed in the cells of the heart’s
ischemic zone [101, 102]. To the authors’ knowledge, this is the first time that
those observations are reported using a human ventricular AP model. That type
of behavior was not observed in either the TP06 or the GPB models. For the TP06
model, conduction block occurred for [K+]o  15 mM without the occurrence of
alternans [104]. For the GPB model, conduction block occurred for [K+]o  9 mM
and alternans were not observed either.
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2.4.3 Data sources
As described in [61], one of the problems on reutilization of model components in
electrophysiology is the inclusion of components adjusted with data from different
species. For that reason, in this work all model developments were made by using
model components formulated based on human data only [51] or by fitting equa-
tions to additional human data available from the literature [76]. We did not try
modifying other ionic currents or concentrations for which human data was not
available. Regarding the types of human data used in the study, they all corre-
sponded to adult humans, except for the data taken from the study by Pelzmann
et al. [1], in which ICaL was measured in children. Those data were used because the
study clearly showed that there were not significant differences in the ICaL current
characteristics measured in children as compared to adults.
2.4.4 Model limitations
The developed CRLP model has a number of limitations, some of them inherited
from the GPB model on which it was based, and others independent of it. In-
herited from the GPB model is the absence of intracellular potassium dynamics
([K+]i is kept constant in the GPB and CRLP models). [K+]i dynamics play an
important role in modeling hyperkalemic conditions, and is, therefore, a pivotal
element for the accurate computational investigation of ventricular arrhythmias
under such conditions. In addition, phase 1 of the AP shows an atypical behav-
ior for the CRLP model. This may be caused by the Ito current. However, no
attempt to modify this current has been made mainly because new human data
was not available for that purpose. This current happens to be the only one whose
definition differentiates endocardial and epicardial cells in the GPB model and in
the CRLP model as well. In this regard, both models lack a description for the
electrophysiology of midmyocardial cells. Another limitation of the CRLP model
has to do with calcium handling. The results of the analysis conducted in this
study point out the importance that the ICaL current as well as [Ca2+]i dynamics
have over different electrophysiological markers. Many studies have attempted to
provide accurate definitions of [Ca2+]i dynamics in human ventricular cells, but
this is still an area of intensive research. The present study suggests the need for
continuing with the development of more reliable calcium dynamics models that
allow improving the performance of whole cell AP models.
On top of the above described limitations, a comment is in order regarding
the comparison of human ventricular AP models. It is clear that each model has
been developed to reproduce certain electrophysiological behaviors observed from
experimental recordings. Also, considering the huge variability in the experimen-
tal data, model comparison becomes a challenging task for which a model should
never be qualified as being an improvement over another one just because it is able
to reproduce specific experimental observations that the other model is not able
to reproduce. In this study we used the term improvement exclusively to refer to
the fact that, considering the set of investigated electrophysiological markers, the
CRLP model provides a response that is more in line with the averaged experimen-
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tal data used for evaluation purposes. The following chapters attempt to resolve
some of the limitations enumerated above. For this purpose, novel methodologies
have been developed and will be presented accordingly.
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Chapter 3
Improvement of Existing
Electrophysiological
Models
3.1 Introduction
Departing from the CRLP model developed in Chapter 2, this chapter aims at
improving its performance by including a relevant characteristic for investigation
of ventricular arrhythmias arising under conditions of hyperkalemia, one of the
components of myocardial ischemia. Such a characteristic refers to formulation of
intracellular potassium dynamics, which were lacking both in the CRLP model as
well as in the GPB model from which it was built. When potassium dynamics
are incorporated into a model, an imbalance in the potassium currents may be
originated, which may in turn lead to a drift in the intracellular potassium concen-
tration. A way to overcome this is by readjusting model parameters to maintain
potassium homeostasis.
As mentioned in Chapter 1, an AP model is described by a system of cou-
pled differential equations that involve the transmembrane current flow as well
as dynamic changes in intracellular ionic concentrations. For each ionic current
a mathematical formulation is employed to represent characteristics like gating
or permeability of the corresponding ion channels. Those formulations rely on a
number of model parameters whose values are commonly estimated based on exper-
imental data obtained from specific protocols for each ionic current. In this context
parameter estimation presents various shortcomings intrinsic to the voltage-clamp
experimental protocols [105]: i) insufficient separation of ionic current activation
and inactivation processes; ii) use of non-selective pharmacological ion channel
blockers; and iii) measurement of non-physiological solutions.
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Despite these limitations, most parameter values of individual ionic currents
have been identified in the past using independent sets of experiments. However,
parameters describing ionic current conductances have not always been success-
fully characterized from experimental datasets, in large part due to the sensitivity
of some ion channels to the cell isolation procedure performed before application of
the voltage-clamp protocols [106]. Also, experimental studies may have purposely
selected cells with large ionic currents, which interfere with model development
based on such data [47]. For those reasons, a common procedure to identify in-
dividual ionic current conductances is based on model parameter fitting aimed at
reproducing plausible values of electrophysiological AP properties like APD, tri-
angulation or upstroke velocity [15, 46]. Other models include also constraints
based on experimental data measured after blocking certain ionic currents [107],
imposed to obtain a correct input resistance [47] or based on additional properties
like APD rate adaptation and rate dependence of ionic concentrations as proposed
in Chapter 2.
Cardiac electrophysiological computational models are commonly used to ana-
lyze the effect of drugs or to study the mechanisms underlying pathological con-
ditions. Under those circumstances, the correct characterization of ionic current
conductances is crucial. Overestimation or underestimation of current conduc-
tance values could lead to completely erroneous predictions. For this reason, while
for many years the adjustment of current conductances in cardiac computational
models has been frequently performed manually [108], a number of techniques have
been developed in recent years to help in the process of parameter identification.
Gradient descent methods [109, 110] and genetic algorithms [111–114] have been
used for this purpose in several studies. Gradient descent methods rely on com-
puting local gradients of the error function to determine a search direction towards
a minimum. On the other hand, genetic algorithms use ideas from evolutionary
biology and test different combinations (populations) of parameters to optimize
the error function. In each iteration they create a new population based on the
best results from previous iterations.
Gradient descent methods and genetic algorithms have a small degree of par-
allelization and, thus, other techniques with higher parallelization capability could
better exploit the possibilities of current computing infrastructures. In this chap-
ter, a novel methodology is proposed for identification of parameters describing
ionic current conductances of cardiac electrophysiological models by using an opti-
mization algorithm with trust region management [115]. The algorithm minimizes
an objective function subject to non-linear constraints associated with a number
of electrophysiological properties. The objective function and constraints are ap-
proximated by polynomial response surfaces that allow the optimization algorithm
searching for a solution to the problem without performing a direct evaluation of
the model. The use of a response surface helps to reduce the number of iterations
of the algorithm and, thus, reduce the time cost of optimizing the model. To guar-
antee the ability of the model to represent physiological behavior, the region where
the solution is searched for is limited based on experimentally reported values of
electrophysiological properties like APD, AP triangulation, diastolic and systolic
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intracellular calcium concentrations and time constants of APD rate adaptation
to abrupt changes in cycle length (CL). The proposed methodology is applied to
adjust the ionic conductances of the human ventricular CRLP model proposed in
Chapter 2 after incorporation of intracellular potassium, [K+]i, dynamics. The
modified CRLP model is compared against the most commonly used human ven-
tricular AP models, namely the TP06 [51], GPB [15], ORd [64] models as well as
with the CRLP model.
The relevance of accounting for [K+]i dynamics is demonstrated by simulating a
number of transitions in the extracellular potassium concentration, as in hemodial-
ysis studies [116], and comparing the behavior of the original and modified CRLP
models.
3.2 Materials and Methods
3.2.1 Optimization problem
General formulation
A minimization problem with constraints can be written as:
min f(x) (3.1)
subject to
h(x) = 0; (3.2)
g(x)  0; (3.3)
xL  x  xU ; (3.4)
where x is the vector of decision variables, xL and xU their respective lower and
upper bounds, f(x) is the objective function, and h(x) and g(x) are vector functions
of equality and inequality constraints, respectively.
Particularization to ionic conductances estimation
The general minimization problem described in previous section was particularized
in this study for estimation of ionic current conductances. Since different ionic
current conductances Gi may differ by orders of magnitude, the following scaling
was adopted for each of the elements of vector x:
xi = 20  log10Gi
G0i
;
where Gi is the unscaled ionic current conductance and G0i is its initial value in
the model.
The objective function is defined for each particular problem. In this study,
it was represented by the integral of the total potassium current during a cardiac
cycle at 1 Hz steady-state pacing, as fully described in 3.2.2. No equality con-
straint function was defined in this case. The inequality constrain function was
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defined by imposing a number of electrophysiological properties to remain within
experimentally observed ranges:
mLL m(x) mUU (3.5)
where mLL and mUU are the lower and upper bounds delimiting physiological
ranges, respectively, and m(x) is the vector of electrophysiological properties cal-
culated for x.
Eq. 3.5 was reformulated to be consistent with the general formulation of the
inequality constraints described in eq. 3.3:
gj(x) =
mj(x) mj;CRmj;RR
  1  0;
where mj;CR = (mj;UL +mj;LL)/2 is the central point of the experimental range for
the electrophysiological property j and mj;RR = (mj;UL  mj;LL)/2 is the distance
between mj;CR and each of the limits of the experimental range.
Optimization using response surfaces
The optimization algorithm used in this study seeks for a solution of the mini-
mization problem, Eqs. 3.1-3.4, by solving a sequence of approximate constrained
optimization problems within a region of trust. For the iteration k of the algorithm,
the approximate problem reads as:
min ~f(x) (3.6)
subject to
~h(x) = 0; (3.7)
~g(x)  0; (3.8)
kxk  k; (3.9)
where ~f(x), ~h(x) and ~g(x) are response surface approximations (RSA) of f(x),
h(x), and g(x) around xk, respectively, and k is the corresponding trust region
radius. The trust region radius defines a region of trust in which the RSA is
assumed to be reliable. The validity of the RSA can be evaluated through the
trust region ratio test. For the objective function f(x), the trust region ratio for
iteration k was defined as:
k0 =
f(xk)  f(xk;)
~f(xk)  ~f(xk;) ; (3.10)
where xk; is a solution of the minimization problem given by Eqs. 3.6-3.9. This
definition of the trust region ratio is based on the consideration that k0 ! 1 as
the trust region radius k ! 0. If k0  0, the approximation is deemed as
unacceptable and, consequently, the trust region radius is reduced. If k0  1 and
kxk;   xkk = k, the RSA is evaluated as acceptable and k is increased. If
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0 < k0 < 1, k is kept unchanged, but the RSA is rebuilt around xk;. Note that
k0 >> 1 is also indicative of poor RSA and k is reduced, but the optimizer is
considered to be moving in the right direction. The update of the trust region
radius offers significant flexibility depending on the implementation. A particular
updating rule will be presented in the following section.
The algorithm proposed in this work is based on the one described in [115] but
it simplifies some aspects on how to manage and use the response surfaces and
it reduces the number of times the database needs to be generated. Instead of
considering the augmented Lagrangian of the problem, the proposal of this study
is based on generating the response surface of the model and looking for the min-
imum in this surface. Subsequently, this solution is validated by using the trust
region test in both the minimization function and the constraints of the model.
This notably reduces the computational cost, as the database is generated once
per iteration rather than every time there is a change in the parameters of the
augmented Lagrangian.
Database generation and response surface approximation
One of the key elements of the minimization algorithm is building the RSA of
the objective and constraint functions that will be used to solve the approximate
minimization problem. To construct a response surface for a function of n variables,
a large number of sample points are required. Also, to construct a reliable RSA,
the sample points must be adequately distributed. Sampling techniques based on
design of experiments are commonly used for this purpose [117]. In this study,
full factorial designs, which require 3n sampling points, were considered. A full
factorial design consists of a three-level factorial: the corner points of a hypercube,
plus the center of the hypercube and of each facet, plus the midpoints of the lines
connecting the corners of the hypercube. In the next sections, the set of results of
the sampling technique in an iteration of the algorithm for both the minimization
and constraint functions will be referred to as database. Second order polynomial
response surfaces were used in all cases.
Minimization algorithm
The minimization algorithm implemented in this work is shown in Fig. 3.1. The
database was computed only once per iteration of the algorithm or whenever the
solution was rejected and the trust region radius was reduced. The trust region
ratio was used to validate the RSA for the objective function and constraints inde-
pendently.
The basic steps of the algorithm shown in Fig. 3.1 are briefly described in the
following. The index k indicates the iteration of the algorithm, i indicates the
variable index and j represents the constraint index.
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Figure 3.1: Flow chart of the proposed algorithm.
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Step 0: Initialization
Define values for the tolerances 1 (solution tolerance), 2 (gradient tolerance) and
3 (improvement tolerance), the minimum acceptable value L for the trust region
ratio to consider a trust region as acceptable and an upper limit max for the
trust region radius. Define an initial value 0 for the size of the trust region and
a starting point x0 for the variables of the problem. Set the iteration counter at
k = 0.
Step 1: Database generation
Compute the database as described in section 3.2.1.
Step 2: Response surfaces
Build the RSA of the objective function and constraints of the problem around the
current iterate xk.
Step 3: Find the minimum of the approximate problem
Find the minimum xk; of the constrained minimization problem defined by Eqs. 3.4-
3.9 in the trust region limited by k.
Step 4: Trust region test
Evaluate f and each of the properties mi in xk; and calculate the trust region
ratio for the objective and constraint functions as in Eq. 3.10.
k0 =
f(xk;)  f(xk)ef(xk;)  ef(xk)
kj =
mj(xk;) mj(xk)emj(xk;)  emj(xk) ; 1  j M:
The solution xk; was accepted when k0 > 0 and one of the following two criteria
was met: i) the constraints in g(x) were feasible or; ii) jkj   1j  L;8j. For this
work, L = 0:25 was used. If the solution was accepted, the flag flgkTR = true was
set and xk+1 := xk;, otherwise flgkTR = false and xk+1 := xk.
Step 5: Trust region radius update
The trust region radius was updated as follows:
k+1 =
8<: 0:25
k if flgkTR = false;
k if flgkTR = true and kxk;   xkk < k;
2k if flgkTR = true and kxk;   xkk = k:
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Step 6: Algorithm termination
The algorithm ended if one of the following conditions was satisfied:
1. kxk+1   xkk < 1 and flgkTR = true: The distance between the last two
accepted iterates was too small to be significant.
2. kr(xk+1)j < 2 and flgkTR = true: The gradient of the Lagrangian function
was too small. The Lagrangian function was defined as:
(x) = f(x) +
MX
j=1
kj mj(x)
where kj are the Lagrange multipliers obtained in the constrained minimiza-
tion problem defined by Eqs. 3.4-3.9 in the trust region (limited by k) in
Step 3.
3. k+1 < 3: The trust region radius became too small.
If none of these criteria was satisfied, then set k := k + 1 and go to step 1.
3.2.2 Upgrade of the CRLP model
[K+]i dynamics in the CRLP model
One of the differences between the CRLP model and the ORd and TP06 models
lies in the representation of [K+]i dynamics. As mentioned above, in the CRLP
model, as well as in the GPB model, [K+]i was assumed to be constant. Under
steady-state conditions, [K+]i variations during an AP can be neglected. Never-
theless, when there is a change in the investigated conditions or if the model is
somewhat altered, [K+]i may reach a new steady-state value. This is the case,
for instance, when the stimulation frequency is varied, as [K+]i becomes reduced
in response to increased stimulation frequency [64, 118]. Another scenario where
[K+]i dynamics are relevant is in the simulation of acute ischemia. Dutta et al.
showed the limitations of using the GPB model with constant [K+]i [119]. In the
present chapter, the methodology described in section 3.2.1 was used to incorpo-
rate [K+]i dynamics into the CRLP model while retaining its capacity to reproduce
experimentally observed values of arrhythmic risk-related markers.
[K+]i dynamics were introduced through the following equation:
d
dt
[K+]i =  IKtot 
Cmem
Vmyo  Frdy (3.11)
where IKtot is the total potassium current, Cmem is the membrane specific capaci-
tance, Vmyo is the bulk cytosol volume and Frdy is Faraday’s constant.
IKtot was calculated as the sum of all potassium currents and the stimulus cur-
rent:
IKtot = Ito + IKr + IKs + IK1   2  INaK + ICaK + IKp + Istim (3.12)
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Figure 3.2: Temporal evolution of [K+]i in CRLP and GPB epicardiacl cell
models after introducing [K+]i dynamics: a) and c) show [K+]i evolution when
the models (CRLP and GPB, respectively) are stimulated with a CL of 1000 ms.
b) and d) show the evolution of the integral of IKtot during one cycle for the same
simulation as in a) and c).
where Ito is the transient outward potassium current, IKr is the rapidly activating
potassium current, IKs is the slowly activating potassium current, IK1 is the inward
rectifier potassium current, INaK is the sodium-potassium pump current, ICaK is the
current generate by potassium ions passing through the L-type calcium channels,
IKp is the plateau potassium current, and Istim is the stimulus current.
If Eq. 3.11 is directly added to the CRLP and GPB models, [K+]i drifts
(Fig. 3.2, panels a) and c), respectively). The continuous increase in [K+]i is due
to a larger potassium influx in each cardiac beat, which can in turn be explained
by an imbalance in the potassium current. Although it is not straightforward to
establish a physiological range for [K+]i because there are no experimental mea-
surements of this concentration, all human ventricular cell models published in
the literature, despite having different [K+]i values under steady-state conditions,
they all lie within the range 120-145 mM. This range is in agreement with the
corresponding experimentally reported values for the resting membrane potential,
which is close to the Nernst potential for potassium [64].
JesúsCarro
62 New Methodologies for the Developmentand Validation of Electrophysiological Models
In Fig. 3.2, panels b) and d), the integral of the total potassium current during
one cardiac cycle is shown, which gives an idea of how far the models are from equi-
librium. The above noted issue associated with the introduction of [K+]i dynamics
into the CRLP model can be sorted out by readjusting the current conductances to
maintain [K+]i homeostasis. Since, at the same time, the performance of the model
in terms of representation of electrophysiological behavior wants to be retained, a
constrained optimization problem was formulated in this study. This problem was
tackled by applying the response surface-based optimization methods presented in
3.2.1.
For further model assessment, optimization was performed as described in the
next paragraph while considering different initial [K+]i values in the range 120-145
mM.
Optimization-driven model parameter update
A new set of current conductances for the modified CRLP model was sought such
that potassium homeostasis was preserved while a number of electrophysiological
properties were guaranteed to remain within experimental limits. This was stated
as a constrained optimization problem of the form:
min
Z
<CL>
IKtot(x)
2
(3.13)
subject to
mLL m(x) mUU ; (3.14)
xL  x  xU ; (3.15)
where x is the vector of scaled current conductances (see 3.2.1), with lower an
upper bounds xL and xU , respectively, R
<CL>
represents the integral during a
cardiac cycle and m is a vector function of selected electrophysiological properties
with lower and upper physiological bounds defined by vectors mLL and mUU .
Initialization was defined based on the epicardial CRLP model (where [K+]i takes
a constant value of 138 mM). Other initializations were additionally tested, as
described in 3.2.2.
Constraint functions
Seven ventricular electrophysiological properties of epicardial cells were considered
for definition of inequality constraints in 3.2.2:
 APD90: APD is considered the main preclinical marker of drug cardiotoxi-
city. APD prolongation has been linked to long QT syndrome and increased
risk of developing Torsades de Pointes [77, 78]. In this study, APD90 was
used to denote AP duration at 90% repolarization.
 Triangulation: This marker quantifies the shape of the final part of the
AP and is defined as the difference between APD at 90% and 50% of repo-
larization. Low triangulation values indicate square APs, while high values
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indicate triangular APs. Triangulation has been proposed as a marker of pro-
arrhythmia [77], with long APD90 values without triangular APs considered
as anti-arrhythmic and with triangular APs considered as pro-arrhythmic in
general.
 Systolic and diastolic intracellular calcium ([Ca2+]i) levels: Calcium
transient properties evaluated at different pacing frequencies have been re-
ported as arrhythmic risk markers [79, 80]. In this study, diastolic (resting
level) and systolic (peak value) calcium transient levels were evaluated at 0.5
Hz and 1 Hz steady-state pacing.
 Time constants of APD90 adaptation to abrupt changes in CL: Adap-
tation of ventricular repolarization duration to abrupt changes in CL has been
proposed as an arrhythmic risk marker [81]. In this study, the dynamics of
APD90 adaptation to abrupt changes in CL were fitted by two exponentials
with associated time constants fast and slow, following the methodology
proposed in Pueyo et al. [13]. Only slow has been considered since there is
no available quantitative experimental data on fast values.
Two stimulation protocols were used to calculate the above described markers:
 Steady-state protocol: A train of 3,000 stimulation pulses was delivered
at a given CL. Simulations were carried out using two different CL values:
1,000 and 2,000 ms. The evaluated markers were: APD90 and triangulation
at 1,000 ms; and diastolic and systolic [Ca2+]i at 1,000 and 2,000 ms.
 Abrupt changes in CL protocol: The cell was stimulated with a CL
of 1,000 ms for 8 minutes and then with a CL of 600 ms for additional 8
minutes. APD90 dynamics after the abrupt CL change were best fitted by
two exponentials, the second of which was characterized by slow.
Physiological bounds for constraint functions
Lower and upper bounds mLL and mUU were defined according to physiological
experimental values reported in the literature for the analyzed properties. The
selected range for APD90 was 280-310 ms. Even though some studies have reported
wider ranges, up to 271-366 ms [2, 8, 96], a restricted interval was used to keep
the model within the same range of existing human ventricular cell models [15, 46,
51, 64, 120]. The range for triangulation was 44-112 ms [2, 96]. For the diastolic
and systolic [Ca2+]i levels at 1 Hz and 0.5 Hz stimulation, the CRLP model, as
occurs with other recent human ventricular AP models (GPB, ORd, TP06, TP04)
[12, 15, 46, 51, 64, 120, 121], is out of the physiological range reported in the
literature [10, 97]. For that reason, the physiological range was extended to ensure
a feasible solution of the optimization problem. Nevertheless, the optimal solution
was evaluated to confirm that either it let the model lie within physiological range
or at least improved the results of the CRLP model. The physiological range for
slow was set to 70-110 s [95]. Table 3.1 summarizes the evaluated markers and
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Physiol.
Range
Selected
Range
CRLP
Model
This
work
APD90 (ms) 271-366 280-310 305.6 280.9
Triangulation (ms) 44-112 44-112 78 84.6
Sys. [Ca2+]i 1Hz (M) 1.59-2.01 0.602-2.01 0.602 0.701
Sys. [Ca2+]i 0.5Hz (M) 0.71-1.68 0.523-1.68 0.523 0.664
Dia. [Ca2+]i 1Hz (M) 0.20-0.33 0.097-0.33 0.097 0.100
Dia. [Ca2+]i 0.5Hz (M) 0.14-0.32 0.091-0.32 0.091 0.096
slow (s) 70-110 70-110 105.6 106.0R
CL
IKtot  dt (mspA/pF) -28.52 -3.910 9
Table 3.1: Electrophysiological markers evaluated in the proposed response sur-
face approximation-based optimization.
their physiological ranges in the second column, whereas the third column indicates
the lower and upper bounds used for the optimization.
Sensitivity Analysis
Prior to solving the minimization problem, a sensitivity analysis was performed on
the CRLP model following the methodology described by Romero et al.[12]. The
aim was to identify the conductances that most notably influenced the objective
function (the integral of the total potassium current) and the constraints (elec-
trophysiological properties) in order to define the set of decision variables for the
optimization.
For the sensitivity analysis, the conductances were varied by 30% one at a
time. Fourteen conductances were considered in the sensitivity analysis, namely:
Gto, the maximal conductance of the transient outward potassium current; GKs,
the maximal conductance of the slowly activating potassium current; GpCa, the
maximal conductance of the sarcolemmal calcium pump; GKr, the maximal conduc-
tance of the rapidly activating potassium current; GKp, the maximal conductance
of the plateau potassium current; GNaK , the maximal activity of the Na-K pump;
Gncx, the maximal activity of the Na-Ca exchanger; GCaL, the maximal conduc-
tance of the L-Type calcium current; GK1, the maximal conductance of the inward
rectifier potassium current; GNa, the maximal conductance of the fast sodium cur-
rent; GClCa, the maximal conductance of the calcium-activated chloride current;
GNa;Bk, the maximal conductance of the background sodium current; GCl,bk, the
maximal conductance of the background chloride current; and GCa,bk, the maximal
conductance of the background calcium current.
For each property m and conductance p, the percentage of change (Dm;p;a) and
sensitivity (Sm;p;a) were calculated as follows [12]:
Dm;p;a =
Mp;a  Mcontrol
Mcontrol
 100;
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Sm;p;a =
Dm;p;a  Dm;p; a
2  a  100;
where Mp;a is the value of property m when the conductance p is varied by the
percentage a and Mcontrol is the value of property m under control conditions. As
shown above, sensitivity (Sm;p;a) is calculated as the ratio of the difference between
the percentage of change (Dm;p;a  Dm;p; a) and the interval of change (2  a). In
particular, for this study a = 30%:
Sm;p;0:3 =
Dm;p;0:3  Dm;p; 0:3
2  0:3  100 =
Mp;0:3  Mp; 0:3
Mcontrol
 10
5
6
Sensitivity was calculated for each of the electrophysiological markers described
in section 3.2.2 and for the integral of the total potassium current (IKtot) during
one cardiac cycle at 1 Hz steady-state pacing.
Model Comparison
Considering the difficulty of directly comparing the absolute value of each con-
ductance for different computational models, due to the dependence on the whole
current formulation, ionic current traces calculated during a cardiac cycle at 1 Hz
steady-state pacing were compared for the CRLP, TP06, GPB and ORd models.
The comparisons aimed at verifying that the modified CRLP model had current
densities of similar magnitude and ionic currents of similar shapes as calculated
with other published models.
3.2.3 Frequency-dependence behavior
Pacing at different frequencies was simulated to assess whether the modified CRLP
model retained the frequency-dependence behavior of the original CRLP model. To
this end, APD90 was calculated at steady-state for CLs ranging from 250 to 5000
ms (in each case computed after pacing for 3,000 cycles).
3.2.4 Simulation of changes in potassium concentration
Hypokalemic and hyperkalemic conditions were simulated with the original and
the modified CRLP models. Two types of simulations were performed to compare
the models with the experimental results.
First, the effect of changing [K+]o was assessed when the cell was not stimu-
lated to compare with the experimental results described in [122]. Subsquently,
and following the experiments performed in [116], the extracellular potassium con-
centration, [K+]o, was increased from 2 mM to 7 mM in 0.5 mM steps using
a homogeneous 4-cm long fiber composed of epicardial cells. The physiological
[K+]o value of 5.4 mM replaced the value of 5.5 mM in the simulations [116]. The
conductivity , defining the velocity of the stimulus propagation, was set to render
a Conduction Velocity (CV) close to 65 cm/s under control conditions [88]. The
cell capacitance was set to Cm = 1 F/cm2. For each [K+]o value, the model was
first stabilized (without stimulation) until the product of the gates hj reached 99%
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of the steady-state value hss  jss, which was subsequently followed by 1 Hz pacing
simulation. Stimulus current pulses twice the diastolic threshold were applied at
one end of the cable. The diastolic threshold was defined as the minimum ampli-
tude required for propagating five pulses along the fiber. The model was studied
by stimulating the tissue with a train of 100 basic stimulations (S1) delivered at a
CL of 1,000 ms. [K+]i was measured at the end of each stimulus at five different
positions along the cable situated at distances from the origin of 1.5, 1.75, 2, 2.25
and 2.5 cm. The average value over the five locations was calculated.
3.2.5 Implementation
The CRLP model was implemented in Matlab based on the original CellML file
[120]. The code used to compute the simulations and to calculate the different
markers is freely available at https://github.com/ChusCarro/MatCardiacMLab/
releases/tag/0.1.0.
The minimization algorithm was implemented in Matlab. For 1D tissue simu-
lations, a semi-implicit operator-splitting scheme implemented in Fortran was used
to solve the propagation [87] with a space discretization of x = 0:1 mm and a
time discretization of t = 0:002 ms, as in [120].
All computations were performed by using the high performance computing
cluster (ICTS) “NANBIOSIS”. Details about the cluster can be found at: http:
//www.nanbiosis.es/u27-e1-hermes-cluster
3.3 Results
3.3.1 Sensitivity Analysis
Results of the sensitivity analysis applied to the epicardial version of the CRLP
model are shown in Figure 3.3. The value of the integral of the total potassium
current, IKtot , in one cardiac cycle was highly dependent on the conductance of
the background chloride current, GCl,bk, and the L-type calcium current, GCaL (S30
values of -412.62% and 396.83%, respectively). Other currents were also found to
play an important role in regulating potassium homeostasis: GNaK , 199.46%; GK1,
-152.06%; Gto, -110.57%; GKr, -81.16%; and Gncx 62.72%. The currents with the
largest effect on the APD were found to be the same as for the objective function,
although the sensitivities were notably reduced: GCl,bk, -48.56%; and GCaL, 33.41%.
Triangulation was mainly modulated by: GK1, -57.7664%; and GKr, -20.1113%.
Diastolic and systolic [Ca2+]i values were mostly influenced by GCaL (27.65% and
171.71%, respectively). These markers were also influenced by changes in the
following conductances: GNaK (-16.08%, -78.62%), Gncx (-15.74%, -74.48%), GCl,bk
(-14.53%, -80.66%) and GCa,bk (11.51%, 47.46%). Regarding slow, GNaK was the
conductance with the largest effect on this marker (-128.37%), with the remaining
conductances not playing a significant role.
Based on these results, five conductances were selected as decision variables for
the minimization problem described in 3.2.2, namely: GCl,bk, GCaL, Gncx, GK1, and
Gto. Of note, GNaK was discarded because any modification on this conductance
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Figure 3.3: Results of the sensitivity analysis applied to the original CRLP model.
The blue scale indicates relative sensitivity for each marker. White color indicates
maximum relative sensitivity and dark blue color indicates that property and pa-
rameter are independent. Percentages in the white boxes indicate the absolute
sensitivity of the property. A minus sign in a box indicates that marker and model
parameter vary inversely. ‘Trian’ stands for Triangulation, ‘Sys’ stands for systolic
and ‘Dia’ stands for diastolic.
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significantly influenced slow, with this effect not being counterbalanced by changes
in any other conductance (see Figure 3.3).
3.3.2 Non-linear optimization
The optimization algorithm found a minimum after four iterations. Variations in
the updated current conductances with respect to their initial values were: GCl,bk,
+19.34%; GCaL, +3.93%; Gncx, -33.25%; GK1, -14.08%; and Gto, +22.35%.
With this new set of conductance values, and after introducing [K+]i dynamics
in the model, [K+]i stabilized at 138 mM. The value of the electrophysiological
markers are described in table 3.1. All markers were within physiological ranges or
closer than with the original CRLP model (last column in table 3.1).
When the model was optimized while considering different initial [K+]i values
in the range 120-145 mM, results were practically coincident with those reported
above for [K+]i initialized at 138 mM. At steady-state, [K+]i reached a value of
138 mM as well, differences in the values of the markers where below 1% and the
maximum difference between optimal conductances was lower than 2.5%. In this
case, the algorithm required six iterations rather than four to reach the optimal
solution.
3.3.3 Model Comparison
To evaluate the impact of the new values for the estimated ionic conductances in
the modified CRLP model, the AP and the associated ionic currents (ICaL, IK1,
Incx, ICl,bk and Ito) were compared with the equivalent properties in the original
CRLP model and in other human ventricular cell models. The results are shown
in Fig. 3.4. Other currents that were not considered for the optimization but that
could be altered as well, like IKr, IKs and IKp, are shown in Fig. 3.5.
The main differences in the AP between the original and modified CRLP models
were a decrease in the membrane potential during the plateau phase as well as
shortening of the APD. There were small differences in the peak value of some
currents, but in all cases the modified CRLP model was within the range of the
other models or within experimentally reported bounds. ICaL peak was larger in the
modified model with respect to the GPB model and the original CRLP model, but
smaller than in the TP06 model. IK1 peak was slightly smaller in the modified model
with respect to the original CRLP model, which had the smallest peak value among
all ventricular models, but in any case within the range reported experimentally
(0.4-1.8 pA/pF[76, 96]).
An important finding was that, while Gncx and GCl,bk in the modified CRLP
model were significantly different from those in the original CRLP model (-33.25%
and +19.34% respectively), the effects in terms of ionic current traces led to both
Incx and ICl,bk not being notably different from those in the original CRLP model.
The IKp current remained as in the original model, while IKs was different but took
really small values in both cases. IKr was diminished in amplitude by 32.6% and
its integral during a cycle was reduced by 30% with respect to the CRLP model.
The extent of APD prolongation following blockade of this current was 10% for the
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Figure 3.4: Model comparison. Blue lines represent the results of this work
with inclusion of [K+]i dynamics, green lines represent the CRLP model, red lines
represent the GPB model, cyan lines represent the TP06 model and purple lines
represent the ORd model. All the figures show results at steady-state (after pacing
for 3,000 cycles at a CL of 1000 ms). a) Action potential; b) Intracellular potassium
concentration; c) Sodium-calcium exchanger Current; d) L-type calcium current; e)
Inward potassium current; f) Transient outward potassium current; and g) Back-
ground chloride Current.
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Figure 3.5: Model comparison. The colors in this figure are the same as those
used in Fig.3.4. Results are shown at steady-state (after pacing for 3,000 cycles at
a CL of 1000 ms). The graphics on the right are zoomed versions of the graphics
on the left. a) Rapid delayed rectifier potassium current; b) Slow delayed rectifier
potassium current; and c) Plateau potassium current.
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Figure 3.6: Steady-state APD90 values as a function of pacing CL.
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Figure 3.7: Results for an unstimulated cell simulated with the modified CRLP
model following changes in [K+]o. a) Temporal evolution of membrane potential;
b) Time to achieve 90% of the steady-state membrane potential (t90%).
modified CRLP model, as compared to 14% for the original CRLP model, being
both values within experimentally defined limits [54].
3.3.4 Frequency response
Fig. 3.6 shows steady-state normalized APD90 values calculated with the original
and modified CRLP models. Normalization was performed with respect to the
APD90 value for CL=1000 ms. Both models presented very similar behaviors,
with the only relevant difference being observed for CL=250 ms. For this CL, the
modified CRLP model showed alternans, while the original CRLP model did not.
3.3.5 Response to changes in extracellular potassium
Fig. 3.7a shows the temporal evolution of membrane potential following changes in
[K+]o for an unstimulated cell simulated with the modified CRLP model. During
the first 100 ms, membrane potential varied following the corresponding change
in [K+]o, in line with the results reported in [122]. Figure 3.7b shows the time
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Figure 3.8: [K+]i evolution following [K+]o changes simulated with the modified
CRLP model. a) [K+]i dependence on [K+]o at different time instants; b) time
course of [K+]i for different [K+]o values.
needed to reach 90% of the steady-state membrane potential (t90%). The value for
t90% in the simulation for the same change in [K+]o than in [122] (from 4.4 mM to
6.6 mM) was 16.2 ms, which is somewhat faster than the experimentally reported
results in [122] for rabbit (80 ms) and rat (147 ms) ventricular myocytes.
Fig. 3.8a shows a snapshot of [K+]i values calculated with the modified CRLP
model at different times following changes in [K+]o as described in 3.2.4. Fig. 3.8b
shows the temporal evolution of [K+]i in response to changes in [K+]o. Under con-
trol conditions, [K+]i remained constant in time. As expected, following simulated
hyperkalemia ([K+]o > 5:4 mM), [K+]i increased as [K+]o increased, whereas
for simulated hypokalemia ([K+]o < 5:4 mM), [K+]i decreased in response to
[K+]o decreases. For [K+]o  2:0 mM , tissue became inexcitable. In table 3.2,
the steady-state value of [K+]i in the optimized CRLP model is shown for each
simulated [K+]o value.
3.3.6 Computational Cost
Each iteration of the optimization algorithm involved computations associated with
a number of stimulation protocols. In Table 3.3, a summary of the computational
cost is shown for each of the protocols. In each iteration, the protocols were run
twice: one for the generation of the database (243 simulations in parallel) and
another one for the evaluation of the solution (6 simulations in parallel). The
variance in the computation times is due to the fact that computations were run in
different nodes of a high performance computing cluster, namely the one described
in section 3.2.5. The four iterations of the optimization algorithm were computed
in 23 hours and 16 minutes.
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[K+]o (mM) [K+]i (mM)
2.5 73.5
3.0 84.8
3.5 95.8
4.0 107.2
4.5 118.3
5.0 129.3
5.4 138.0
6.0 151.4
6.5 161.6
7.0 172.5
Table 3.2: Steady-state values of [K+]i for different [K+]o values as calculated
with the optimized CRLP model.
Protocol Mean STD Max
Steady-state CL = 1000 ms 01:31:45 00:41:31 02:29:31
Steady-state CL = 2000 ms 02:35:38 01:03:47 03:41:11
APD Rate Adaptation 00:28:36 00:14:17 00:53:57
Table 3.3: Computational cost of the different protocols used for the optimization.
3.4 Discussion
In this chapter a mathematical framework to adjust ionic current conductances of
cardiac AP models by using response surface approximation-based optimization is
proposed. The framework has been applied to update the CRLP human ventric-
ular AP model, described in Chapter 1, by incorporating [K+]i dynamics. Such
incorporation involves readjustment of ionic current conductances to avoid drifting
in intracellular potassium. While adjusting for current conductances, a number of
electrophysiological properties are required to remain within available experimental
ranges by properly defining constraints to the optimization problem that is being
solved. The proposed framework can be easily extended to solve other problems
frequently arising when developing cardiac computational models, for instance re-
lated to the update of existing models to reproduce the response to pharmacological
ion channel inhibitions on top of baseline conditions. In the following subsections,
the main aspects of the proposed methodology and the results obtained in this
work are discussed.
3.4.1 Response surface optimization
The use of response surfaces to minimize an objective function subject to a number
of constraints, as proposed in this chapter, allows reaching a solution to the pro-
posed problem in a small number of iterations, thus reducing the computational
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cost with respect to other previously published approaches. In [115], Rodriguez
et al. proposed an algorithm that uses augmented Lagrangian techniques and
relies on successively building RSA of the augmented Lagrangian to solve a mini-
mization problem like that defined by Eqs. 3.1-3.4. In this chapter, the trust region
ratio was used to independently validate the RSA for the objective function and the
constraints instead of considering the augmented Lagrangian of the problem. Our
proposal led to a reduction in the number of times the database was generated and,
thus, simplified the implementation. The model that is optimized in the present
work is much more complex than those used in [115], but the number of times the
database was generated was smaller than in all the cases described in [115].
Also, differently to other optimization algorithms based on e.g. Genetic Algo-
rithms [112, 114], the response surface approach proposed in this chapter guaran-
tees the convergence to a local minimum of the problem when the response surfaces
are built such that they match the objective function up to the first order around
the point where the approximation is built. In addition, our response surface ap-
proach allows identifying a potential minimum anywhere within the trust region,
not necessarily contained in the database.
Finally, in this chapter the proposed optimization algorithm was used to solve a
problem where a new characteristic was added to a human ventricular cell model,
the CRLP model, while a number of electrophysiological markers were guaranteed
to remain within physiological range or closer to it than with the original CRLP
model. In other studies, like [123], the aim of the analysis is similar, but, as opposed
to the present study, the objective function is defined to include multiple electro-
physiological properties, for some of which a physiological range may be available
while for others it may not, rather than considering the electrophsyiological proper-
ties as elements to define the constraints imposed in the optimization. In any case,
the same response surface approximation-based optimization algorithm employed
in the present study could be applied to the problem defined in [123].
3.4.2 Database generation
The size of the database depends on the selected sampling technique. In this
chapter a three-level full factorial design was used for sampling, which involved
3N sample points, with N the number of variables to be adjusted (five in this
study). However, the proposed optimization framework is independent of the sam-
pling strategy or the size of the database as long as the database provides enough
information to fit the response surface. For instance, increasing the factorial num-
ber from 3 to 5 (the database size increased from 35 = 243 to 55 = 3125 sample
points) only reduced the total number of iterations from 4 to 3, without changing
the identified optimum. However, the computational cost increased tenfold.
The advantage of using factorial designs is that they provide unbiased informa-
tion for parameter identification with polynomial RSAs since they provide optimal
space filling [117]. However, other sampling strategies are also possible. Monte
Carlo simulations represent a very flexible sampling strategy where the optimal
number of sampling points can be defined in terms of the type of RSA to be used.
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In this regard, Monte Carlo simulations were used in [124] to perform sensitivity
analysis in electrophysiological models by means of linear multivariate regression.
In addition to generating the required data for model fitting, Monte Carlo simula-
tions were also used to perform population-based simulation studies, as in Wamsley
et al. [125].
In this chapter, the full factorial technique was implemented in order to guar-
antee that the algorithm was not limited by the sampling technique since the
generated database is sufficient to build a second order response surface. However,
as mentioned above, other techniques could be tested to reduce the computational
cost when a larger number of current conductances are involved or when large
parallel computing capacity is not available.
3.4.3 Computational cost
The major benefit of the methodology proposed in this chapter in terms of com-
putational cost is the high degree of parallelization. It should be noted that the
global computation time depends mainly on two factors: the employed cell model
and the stimulation protocols that are performed. As compared to the CRLP or
GPB models, which take long computation times, the computational time for a
model like TP06 could be reduced to just a few hours. For the computations of
this study a high performance computing cluster was used. The number of simula-
tions involved per iteration makes it possible to use other types of infrastructures
such as GPUs.
Nevertheless, the computation times associated with the presented methodology
based on response surface approximations are short if compared with those for the
same optimization solved by using a genetic algorithm, which could require around
100 generations and would cost more than 350 hours, even if all individuals in the
population were simulated in parallel. In [112], 500 generations were needed to fit
the model, which would still involve longer computation times.
3.4.4 Definition of the optimization problem
In this chapter, the integral of the total potassium current (IKtot) during one cardiac
cycle was selected as the objective function for minimization. This selection was
made to maintain [K+]i homeostasis after incorporation of [K+]i dynamics into
the CRLP human ventricular model. Optimal current conductances were identi-
fied, with additional constraints imposed to guarantee that fundamental electro-
physiological properties took values within experimental limits. For some of those
properties the physiological range reported in experimental studies of the literature
is extremely large. To avoid a solution for the modified CRLP model that, although
in physiological range, was very far from the average experimental behavior, the
range of allowed APD values was somewhat restricted, as described in 3.2.2.
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3.4.5 Model comparison
The adjusted CRLP model developed in this study was compared with previous
human ventricular AP models published in the literature, namely the CRLP, GPB,
TP06 and ORd models. This comparison was made in terms of AP traces, [K+]i
concentrations and ICaL, IK1, Incx, ICl,bk and Ito currents. In practically all cases,
the results obtained for the adjusted CRLP model were along the lines of those
obtained with the other models. The only current that was found to be smaller for
the modified CRLP model as compared to the other models, including the original
CRLP model, was IKr. This reduced current led to shorter APD prolongation
following IKr blockade, but still within experimentally reported limits. Specifically,
in [54] an average APD prolongation of 56.3% with a standard deviation of 34.6%
was reported. The difference between the mean experimental prolongation and
that obtained for the modified CRLP model was within twice the experimental
standard deviation.
One of the differences between the GPB / CRLP models and the other human
ventricular models is the inclusion of the ICl,bk current. This current was expected to
have a minor role in modulating electrophysiological properties, but, as reported in
[121], APD showed the highest sensitivity (-86%) to changes in the maximal ionic
conductance of the ICl,bk current. In the CRLP model, this sensitivity was reduced
(-46%) but it was still large. As there is similarity between the sensitivities of
the APD and the integral of the total potassium current to variations in ionic
conductances (see Figure 3.3), the ICl,bk current ended up having a very important
indirect role in modulating potassium balance.
As shown in the presented results, major differences between the modified and
the original CRLP models include APD shortening and decrease in the membrane
potential during the plateau phase. Regarding the latter, experimental results [126]
show that the plateau voltage takes values around 18 mV, while in the modified
CRLP model the plateau voltage is 8 mV. Differences in Incx and ICl,bk, even if not
large, could still underlie those major deviations of the modified CRLP model with
respect to the original one. Future studies could include the membrane potential
during the plateau phase as an electrophysiological marker to be included in the
optimization algorithm for model refinement. This could definitely have an impact
on balancing the currents involved in this phase of the AP.
Our results demonstrate that with the proposed methodology it was possible
to successfully update the CRLP model by incorporating [K+]i dynamics while
keeping the model’s ability to reproduce risk-related markers for investigation of
cardiac arrhythmias. As described in Table 3.1, the evaluated risk markers remain
within experimental limits or are closer to their physiological values than with the
original CRLP model.
3.4.6 Response to potassium concentration changes
While for some investigations the assumption of constant [K+]i may be valid,
there are many situations where [K+]i varies, for instance following changes in the
frequency of stimulation or in [K+]o values. As shown in 3.2.2, the assumption of
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constant [K+]i may also hide an imbalance between potassium currents and [K+]i,
as the latter is not allowed to change.
Simulation results obtained when varying the level of [K+]o allowed confirming
that both the incorporation of [K+]i dynamics and the use of the optimization algo-
rithm to readjust the ionic conductances improved the CRLP model for simulation
of abnormal conditions (see section 3.3.5). Although there are no experimental
measurements of [K+]i, the model can be assessed by using measurements that
indirectly validate its behavior. On the one hand, the model is able to reproduce
behaviors similar to those of the experimental results presented in [122]. On the
other hand, the inclusion of [K+]i dynamics make it possible to evaluate variations
in [K+]i in response to [K+]o changes like those reported in hemodialysis scenarios
[116]. In this latter case, simulated [K+]i variations were in the expected direction
as to compensate for the effects of changing [K+]o.
When [K+]o increases, there is an increase in the Nernst potential for potas-
sium and, thus, a reduction in the driving force of potassium, which diminishes
the amount of potassium leaving the cell. Additionally, an increase in [K+]o al-
ters the current through the sodium-potassium pump. Both effects contribute to
increase [K+]i, which leads to a reduction in the Nernst potential for potassium,
thus returning the cell to an equilibrium state.
3.5 Conclusions
The optimization framework proposed in this chapter allows estimating ionic cur-
rent conductances of AP models at an affordable computational cost while guar-
anteeing physiologically plausible values of selected electrophysiological properties.
This framework has been applied to introduce [K+]i dynamics into the CRLP
human ventricular AP model developed in Chapter 1. Solving the formulated
optimization problem avoids the imbalance generated in the CRLP model after
introducing [K+]i dynamics, without deteriorating the performance of the model
in terms of representation of electrophysiological behavior and arrhythmic risk-
related properties. The updated CRLP model built in this chapter is thus suitable
for investigation of cardiac arrhythmias, particularly under conditions involving
large changes in [K+]i.
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Chapter 4
Limitations in
Electrophysiological
Model Development
and Validation
4.1 Introduction
Chapter 2 and chapter 3 deal with methodologies for the development and update
of electrophysiological models. Importantly, methodologies are also required for
validation of new or updated model formulations based on available experimental
data. Any methodology proposed for such purpose should consider all variables
and spatio-temporal scales involved in the corresponding modeling and simulation.
This becomes a challenging task, particularly for complex biophysically detailed
models. From the earliest mathematical model of an electrical cell’s action poten-
tial (AP) developed by Hodgkin and Huxley in the fifties, the complexity of current
AP models has grown considerably. The advent of new experimental techniques
has made large sets of experimental data readily available, which has motivated
the development of more complex models to accurately describe cellular electri-
cal activity. Whereas growing in model complexity is a natural consequence of
the increased knowledge [127], the more complex the model, the more difficult the
identification of model parameters tends to be. An AP model involves the sum of
different transmembrane ionic currents and the balance between intra- and extra-
cellular ionic concentrations. Each ionic current follows a mathematical formulation
in which several effects are modeled, e.g., ion channel activation and inactivation
gating or current conductance. For each effect, a number of model parameters are
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identified based on data from experimental protocols specific for each particular
ionic current.
The experimental protocols used to obtain most of the parameters of each ionic
current are performed in isolated cells. But, due to the sensitivity of some ionic
channels to the cell isolation procedure applied prior to voltage-clamp experiments
[106], the conductances of the ionic currents in cardiac models are often not esti-
mated from direct measurements of the current density. Instead, individual chan-
nel conductances are adjusted so that measures from model-generated APs closely
match experimental AP measurements in tissue such as AP duration (APD) or
others. In the Courtemanche-Ramirez-Nattel (CRN) model [47], the ionic conduc-
tances GNa, GK1, Gto, GKr and GKs were fitted to obtain a correct input resistance,
AP morphology, AP amplitude (APA) and upstroke velocity (dV /dtmax). In a late
version of the Luo-Rudy (LR) model [107], GKs was fitted to get the right APD
prolongation when the IKs current was blocked. Taking those models as an exam-
ple, in the tenTusscher-Noble-Noble-Panfilov (TNNP04) model [46], GKs was set
to obtain physiologically plausible APD values for each cell type (epicardial, mid-
myocardial and endocardial). In the Grandi-Pasqualini-Bers (GPB) model [15],
GNa was set so as to reproduce experimental measurements of APA and maxi-
mum value of the transmembrane potential (Vmax). In the O’Hara-Rudy dynamic
(ORd) model [64], the potassium current conductances were fitted to reproduce the
experimental effect on the APD when they were blocked. In the Carro-Rodríguez-
Laguna-Pueyo (CRLP) model [120], using the sensitivity analysis proposed in [12],
GK1, GNaK , GCaL, and GNa were fitted to obtain not only APD values within physio-
logical ranges, but also other markers of arrhythmic risk, including time constants
of APD rate adaptation or rate dependence of ionic concentrations.
On the contrary, the parameters that model current kinetics (gating parame-
ters) are usually identified from single-cell experiments. The calibration process
is usually performed using a nonlinear least square fitting of voltage clamp data
by assuming that each parameter’s effect is independent from the rest (e.g., the
steady-state of an inactivation gate is calibrated against experimental results while
considering that the time constant of the gate does not affect such results, which
might not be correct). However, when the complexity of the model increases, the
interaction between effects becomes increasingly important. Therefore, assuming
independence of the effects when identifying model parameters may be misleading.
While other techniques have been proposed in recent years to improve the fitting of
the gating parameters [109, 128–130], none of the models analyzed in the present
thesis have used such techniques.
Once model parameters have been identified, the resulting AP models are val-
idated against experimental measurements commonly obtained also from tissue
preparations. Characteristics such as resting membrane potential (Vmin) and up-
stroke velocity (dV /dtmax) are usually compared between model-generated and
experimental APs. In the CRN model, the role of different ionic conductances,
the morphology of the AP and the behavior of the model for different pacing cycle
lengths (CLs) were compared with experimental observations. In the updated ver-
sion of the LR model [107], the theoretical APD restitution curve was compared
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with experimental restitution curves obtained from optical recordings of cardiac
APs. In the TNNP04 model, simulated APD restitution curves (at 90% repo-
larization, APD90) were evaluated in single cells to validate the model against
experimental results measured in tissue preparations. Also in this model, prop-
agation in a homogeneous one-dimensional (1D) tissue was simulated to validate
the model in terms of Conduction Velocity (CV). In a subsequent version of the
model, the ten Tusscher-Panfilov (TP06) model [51], simulated APD restitution
curves (at 90% and 50% repolarization) in single cells were compared with experi-
mental results. The GPB model was validated by comparing the predicted APD90
prolongation caused by blockade of different potassium currents with experimental
results. The CRLP model, as the GPB model, was validated by comparing APD90
prolongation caused by potassium current blockades with experimental results, but
also by comparing a number of computed markers not used in the fitting process.
For the aforementioned reasons, issues may appear in the calibration and/or
validation of electrophysiological models caused by two related aspects: submodel
variable relationships and cell-to-cell interactions during AP propagation. Regard-
ing the first of such aspects, model parameters related to ion channel gating kinet-
ics are commonly obtained by considering each gate of the channel independently.
Regarding the second one, ionic conductances are adjusted or validated against
experimental data obtained from tissue preparations while considering single cell
computer simulations. In both circumstances, differences caused by not consid-
ering the corresponding interactions introduce non-negligible cross-effects between
model parameters that are not considered in the fitting process.
Other studies have analyzed issues related to the two aspects mentioned above.
In [131] differences between models of the same species to represent electrophysi-
ological properties and how these differences propagate to tissue simulations were
analyzed. In [132] how the uncertainty in the definition of gating variables prop-
agates in multi-scale models was studied and the need to use observations across
multiple scales was highlighted. In [133] problems caused by the use of obser-
vations across multiple scales and how to characterize the relationships between
model parameters and the effect they have in the multi-scale model outputs was
explored.
In this chapter, experimental protocols are simulated in silico to analyze the
consequences of the corresponding interactions in two scenarios involving scales
ranging from ion channels to tissue: 1) characterization of L-type calcium voltage-
dependent inactivation; 2) identification of ionic current conductances with the
largest contribution to steady-state AP markers. In the first case, differences be-
tween the mathematical model, simulation results and experimental measurements
are analyzed to evaluate how interactions between model components affect the
development and validation of mathematical ion channel models. In the second
case, differences between AP-based markers simulated in isolated cells and in ho-
mogeneous 1D tissue are analyzed to evaluate how propagation affects their values
as well as to assess the contribution of each ionic current to each marker.
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4.2 Materials and Methods
4.2.1 L-type calcium channel gating
In AP models, ionic currents are controlled by activation and inactivation gates.
Gates are modeled by functions varying between 0 and 1. Below a threshold poten-
tial, the activation gates are closed (the function value is 0) and the inactivation
gates are open (value 1). When transmembrane potential increases, the activa-
tion gates open (their values increase towards 1) and the inactivation gates close
(their values decrease towards 0). In particular for the ICaL current, all human ven-
tricular cell models analyzed in this thesis have one voltage-dependent activation
gate d. This activation gate d multiplies the expression for the inactivation gat-
ing, whose formulation largely differs between models. In this chapter four of the
most recently developed human ventricular cell models were considered: the GPB
model, the TP06 model, the ORd model and the CRLP model. Voltage-dependent
inactivation of the L-type calcium current was studied in all of them.
The TP06 model is one of the most extensively used human ventricular AP
models. It represents an improved version of the model published in 2004 [46]
in which the calcium dynamics, the slow delayed rectifier potassium current (IKs)
and ICaL were reformulated. The TP06 model is based on experimental data from
human cardiomyocytes for most ionic currents and is defined for three types of
cells: epicardial, midmyocardial and endocardial. In the TP06 model, voltage-
dependent ICaL inactivation is modeled as the product of a fast, f2, and a slow, f ,
voltage-dependent inactivation gates as well as a calcium-dependent inactivation
gate, fCa:
InactTP06Ca,L = f  f2  fCa
These gates have different time constants (f2 , f and fCa) and steady-state values
(f2;1, f1 and fCa;1). This formulation is based on experiments that indicate the
presence of both fast and slow voltage-dependent ICaL recovery processes [1, 134,
135].
The GPB model is based on the rabbit AP model proposed in [63], which
includes subsarcolemmal and junctional compartments in the formulation of the
currents and provides a detailed description of calcium handling. The GPB model
includes new definitions of ionic current densities and kinetics and is defined for
endocardial and epicardial cells. In the GPB model, voltage-dependent ICaL inacti-
vation is modeled by a single voltage-dependent gate f and two calcium-dependent
gates, one for the subsarcolemmal compartment, fCa;sl, and another one for the
junctional compartment, fCa;j . The formulation of ICaL inactivation in the GPB
model is as follows:
InactGPBCa,L = f  (Aj  fCa;j +Asl  fCa;sl)
where Aj and Asl are the ratios of calcium-dependent inactivation channels in the
junctional and the subsarcolemmal compartment, respectively (Aj +Asl = 1).
The CRLP model is a modification of the GPB model. As in the original model,
the modified CRLP model describes the AP of endocardial and epicardial human
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ventricular myocytes. As described in previous chapters, the CRLP model includes
reformulation of ICaL, readjustment of the parameters describing IK1 and redefinition
of a number of other model parameters, including GNa (maximum INa conductance)
and GNaK (maximal INaK value). In the CRLP model, the formulation of voltage-
dependent ICaL inactivation is similar to that of the TP06 model. However, the
associated voltage-dependent inactivation time constants were adjusted to better
match experimental evidences on APD adaptation to CL changes. The calcium-
dependent inactivation gates were maintained as in the original GPB model. The
formulation of ICaL inactivation in the CRLP model is as follows:
InactCRLPCa,L = f  f2  (Aj  fCa;j +Asl  fCa;sl)
The ORd model is the most recent human ventricular AP model out of the
four analyzed models and it has the most complex ICaL definition. ICaL inactivation
is modeled as a weighted average involving voltage-dependent gates. The gates
ff and fs represent the behavior of the voltage-dependent gates when there is
no calcium. The gates fCa;f , fCa;s and jCa represent the behavior of the voltage-
dependent gates when calcium is present. The calcium-dependent gate nmodulates
the relative weight of both families of gates. The n gate is modeled via a Markov
chain. The gates ff , fs, fCa;f , fCa;s and jCa have different time constants, f;f ,
f;s, f;Ca;f , f;Ca;s and j , but the same steady-state value fss. As discussed by
Thomas O’Hara in the online version of the article presenting the model [64], there
are some issues related to the INa current formulation in the model. The authors
propose to replace the INa current formulation of the original ORd model with the
formulation proposed in the TP06 model. In this work we analyze the original
ORd model and the ORd model with the INa current of the TP06 model (ORdNa).
The formulation of ICaL inactivation in the ORd and ORdNa models is as follows:
InactORdCa,L = (Af;f  ff +Af;s  fs)  (1  n)+
jCa  (Af;Ca;f  fCa;f +Af;Ca;s  fCa;s)  n
where Af;f and Af;Ca;f are the ratios of the fast voltage-dependent inactivation
gates ff and fCa;f , respectively, and Af;s and Af;Ca;s are the ratios of the slow
voltage-dependent inactivation gates fs and fCa;s, respectively.
4.2.2 Characterization of L-type calcium voltage-dependent inactivation
Voltage-dependent ICaL inactivation is experimentally characterized using the paired-
pulse protocol, which is illustrated in Figure 4.1. This protocol consists of clamping
the membrane potential from a holding potential Vhold to different pre-pulse po-
tentials Vpre during a specified time interval tpre. After this time, the potential is
clamped to a pulse potential Vpulse during an interval tpulse. Following this, the
membrane potential is clamped back to Vhold. Variations of this protocol introduce
a separation between the pre-pulse and the pulse potential, during which the poten-
tial is set to Vhold for a short period of time, tsep, before clamping the membrane
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Figure 4.1: Paired-pulse voltage clamp protocol and measurement of the steady-
state value fss of voltage-dependent inactivation.
potential to Vpulse. Steady-state voltage-dependent ICaL inactivation is obtained
during the tpulse interval. In this part of the test, peak ICaL current is measured
for each potential used as pre-pulse and results are normalized by the peak value
of the current measured for the minimum pre-pulse potential. The resulting curve
is used in the models as the steady-state value of voltage-dependent inactivation
(fss).
Human ventricular cell models use different experimental datasets to define
their voltage-dependent ICaL inactivation functions. With the aim of comparing
the simulation results of steady-state ICaL inactivation with experimental results,
the same experimental dataset that was used to adjust each model in the original
articles was considered. For the TP06 model no indication was provided on the
experimental dataset used to fit steady-state voltage-dependent ICaL inactivation,
whereas in the previous version of the model [46] data from [1] was used. For the
TP06 model the authors redefined the ICaL expression by adding a second voltage-
dependent inactivation gate. Only the I/V curve for ICaL was compared with
experimental results from [3]. The GPB model used experimental results from [2]
and the ORd model from [3].
Each set of experimental results was based on a different configuration of the
paired-pulse protocol to characterize steady-state voltage-dependent ICaL inactiva-
tion (Table 4.1). Also, different calcium concentrations in the extracellular solution
and in the patch pipette solution, varying from 1.8 to 5.4 mM and from 0 to 2.0
mM, respectively, were used for each experimental dataset.
UniversidadZaragoza
4. Limitations in Electrophysiological Model Development and
Validation 85
[1] [2] [3]
Vhold (mV ) -45 -80 -80
Vpulse (mV ) 10 10 5
Vpre;ini (mV ) -40 -100 -55
Vpre;fin (mV ) 40 60 15
Vpre (mV ) 5 10 5
tpre (ms) 400 400 500
tsep (ms) 10 5 0
tpulse (ms) 400 300 390
Table 4.1: Paired-pulse test parameters in experimental protocols.
In this chapter, in silico simulations were performed in which the experimental
paired-pulse tests were implemented for ICaL characterization. Intracellular and
extracellular concentrations were set at the values used in the experimental proto-
cols against which simulated data were compared. In particular, free intracellular
calcium ([Ca2+]i) was set as the value of the pipette solutions of the experiments,
with the time derivative being set to zero (i.e. d[Ca2+]i/dt = 0). All the cal-
cium buffers and the diffusion and transportation of calcium inside the cell were
maintained as in the original models. This allowed calcium concentrations in all
remaining intracellular compartments to follow the dynamics described in the cor-
responding model equations. The same values for Vhold, Vpre, and Vpulse as in the
corresponding experiments (see Table 4.1) were used. All currents except for ICaL
were blocked.
4.2.3 Steady-state AP markers
To study the effect of considering data measured at tissue level for characterization
of single cell models, AP markers calculated at single cell and tissue levels with
the four ventricular models were compared. The following markers were analyzed:
i) Action potential duration at different percentages of repolarization (90%, 75%,
50%, 25%); ii) Triangulation; and iii) Minimum and Maximum Transmembrane
Potential and Transmembrane Potential Velocity. The maximum value of the AP
is used in many models to adjust the cardiac conductances [15, 47] whereas the
minimum potential is used for model validation [64]. These values are, however,
very sensitive to cellular electrophysiological changes like, for instance, those asso-
ciated with hyperkalemia, where the resting membrane potential can be increased
from -85 mV to up to -60 mV and the maximum potential falls, in combination
with a potential splitting of the AP upstroke into more than one component [20].
4.2.4 Ionic contributors to AP markers
To evaluate the role played by each ionic current in contributing to each electro-
physiological marker, the results of the simulations carried out by varying individual
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ionic conductances were adjusted by a first order response surface model:
Mj  Cj +
NX
i=1
i mj;i
where Mj is the value of the electrophysiological marker j under the analyzed
condition, Cj is the value of the marker j under control conditions, mi;j is the
weight of the current i in contributing to the marker j and i is the variation of
the ionic conductance:
i =
Gi  Gi;0
Gi;0
where Gi;0 and Gi are the values of the ionic conductance under control and under
the analyzed condition, respectively.
For each individual marker, if the results for the different evaluated conditions
k = 1; : : : ;K are concatenated, the above system can be expressed in matrix form
as: 26664
Mj;1
Mj;2
...
Mj;K
37775 
26664
1;1    N;1
1;2    N;2
... . . . ...
1;K    N;K
37775 
26664
mj;1
mj;2
...
mj;K
37775+ Cj 
26664
1
1
...
1
37775
#
M j   mj + Cj  JK;1
whereMj;k is the value of the marker j andi;k is the variation of the ionic conduc-
tance i at condition k. Using this notation, the weights of the ionic conductances
can be calculated as follows:
mj =


T 
 1
T   M j   Cj  JK;1
4.2.5 Computational simulations
The models were stimulated with square current pulses with an amplitude twice the
diastolic threshold and a duration of 1 ms. Depending on the simulation scale, the
diastolic threshold was defined as the minimum amplitude required to (a) generate
five APs (single cell simulations) or (b) propagate five APs (1D tissue simulations).
To simulate steady-state conditions, models were stabilized with a train of 100
stimulations at a CL of 1000 ms. Electrophysiological markers were calculated from
the last simulated beat. Every model was first simulated under control conditions
and subsequentyly after varying each ionic conductance by 15 and 30%.
For 1D tissue simulations, a homogeneous 3-cm fiber composed of epicardial cells
was used. The value of the conductivity, , was set to obtain a Conduction Velocity
(CV) close to 65 cm/s [88]. The cell capacitance was set to Cm = 1 F/cm2. The
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AP markers were computed as the mean value of the markers measured at five
different positions within the fiber located at: 1, 1.25, 1.5, 1.75 and 2 cm.
For single cell simulations, a forward Euler scheme was used to solve the models
with a time step of t = 0:002 ms for GPB, ORd and CRLP, and t = 0:02 ms
for TP06. For 1D tissue simulations, a semi-implicit operator-splitting scheme was
used to solve the propagation [87] with a space discretization of x = 0:1 mm and
the same t used in single cell simulations.
The results from single cell and in 1D tissue simulations were compared using
the absolute (Ea) and relative (Er) differences:
Ea = M
cell
j  M tissuej
Er(%) =
M cellj  M tissuej
M tissuej
 100
where M cellj and M tissuej are the values of the electrophysiological marker j in cell
and tissue for the condition under analysis.
4.3 Results
4.3.1 Characterization of L-type calcium voltage-dependent inactivation
Results of the paired-pulse protocol for steady-state voltage-dependent ICaL inacti-
vation are shown in Figure 4.2. Each model was compared with the set of exper-
imental data that was used to characterize voltage-dependent ICaL inactivation in
the original article were the model was presented.
The TP06 model was able to adequately reproduce the experiments from [1]
(see Figure 4.2.a)). In this case, the modeled steady-state voltage-dependent ICaL
inactivation is the product of the steady-states values (f2;ss, fss) of the two inac-
tivation gates (f2, f). The results from the in silico simulations, which account
for additional interactive effects, were closer to the experimental data than those
obtained by evaluation of the corresponding ICaL mathematical equations. Fig-
ure 4.3.a) shows that, for the TP06 model, the slow inactivation gate f did not
reach steady-state for high Vpre potential values (Vpre = -5 mV and Vpre = 40 mV).
Figure 4.3.a) also shows that the calcium-dependent inactivation gate has a less
significant effect than the other gates, being this effect slightly more pronounced at
lower Vpre potentials. Finally, one of the most significant differences between the
model outcome (multiplication of the steady-state values of the gates, black dashed
line in Figure 4.2.a) and the result of the in silico simulations (yellow crosses) was
that the curves were shifted.
Simulation results obtained with the GPB model fit quite well the model defi-
nition (see Figure 4.2.b)). Differences between model outcome and in silico simu-
lation increased as fss decreased. As shown in Figure 4.3.b), the separation pulse
produced different effects depending on the pre-pulse potential. For Vpre = -100
mV, the effect was minimal, but in the other two cases shown in the figure (Vpre =
-20 mV and Vpre = 60 mV), the value of f increased during the separation pulse.
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Figure 4.2: Comparison between model definition (continuous and discontinuous
lines), in silico simulations (yellow crosses) and experimental results (red circles)
for fss. a) TP06 model and data from [1]. b) GPB model and data from [2]. c)
ORd model and data from [3]. d) CRLP model and data from [1].
Calcium-dependent inactivation gates had minimal effects, as these gates remained
open during most of the protocol duration. Finally, differences between experi-
ments [2] and in silico simulations increased for positive potentials (Figure 4.2.b).
Simulation results with the ORd model showed a significant discrepancy with
experimental data for potentials between -20 mV and -10 mV (see Figure 4.2.c)).
The largest difference was observed for a pre-pulse potential of -15 mV. The sim-
ulated probability at this potential was 18% larger than the one obtained in the
experiments. The evolution of the voltage-dependent ICaL gate variables during the
pre-pulse potential is shown in Figure 4.3.c). For potentials below -15 mV, the n
gate was nearly closed and the effects of fs and ff gates dominated. On the con-
trary, for positive potentials, the effects of the gates fCa;f , fCa;s and jCa prevailed.
This figure also shows that for potentials above -15 mV, the fast inactivation gates,
but not the slow ones, reached a steady-state value during the pre-pulse. For high
pre-pulse potentials, the gate fCa was not able to reach steady-state (close to 0),
but the gate j was. However, the multiplication of both gates almost achieved a
steady-state value.
The results obtained with the CRLP model were very similar to those found
for the TP06 model. This was expected, since both models have a very similar
formulation for ICaL inactivation. However, the difference between the results of
the CRLP model and the experiments from [1] was smaller than for the TP06
model (see Figure 4.2.d)).
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Figure 4.3: Temporal evolution of the ICaL gates during simulation of the paired-
pulse protocol (see text for specific values of tpre, tsep and tpulse used in the simu-
lations): a) TP06 model. b) GPB model. c) ORd model. d) CRLP model
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TP06 GPB CRLP ORd ORdNa
Cell Fiber Cell Fiber Cell Fiber Cell Fiber Cell Fiber
APD90 (ms) 300.5 300.2 286.1 283.5 306.2 306.7 224.3 224.2 223.2 224.0
APD75 (ms) 292.1 292.4 272.6 271.8 281.1 284.5 208.1 208.6 206.2 208.5
APD50 (ms) 272.4 277.0 235.0 243.8 228.1 239.6 177.8 179.1 174.4 179.2
APD25 (ms) 212.3 242.1 127.3 180.4 111.8 179.1 137.0 144.1 126.5 144.3
Trian: (ms) 28.1 23.2 51.1 39.7 78.1 67.1 46.5 45.1 48.8 44.8
Vmax (mV) 38.5 24.6 38.7 23.4 38.1 21.9 36.2 31.1 41.9 30.9
Vmin (mV) -85.4 -85.4 -81.4 -81.4 -84.1 -84.2 -87.8 -87.8 -87.8 -87.9
dV
dt max
(V/s) 292.6 193.7 322.8 234.5 335.4 227.5 234.9 78.1 364.2 237.9
dV
dt min
(V/s) -9.5 -3.3 -6.2 -1.4 -5.9 -0.8 -1.8 -1.1 -2.9 -1.2
Table 4.2: Comparison of electrophysiological markers simulated in single cell and
1D tissue under control conditions.
4.3.2 Ionic contributors to AP markers
The results of the analyzed AP markers under control conditions are shown in
Table 4.2 for the four analyzed models. Table 4.3 shows absolute and relative
differences between cell and tissue values for each electrophysiological marker. APD
was very similar in cell and tissue simulations at 90% and 75% repolarization. The
differences between cell and tissue increased at lower percentages of repolarization:
the relative differences for APD at 50% repolarization were between -0.7% and
-3.6% and considerably higher at 25% repolarization, between 4.9% and 37.4%.
The differences in Triangulation were mainly due to differences in APD50. Due
to the smaller values of Triangulation, the relative differences for this AP marker
were higher (between 3.0% and 28.8%). The GPB model and the CRLP model
were the ones that showed larger differences between cell and tissue results. On
the contrary, the ORd model was the one showing less differences between cell and
tissue in the AP-based electrophysiological markers.
The value of the resting potential (Vmin) was the same in cell and tissue. On
the contrary, peak AP value (Vmax) showed large differences between cell and tissue
simulations (from 16.3% to 73.5%). Similarly, large differences were quantified for
dV /dtmax and dV /dtmin. The ORd model showed the smallest differences in those
voltage-related electrophysiological markers except for dV /dtmax. The other three
models showed similar values, in particular for the absolute differences.
For the TP06 model, the ICaL current played different roles in cell and tissue
simulations (see Figure 4.4). While in tissue it was the most important current
to determine Vmax, in cell its effect on Vmax was negligible. A similar effect was
observed for the Triangulation, where ICaL was a highly relevant current in tissue
simulations, whereas in cell simulations it had almost no effect on Triangulation.
On the contrary, the impact of INa current in cell was notably diminished in tissue
simulations. For Vmax, the weight of the INa current in cell was 51.6%, while in
tissue it was nearly 5%. This also happened with the Ito current, although to a
lesser extent. Gto conductance affected dV /dtmin in cell simulations, whereas in
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Ea Er(%)
TP06 GPB CRLP ORd ORdNa TP06 GPB CRLP ORd ORdNa
APD90 (ms) 0.3 2.6 -0.5 0.1 -0.8 0.1 0.9 -0.2 0.0 -0.3
APD75 (ms) -0.3 0.8 -3.4 -0.5 -2.3 -0.1 0.3 -1.2 -0.2 -1.1
APD50 (ms) -4.6 -8.8 -11.5 -1.3 -4.8 -1.7 -3.6 -4.8 -0.7 -2.7
APD25 (ms) -29.8 -53.9 -67.3 -7.1 -17.8 -12.3 -29.4 -37.6 -4.9 -12.3
Trian: (ms) 4.9 11.4 11.0 1.4 4.0 20.7 28.8 16.4 3.0 9.0
Vmax (mV) 13.9 15.3 16.2 5.1 11.0 56.4 65.7 73.5 16.6 35.5
Vmin (mV) 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0
dV
dt max
(V/s) 98.9 88.3 107.9 156.8 126.3 51.1 37.7 47.5 200.7 53.1
dV
dt min
(V/s) -6.2 -4.8 -5.1 -0.7 -1.7 187.8 343.2 616.3 52.5 143.1
Table 4.3: Absolute (Ea) and relative (Er) differences between electrophysiological
markers in single cell and 1D tissue simulations.
tissue simulations this marker was mainly controlled by ICaL.
The more influential currents in the GPB model differed from the TP06 model
(Figure 4.5). In this model, the ICl,bk current, which is not present in the TP06
model, was the most relevant contributor to APD in both cell and tissue simula-
tions. Other effects were similar in both models. As an example, the INa current
contribution was reduced in the GPB model when the electrophysiological mark-
ers were calculated in tissue as compared to cell. This reduction was found for
all markers except for dV /dtmax. Similarly to the TP06 model, one current had
a larger contribution to Vmax in tissue than in cell, but in the GPB model that
current was Ito. The same behavior was found for Triangulation and IK1.
The APD of the ORd model was mainly controlled by IKr in cell, whereas
in tissue the INa current also played an important role. The original ORd model
showed large differences in the role played by the INa current in tissue compared with
the one in cell (Figure 4.6). In cell simulations, when INa conductance was increased,
the APD at different percentages of repolarization was slightly decreased. On the
contrary, in tissue, when INa conductance was increased, the APD was considerably
prolonged. These differences in the ORd model disappeared when the INa current
formulation was replaced with the one described in the TP06 model. For Vmax,
when INa was replaced with the one defined in the TP06 model (Figure 4.7), the
different behavior between cell and tissue simulations was interchanged.
The APD of the CRLP model highly depended on the conductance of the ICl,bk
current (see Figure 4.8). This behavior is inherited from the GPB model but its
weight in the CRLP model was found to be slightly smaller than in the GPB model.
Likewise, the role of the ICaL current was very similar to the one in the GPB model.
The only difference was the role in dV /dtmin: in the CRLP model it was larger than
in the GPB model due to the particular AP shape at the beginning of the plateau
phase for the CRLP model, which is related to the definition of ICaL formulation.
Also, the contribution of IK1 to Triangulation was 16% larger in tissue than in cell
simulations.
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Figure 4.4: Contribution of ionic conductances to electrophysiological markers
simulated in tissue and cell with the TP06 model. Dark colors (blue or brown)
indicate maximum correlation between changes in a conductance and changes in
a marker; white color indicates no correlation. Percentages in boxes indicate the
contribution of changes in a conductance to changes in a marker. Minus signs
indicate that conductances and markers vary inversely; plus signs indicate that
conductances and markers vary in the same direction.
Figure 4.5: Contribution of ionic conductances to AP markers simulated in cell
and tissue with the GPB model. The legend of the figure is the same as in see
Figure 4.4.
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Figure 4.6: Contribution of ionic conductances to AP markers simulated in cell
and tissue with the ORd model. The legend of the figure is the same as in see
Figure 4.4.
Figure 4.7: Contribution of ionic conductances to AP markers simulated in cell
and tissue with the ORdNa model. The legend of the figure is the same as in see
Figure 4.4.
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Figure 4.8: Contribution of ionic conductances to AP markers simulated in cell
and tissue with the CRLP model. The legend of the figure is the same as in see
Figure 4.4.
4.4 Discussion
This chapter has been focused on analyzing issues arising during model develop-
ment and validation, namely: i) the effect of submodel variable interactions in the
characterization of ion channel gating, and ii) the effect of cell-to-cell interactions in
the evaluation of ionic contributors to AP markers. A methodology for validating
computational model formulations has been introduced. The proposed methodol-
ogy consists in performing in silico simulations using the same protocol as in the
experiments used to characterize a given current or AP marker. The methodology
accounts for all variables and scales involved in modeling and simulation as well as
their interactions. It has been applied to evaluate voltage-dependent ICaL inactiva-
tion and contributors to electrophysiological AP markers in four human ventricular
models presenting different ionic formulations.
4.4.1 Effect of submodel variable interactions in the evaluation of voltage-de-
pendent L-Type Calcium Current inactivation
In the case of voltage-dependent ICaL inactivation, our results show large differences
between ICaL inactivation as calculated from the model equation and ICaL inactiva-
tion from the in silico simulations. Such differences were due to the interaction
between voltage-dependent ICaL inactivation gating and other effects such as ICaL
activation gating, protocol definition or duration of the voltage pulses used to cal-
culate inactivation properties. This suggests that, when proposing any new model
formulation, consistency between such formulation and the corresponding experi-
mental data that is aimed at being reproduced needs to be first verified considering
all involved factors.
In the TP06 model, the product of the steady-state values of the two voltage-
dependent ICaL inactivation gates was very different from the experimental behav-
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ior. However, the results of the in silico simulations obtained with this model were
in good agreement with the experiments. There are two effects that explain these
results: i) normalization by ICaL current peak at the minimum pre-pulse potential,
as performed in the experimental protocol [1], is done for a transmembrane poten-
tial value where the product of the two voltage-dependent inactivation gates is less
than 1; ii) voltage-dependent inactivation gates do not reach a steady-state value
at the end of the pre-pulse interval for some potentials. One of the most significant
differences between the model outcome (multiplication of the steady-state values of
the gates) and the result of the in silico simulations is that the curves representing
steady-state voltage-dependent inactivation (Figure 4.2.a)) were shifted. This shift
made the in silico simulations approximate the experimental behavior due to the
performed current peak normalization at a potential where inactivation probability
is less than one.
The GPB model and the associated in silico simulations provided similar re-
sults to the experiments used to fit the steady-state value of voltage-dependent
inactivation gating. Differences were mainly caused by the protocol used to mea-
sured fss, as explained in the following: the separation pulse had a different effect
depending on the pre-pulse potential. For pre-pulse potentials similar to Vhold the
value of fss obtained at Vpulse is minimally affected since the steady-state values
of f for Vhold and Vpre are very similar. However, for larger values of Vpre, and
therefore larger differences between Vhold and Vpre, the steady-state value of f
corresponding to Vpre is very different to the steady-state value corresponding to
Vhold, which corresponds to one. This causes that during the separation pulse the
value of f increases (see Figure 4.2.b)) and the difference in fss between the model
definition and the simulation increases with Vpre. In addition, the interaction with
voltage-dependent activation, represented by gate d, always reduced the measured
value, but the normalization, using the result of the minimum pre-pulse potential,
nearly corrected this behavior. Finally, differences between experiments [2] and in
silico simulations get larger where differences between the model definition for fss
and experimental data are larger (see Figure 4.2.b) for positive potentials). These
results suggest that a simple ICaL inactivation formulation like that in the GPB
model, with only one voltage-dependent inactivation gate, suffices to reproduce
the experimental behavior of steady-state voltage-dependent ICaL inactivation [2].
In the ORd model, the definition of voltage-dependent ICaL inactivation as a
weighted sum of fast and slow inactivation gates is consistent with how experimen-
talists calculate inactivation time constants [1, 64]. Time constants are calculated
by fitting a biexponential function to the inactivation phase of the experimental
current traces. However, important discrepancies between in silico ORd simula-
tions and the experiments used to develop the model [3] were found for pre-pulse
potentials between -20 mV and -10 mV. There are two possible causes behind such
discrepancies: i) the time constant of the slow voltage-dependent inactivation gate;
ii) the definition of voltage-dependent ICaL inactivation as the sum of two gates.
The first cause has to do with the fact that ORd model time constants are iden-
tified based on a simple-pulse test protocol of 75 ms duration, whereas the slow
time constant of voltage-dependent ICaL inactivation in the ORd model is of the
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order of 10 seconds. The slowness of the inactivation gate prevents reaching the
steady-state value by the end of the pre-pulse, which overestimates the value of fss
at Vpulse. This is reinforced by the fact that voltage-dependent ICaL inactivation is
formulated as a sum of two gates. If inactivation is expressed as a product, as in the
case of the TP06 model, when one of the gates reaches zero, the product reaches
zero. However, for the ORd model the situation is more complex. Due to the
interaction between the inactivation gates and the n and jCa gates in this model,
as shown in section 4.3.1, the result for potentials above -10 mV is equivalent to
the product of two gates since the jCa gate is almost zero, and therefore the result
from the simulation is similar to the model formulation of fss and experiments.
On the contrary, for potentials between -20 mV and -10 mV, where by the end of
the pre-pulse the jCa gate is far from zero and the slow inactivation gates, in par-
ticular fCa;s, are far from reaching their steady-state value, the fss value obtained
from the simulation is considerably larger than the fss value defined in the model
formulation and the experiments.
For the CRLP model, similarly to the TP06 model, the largest differences be-
tween model equations, in silico simulations and experiments are due to the time
constants of the activation and inactivation gates. Nevertheless, the results of
the in silico simulations with this model reproduced the experimental observations
slightly better than the TP06 model. In the CRLP model, the voltage-dependent
ICaL inactivation gate f2 is faster than in the TP06 model (as defined by the time
constant f2). Due to this gate being faster, the effect of the separation pulse was
larger than in the TP06 model, as during this interval the f2 gate opened more
than in the TP06 model (see Figure 4.3.d)). As a consequence, the CRLP model
yielded a larger fss value in the in silico measurements, which was closer to the
experimental values. This effect was not very pronounced but it could be better
observed for voltages where f2 is larger (around -20 mV).
This chapter has focused on the difficulties of fitting model parameters asso-
ciated with the steady-state value of ICaL inactivation using data obtained from
voltage-clamp experiments. Such difficulties arise from submodel variable interac-
tions in the ICaL formulation. This situation is a common problem to many gating
variables in cardiac electrophysiological models. In this regard, most experimental
protocols cannot measure the behavior of one gate at a time, but instead measure
the behavior of all gates of the same nature (activation, inactivation, etc.) together
(e.g. for ICaL inactivation the experimental protocol measures fast and slow inacti-
vation together). Therefore model development needs to consider the coexistence
of all gates during parameter identification to accurately reproduce experimental
results. This issue is also present in the estimation of the time constants asso-
ciated with the different gates. In this regard, the gating interactions associated
with an experiment implies that the identified time constants associated with the
experimental data cannot, in general, be associated with an individual gate of the
model.
Some studies have explored the effect of gating interactions on voltage-clamp
data [129, 130]. The voltage-clamp protocol is not designed to measure this di-
rectly, but the corresponding effects are included in the experimental results. Nev-
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ertheless, most of these techniques have been developed for currents with only one
inactivation and one activation gate. Approaches to extend those methods to better
calibrate complex gate combinations remain to be investigated.
4.4.2 Effect of cell-to-cell interactions in the evaluation of ionic contributors
to AP markers
While the ionic currents identified as having the largest contribution to each ana-
lyzed AP-based marker varied from one model to another, the differences between
single cell and tissue simulations were comparable for all the analyzed markers in
the four considered human ventricular models.
As expected, measurement of depolarization-related AP markers in single cell
simulations was significantly affected by the externally applied stimulation current.
In particular, dV /dtmax in single cell simulations was quite different from that
obtained in tissue for all considered models. Although some models use dV /dtmax
or Vmax measured in single cell simulations to adjust INa [15, 47, 64], our results
suggest that INa should be adjusted with the results obtained from, at least, a 1D
tissue simulation as in [120], particularly considering that many experiments are
performed in tissue.
For repolarization-related AP markers, the largest differences between cell and
tissue were observed for Triangulation and APD25. The results for APD90 and
APD75 were very consistent between cell and tissue, while small discrepancies were
found for APD50. Although differences for APD90 and APD50 were small, their
added contribution together with the small value of Triangulation caused a rela-
tively large accumulated difference for this marker. For this reason, Triangulation
should be used with caution as a marker in single cell simulations when used to
calibrate an AP model.
Importantly, the differences between markers computed from single cell and 1D
tissue simulations were not only the reflect of a constant bias, as shown in Table 4.2
and in Table 4.3. For repolarization markers, those differences reflected the different
contribution of ionic currents to the markers. Computational studies using single
cell simulations to analyze the sensitivity of different ionic current conductances
on the repolarization behavior of the model should only consider markers with
a validated correspondence between cell and tissue simulations or, otherwise, use
markers computed from tissue rather than from single cell simulations.
4.5 Conclusions
When proposing a new model, or when evaluating an existing model, consistency
between simulated and experimental data should be verified considering all in-
volved effects and scales. The closer the experimental conditions are reproduced in
the computer simulations, the more robust the process of model development and
validation will be.
As discussed in this paper, proper characterization and validation of a given
model should be performed with the in silico simulation of the experimental proto-
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col. In this way, the effects of the interaction between model variables are accounted
for and modeling inconsistencies are avoided.
While the information provided by electrophysiological markers is very valu-
able for model development and validation, markers should be computed using
simulations that resemble as closely as possible the conditions associated with the
experimental measurements, or, at least, the consistency of the marker at different
scales should be previously validated.
As a final remark, complex models represent a real challenge for parameter
identification and validation. This does not mean that models should be necessarily
simple, but that complex models require additional testing to fully verify adequate
performance.
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Chapter 5
Reformulation of Ionic
Current Expression
5.1 Introduction
The human ventricular AP model proposed in Chapter 2 and subsequently up-
dated in chapter 3, despite reproducing experimental observations in relation to
a range of electrophysiological characteristics (see also Chapter 4), renders an
AP lacking the peak-and-dome morphology characteristic of ventricular epicardial
cells. Specifically, the end of phase 1 is followed by an atypical low-magnitude
bump that precedes the AP plateau phase. In this chapter a readjustment of ICaL
voltage-dependent inactivation gates is proposed to provide a more physiological
AP shape while guaranteeing an improved fitting of the model to experimental data
in relation to all the electrophysiological properties the model had been validated
against in previous chapters.
The proposed readjustment lies on the methodologies described in chapters 3
and 4. As a first step, the time constants of ICaL voltage-dependent inactivation
gates were modified to render a more realistic AP shape. Due to the implica-
tions that a partial modification of an ionic model may have on the performance
of the model, as highlighted in chapter 4, the steady-state value of ICaL voltage-
dependent inactivation gates was adjusted to better reproduce experimental current
data available from three different studies [1–3] by using the algorithm proposed in
the chapter 3 and the in silico simulation of these experimental protocols described
in chapter 4. Finally, the model was evaluated at cell and tissue levels to confirm
that its performance was maintained or improved with respect to the model of
chapter 2 for all evaluated electrophysiological properties.
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Figure 5.1: Time constants of ICaL voltage-dependent inactivation in the CRLP
model and following the readjustment proposed in this chapter. Comparison with
experimental data [2, 4–7] is provided as well.
5.2 Methods
5.2.1 Modification of ICaL voltage-dependent inactivation time constants
To improve the AP shape of the CRLP model, the time constants of the slow
(f ) and fast (f2) ICaL voltage-dependent inactivation gates were modified. After
evaluating all model parameters defining the currents with a major contribution
to the AP part immediately following phase one, namely ICaL and Ito, those two
time constants were identified as the ones with the largest influence on the AP
shape in that specific part. In particular, exploration of the parameter space led
to redefinition of the  components of both time constants f and f2, as follows:
f =
200
1 + e
20:6 V
10
(5.1)
f2 = 0 (5.2)
where V is membrane potential.
The effect of varying f and f2 is shown in Figure 5.2 and Figure 5.3. In
Figure 5.1, the new ICaL inactivation time constants are compared with the original
ones and with the experimental data from [2, 4–7].
5.2.2 Adjustment of ICaL voltage-dependent inactivation steady-state
To best fit ICaL voltage-dependent inactivation steady-state after readjustment of
the time constants described in previous section, the expression of the steady-state
value for inactivation gates f and f2 was parameterized as follows:
gss =
1  gss;1
1 + e
V Vg;1/2
qg
+ gss;1 (5.3)
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Figure 5.2: Effect of varying f2 in the AP shape. Red line represents control
conditions. Dark grey lines correspond to reductions in f2, while light grey lines
correspond to increases in f2.
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Figure 5.3: Effect of varying f in the AP shape after having modified f2 in the
CRLP model. Red line represents control conditions. Dark grey lines correspond
to reductions in f , while light grey lines correspond to increases in f .
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where g represents f or f2 (depending on the gate under consideration), V is
membrane potential, gss;1 is the steady-state value of gate g when V tends to
infinity, qg is a parameter controlling the maximum slope of gss and Vg;1/2 is half-
inactivation voltage for gate g.
Optimization problem
A minimization problem was defined in which the value of the parameters fss;1,
f2;ss;1, qf , qf2, Vf;1/2, Vf2;1/2 are searched for to best fit experimental steady-
state ICaL voltage dependent inactivation data. The response surface optimization
approach described in chapter 3 was used to solve the minimization problem. The
objective function of the minimization problem was defined in terms of the mean
square error between a set of experimental data [1–3] and the corresponding results
of the in silico simulations (see chapter 4) as follows:
msei =
1
ni
niX
j=1
(fss;expi(Vj)  fss;simi(Vj))2 (5.4)
where ni is the number of prepulse voltages used in experiment i, fss;exp(Vj) is the
experimental result for voltage Vj in experiment i and fss;sim(Vj) is the in silico
result for voltage Vj in the simulation of the experiment i.
Since several experimental measurements of ICaL inactivation were available,
the objective function was defined as the addition of the mean square errors for
the different experiments weighted by the number of cells used in each experi-
ment to reduce the mean square error of the simulations in comparison with the
experimental results:
min
fss;1;f2;ss;1;qf ;qf2;Vf;1/2;Vf2;1/2
NexpX
i=1
Ni msei (5.5)
where Nexp is the number of experimental studies used in the minimization problem
and Ni is the number of cells used in experiment i.
Constraints
For the above minimization problem, the following constraints were imposed on
the aforementioned gating parameters:
 C1: Both gates must have the same slope (qf = qf2).
 C2: Vf;1/2 must be smaller or equal to Vf2;1/2.
 C3: When V tends to infinity, the values of fss and f2;ss must be the same
as in the original model (0 and 0.33, respectively).
 C4: f2;ss must tend to 0 when V tends to infinity.
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Each constraint was approximated using a second order response surface built
with a full factorial experimental design (see chapter 3). The second order response
surface was enough to find a solution within a reasonable time.
An additional step was included to validate that the solution to the minimiza-
tion problem led to physiological results at current, cell and tissue levels. At the
ionic level, the in silico simulation of ICaL voltage-dependent inactivation steady-
state was required to decrease monotonically and have only one inflection point at
negative voltages. At cell and tissue levels, a set of electrophysiological markers
were computed, including: systolic and diastolic intracellular calcium concentration
([Ca2+]i), AP duration (APD) at 90% of repolarization (APD90), AP triangulation
at 1Hz and 0.5 Hz and APD adaptation to abrupt cycle length changes (from a
cycle length of 1000 ms to a cycle length of 600 ms). A complete description of
these markers and the protocols used to compute them can be found in section 2.2.
Each marker was computed for varying ICaL conductance ranging from -30% to
+30% of the original value in the CRLP model. A solution of the minimization
problem was accepted at the cell level when, for some value of GCaL, all markers
were within physiological range or, in the case of markers that were originally out
of physiological range, when they were at an equal or closer distance to the physi-
ological range than for the CRLP model. For the definition of physiological range,
the same values described in chapter 2 (see Table 2.2) were used, as proposed in
[12].
Solution for ICaL voltage-dependent inactivation
After selecting the minimum set of requirements as constraints, the minimization
problem was solved once more using a fourth order response surface for the objec-
tive function and constraints to increase the sampling of the searching space. Based
on the conclusions of chapter 4, the solution was additionally evaluated in tissue.
A homogeneous 3-cm long fiber composed of epicardial cells was considered. Cell
capacitance was set to Cm = 1 F/cm2. Values for evaluated electrophsyiological
markers were computed as the mean of the values measured at five different posi-
tions within the cable located at: 1, 1.25, 1.5, 1.75 and 2 cm. Numerical simulations
were solved using ELVIRA software [87].
5.2.3 Numerical methods and implementation
Cells and tissues were stimulated with square transmembrane current pulses twice
the diastolic threshold in amplitude and 1-ms duration. The diastolic threshold in
fiber simulations was calculated as the minimum value that generated ten pulses
that propagated through the fiber with a CL of 1000ms as described in [136]. For
cell simulations, the diastolic threshold was calculated as the minimum value that
generated ten pulses.
When comparing with experimental data, extracellular concentrations in the
model were defined to have the same values as those described for the bath solution
of each experimental study.
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Computations at cell and ionic levels were performed using MatCardiacMLab
Simulator (http://github.com/ChusCarro/MatCardiacMLab). This MatLab-based
software uses the ode15s solver with a maximum step of 0.1 ms to solve the
ODEs of the model. The original CellML file of the CRLP model was consid-
ered. Fiber simulations were implemented in FORTRAN and simulated using the
software ELVIRA. The value of the conductivity, , was calculated to obtain a CV
value close to 65 cm/s [88]. The fiber was stimulated at one end. A semi-implicit
operator-splitting scheme [87] was used to solve the model with a space discretiza-
tion of x = 0:1 mm and a time step of t = 0:002 ms. Cell capacitance was set
to Cm = 1 F/cm2.
5.3 Results
5.3.1 Solution to the minimization problem
Table 5.1 summarizes the results of the optimization algorithm for each combination
of constraints. In each of the tested cases, which are identified by letters A to L,
one, two, three or four constraints in the set {C1, C2, C3, C4 } were imposed. As
can be observed from Table 5.1, all the solutions that allowed qf and qf2 to be
different (C1 not satisfied) rendered non-valid results at the ionic level. Only one
solution where Vf;1/2 was larger than Vf2;1/2 (C2 not satisfied) rendered a valid
solution at the ionic level. In that case, the distance between Vf;1/2 and Vf2;1/2
was smaller than in simulations G, H, and I, which were associated with non-valid
solutions (either at ionic or cell levels). When constraint C2 was active, Vf;1/2 was
always equal to Vf2;1/2.
Simulation results accepted as valid after evaluation at the ionic level (G, J,
K, L) were subsequently evaluated at cell and tissue levels by computation of a
set of electrophysiological markers. The three solutions that increased the value of
f2;ss;1 (H, J, K) greatly reduced the value of APD90 and, of note, varying GCaL
within the percentages indicated in section 5.2.2 did not lead to APD90 values
within physiological range. Only the solution obtained after having imposed the
four constraints rendered a valid solution at both cell and tissue scales.
5.3.2 New definition of ICaL current
The solution obtained from the minimization problem with all constraints led to
the following definition of ICaL voltage-dependent inactivation steady-state:
fss =
1
1 + e
V+24:63
5:87
(5.6)
f2;ss =
0:67
1 + e
V+24:63
5:87
+ 0:33 (5.7)
The mean square error between data simulated with the modified CRLP model
and experimental data, calculated according to the expression in equation 5.5, was
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C1 C2 C3 C4 Id Improvement ValidationIonic Cell
No
No No
No A 62.74% No —
Yes B 54.93% No —
Yes Yes C 41.59% No —
Yes No
No D 53.44% No —
Yes E 54.27% No —
Yes Yes F 35.28% No —
Yes
No No
No G 43.06% No —
Yes H 20.60% Yes No
Yes Yes I 19.79% No —
Yes No
No J 38.57% Yes No
Yes K 18.66% Yes No
Yes Yes L 17.14% Yes Yes
Table 5.1: Results of the minimization problem and subsequent validation. Im-
provement represents the error for each combination of constraints normalized by
the error before the optimization.
20% lower than the corresponding error for the initial CRLP model. Fig. 5.4 shows
how the proposed solution satisfactorily reproduced available experimental data.
In tissue, the obtained solution rendered values of APD, triangulation and APD
adaptation to abrupt cycle length changes within physiological range, although
systolic and diastolic [Ca2+]i values were somewhat further away from physiological
range than for the initial CRLP model (see Table 5.2).
Marker PhysiologicalRange CRLP
This
Work
APD90 (ms) 271-366 305.7 279.2
Triangulation (ms) 44-112 67.1 67.8
Sys. [Ca2+]i @ 1Hz (mM) 1.59-2.01 0.605 0.335
Sys. [Ca2+]i @ 0.5Hz (mM) 0.71-1.68 0.538 0.305
Dia. [Ca2+]i @ 1Hz (mM) 0.20-0.33 0.097 0.090
Dia. [Ca2+]i @ 0.5Hz (mM) 0.14-0.32 0.092 0.087
slow (s) 70-110 101.9 99.5
Table 5.2: Evaluation of electrophysiological markers in tissue for the initial and
adjusted CRLP models (third and fourth columns). Available physiological ranges
are provided in the second column [12].
In Figure 5.5, simulated electrophysiological markers in tissue are shown. Fol-
lowing the readjustment proposed in this chapter, the AP presents a physiological
shape at the end of phase 1.
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Figure 5.4: Comparison between the results of the in silico simulations for the
CRLP model and the adjusted model of this chapter and the experimental results
of [1–3].
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Figure 5.5: Results of tissue simulations computed with the readjusted CRLP
model proposed in this chapter. a) AP at a cycle length of 1000 ms. b) [Ca2+]i at
a cycle length of 1000 ms. c) APD adaptation to abrupt cycle length changes.
5.4 Discussion
In cardiac electrophysiological modeling and simulation, there are ionic currents
whose definition is particularly challenging. Many ionic parameters can not be
directly measured due to the interaction with other model components or due to
technical limitations. As an example, some gating dynamics are so fast that its ac-
tivity overlaps with the capacitive current, thus preventing its direct measurement.
In other cases, experimental protocols have been designed to specifically isolate
the effects of one parameter of interest in a given model, but, when the complexity
of the model increases, it is not possible to isolate it completely. For those rea-
sons: i) when an ionic current is aimed at being formulated, its definition, or at
least its validation, should be performed considering the whole model of the ionic
current; ii) when an element of an ionic current is modified, the other elements
should be readjusted to guarantee that model ionic behavior is in agreement with
experimental evidences.
This chapter focused on adjusting the formulation of the time constants of ICaL
voltage-dependent inactivation to improve the AP shape of the CRLP model at the
end of phase 1. As shown in chapter 4, due to the interactions between different
elements of the ICaL current, simulation of in silico protocols should be run to
adjust parameters defining ICaL voltage-dependent inactivation steady-state, thus
accounting for the effects on the whole ionic current.
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5.4.1 Development and validation of a new ionic current formulation
A minimization problem was mathematically defined to adjust the formulation of
the ICaL current in the CRLP model. Different sets of experimental data providing
steady-state measurements of ICaL voltage-dependent inactivation were considered
to fit the ionic gating parameters. If no constraints were imposed on the mini-
mization problem, the obtained result was associated with a very small error, but
rendered unphysiological results due to the fact the two inactivation gates (fast
and slow) did not act in a coordinated way as in the experiments. For that reason,
constraints were imposed when fitting the parameters describing voltage-dependent
inactivation steady-state. These constraints were selected based on the formula-
tion of ICaL gating proposed in [51]. Our results showed that to all constraints were
necessary to reproduce experimental results on ICaL inactivation and at the same
time guarantee that electrophysiological markers (APD90, AP triangulation, APD
adaptation to abrupt cycle length changes and systolic and diastolic [Ca2+]i levels)
were within physiological ranges.
This chapter considered evaluations at ionic, cell and tissue scales that were
performed as a model validation step once the solution to the above described
constrained minimization problem had been obtained. Future studies could develop
the methods to integrate at least part of the validation rules as constraints in the
formulation of the minimization problem.
5.4.2 Reproducing experimental data from different laboratories
One of the difficulties in using different experimental datasets to adjust the pa-
rameters of an ionic current is that each dataset is commonly measured under
specific experimental conditions. For this reason, the results of different experi-
mental studies can not be directly compared and, consequently, they cannot be
used concomitantly when for parameter estimation without considering such dif-
ferences. On the other hand, the benefit of having experimental datasets recorded
under different conditions provides a wider range of data that can be taken into
account for model adjustment. Thus, if used correctly, the fact of having highly
heterogeneous experimental sets of data can be seen as an advantage rather than
a limitation.
Specifically, in this chapter the use of the described experimental datasets made
it possible to improve the overall behavior of ICaL voltage-dependent inactivation
steady-state without modifying the theoretical expression of the involved gates but
rather by modifying the values of the associated parameters. Replication of the
experimental data in [1] and [3] with the optimized ICaL model led to differences
between in silico and experimental results were remarkably smaller than for the
initial CRLP model. Only when comparing with the experimental data in [2],
the observed differences were small. In overall terms, the optimization problem
proposed and solved in this chapter led to relevant improvements in almost all
performed evaluations.
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5.5 Conclusions
In this chapter the expression of the ICaL current in the CRLP model has been
adjusted to correct for the unphysiological shape of the AP following phase 1.
Although the CRLP model, developed in chapter 2 and updated in chapter 3,
had been tested against various sets of experimental data, considering different
scales and interactions between model components as reported in chapter 4, it
presented a rather uncommon bump following AP transient repolarization in phase
1. In silico simulations of experimental protocols described in chapter 4 were ran
and the corresponding results were included as part of an optimization problem
with a number of carefully defined constraints, which was solved to adjust model
variables in such a way that experimental outcomes were more closely represented.
The methodology described in chapter 3 was used for optimization solving. To
guarantee that model overfitting was avoided, validation was performed at ionic,
cell and tissue scales.
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Chapter 6
A Human Ventricular
Electrophysiological
Model with Improved
Description of
Experimental Behavior
6.1 Introduction
In chapter 3 and chapter 5, updates to the model described in chapter 2 were ad-
dressed. The update in chapter 3 allowed the inclusion of intracellular potassium
dynamics, while the update in chapter 5 involved refining the expression of the
L-type calcium current, ICaL, to render an AP shape closer to experimental shapes,
particularly regarding AP phase 1. When developing the CRLP model in chapter 2,
departing from the GPB model, a paradigm based on reproducing a set of experi-
mentally measured electrophysiological markers was used to guide the development
process. Within that paradigm, model variables or parameters were updated one
at a time along the iterations of the proposed methodology. When [K+]i dynamics
were included in the CRLP model (chapter 3), an optimization algorithm was used
to update several ionic conductances concomitantly, while guaranteeing that the set
of electrophysiological markers remained within physiological ranges or, otherwise,
their values were closer to the physiological range than with the original CRLP
model. When updating the expression of the ICaL current (chapter 5), the method-
ologies described in chapter 4 were used and parameters related to the steady-state
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value of voltage-dependent inactivation gates were modified while considering the
effect on global gating behavior and the improvement in in silico simulations of
experimental results.
As discussed in chapter 4, when comparing simulations of electrophysiological
models against experimental results, in silico simulations should replicate the cor-
responding experimental protocols as closely as possible. For that purpose, the
conditions in which the experiments were performed should be carefully taken into
account. In addition, the spatial scales involved in the experiments should be
considered when comparing, for instance, simulated and experimental electrophys-
iological properties. Regarding the latter, experiments performed to characterize
the AP usually employ small pieces of tissue to avoid the problem of sensitivity of
some ion channels to the cell isolation procedure [106]. However, for computational
reasons, simulations are commonly carried out using single cell models. As shown
in chapter 4, this may represent a limitation, particularly for a number of markers
whose values highly differ when evaluated in single cells or tissues. Importantly,
not only do results differ from cell to tissue but the underlying ionic contributions
can be different as well. This makes identification of ionic current conductances
even more challenging.
Another important point to consider when comparing in silico results with ex-
perimental measurements is the definition of experimentally-based physiological
ranges. In chapter 2, physiological ranges were defined following the criteria used
in [12]. Specifically, the upper and lower limits of the physiological range of a given
electrophysiological property were determined by the maximum and the minimum
value of that property found in the literature. This definition has two main limita-
tions. The first limitation refers to the fact that in many experimental studies only
an average value of a set of experiments is provided. Consequently, if the maximum
or the minimum value is selected based on such average values, the physiological
range will surely be smaller than the experimental range. The second limitation is
in regards of the fact that, in each experimental study, electrophysiological prop-
erties are measured by using different bath solutions. This means that part of the
differences found between experimental studies could be due to differences in the
extracellular ionic concentrations.
The main objective of this chapter is to integrate all the initial formulations
and subsequent updates of the CRLP model proposed in previous chapters and
to readjust the ionic conductances of the integrated model to improve replication
of experimental electrophysiological measures. All the methodologies introduced
throughout the thesis are used to build this human ventricular AP model. In par-
ticular, to compare the simulation and experimental results, each experiment was
initially considered individually, making sure that the conditions underlying the
experiment were replicated as faithfully as possible. In line with the conclusions
reported in chapter 4, a physiological range was established for each individual ex-
periment by using the mean value and the standard deviation reported in the corre-
sponding study (see section 6.2 for details). Additionally, based on the mentioned
differences found between cell and tissue in many electrophysiological properties,
only those that remain essentially the same in one and another scale were consid-
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ered for model development, while other properties were included in the validation
process, in which tissue simulation results were contrasted with experimental tissue
data.
The final version of the CRLP model built in this chapter is compared with
that of the most recent human ventricular cell models: ten Tusscher-Panfilov
(TP06) [51], Grandi-Pasqualini-Bers (GPB) model [15], O’Hara-Rudy-dynamic
(ORd) model [64], and the original Carro-Rodríguez-Laguna-Pueyo (CRLP) model
[120]. Results are in all cases compared against experimental results and conditions
where one or another model best represents experimental outcomes are highlighted.
6.2 Methods
6.2.1 Adjustment of ionic conductances
The CRLP model with the updates of chapter 3 and chapter 5 was considered as a
starting point. The ionic conductances of that model were redefined following the
procedure introduced in chapter 3 with the following modifications:
 All the ionic conductances and the calcium diffusion coefficients between the
intracellular spaces were considered as variables to be adjusted.
 A large number of markers obtained from different experimental datasets
were considered. In the simulation of each dataset, the stimulation protocol
was reproduced and the specific experimental conditions were considered by
setting the values of the extracellular ionic concentrations as those in the
experiments.
 A new optimization function was proposed to make as many markers as
possible lie within established physiological ranges.
Details on each of the above aspects are provided in the following paragraphs.
Minimization function
With the aim of developing a model that closely reproduces the average behav-
ior of human ventricular epicardial cells, a minimization function was introduced
that accounts for the sum of errors associated with the different evaluated electro-
physiological markers. For each marker, mi, the error was defined in terms of the
experimental mean and standard error of the mean (SEM) as follows:
errmi(x) =
i  mi(x)
SEMi
(6.1)
where i is the experimental mean value of marker mi; mi(x) is the simulated
value of marker mi obtained for model parameter values in vector x; and SEMi is
the experimental standard error of the mean of marker mi.
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The objective function was defined as the sum of the square of the errors asso-
ciated with all evaluated electrophysiological markers as follows:
f(x) =
MX
i=1
(errmi(x))2 =
MX
i=1

i  mi(x)
SEMi
2
(6.2)
where M is the total number of electrophysiological markers evaluated in the op-
timization problem.
Of note, SEM represents the confidence in the experimental average value of
a marker and depends on the number of experiments and on the sample standard
deviation. If the sample standard deviation is high but there are a larger number of
experiments, the mean experimental value could be trusted more than another one
for which the sample standard deviation was lower but was obtained from a fewer
number of experiments. When the difference between the simulated and mean
experimental values of the marker is within the SEM, the error for that marker is
between -1 and 1. Consequently, The defined objective function reduces the error
for markers within that range and increases it for markers out of that range.
Experimental data sets
The following experimental datasets were included in the optimization problem
defined to fit ionic current conductances:
 TESZT: AP traces from healthy human ventricular endocardial tissues at
steady-state were acquired at the University of Szeged. After reaching steady-
state following pacing at a CL of 1000 ms, 10 pulses were recorded. Following
this, different drugs were added to inhibit potassium currents: 1 M of HMR-
1556 and 100 nM of L735,821 corresponding to approximately 95% IKs block
[137, 138]; 50 nM of dofetilide corresponding to 15% IKr block [139]; 1 M of
dofetilide and 1 M of E-4031 corresponding to 70% IKr block [34, 139]; 100
M of BaCl2 corresponding to 75% IK1 block [140]. After reaching steady-
state following each of the above drug actions, 10 pulses were recorded at a
pacing CL of 1000 ms.
For each AP recording, two markers were measured: APD90 and resting
membrane potential (Vrest). According to the results presented in chapter 4,
these two markers show similar values and underlying mechanisms when eval-
uated at cell or tissue levels. In Table 6.1, evaluation of these two markers
in the TESZT dataset, both at baseline and following each of the described
pharmacological potassium inhibitions, are summarized. For potassium in-
hibition experiments, results are expressed as percentage of variation with
respect to control conditions.
The bath solution in the experiments of the TESZT dataset is described
in [64]. Values of ion concentrations in the bath solution were as follows:
[Ca2+]o = 1:8 mM , [K+]o = 4:0 mM , [Na+]o = 135:0 mM , [Cl ]o =
124:6 mM .
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Experiment Marker Mean SEM n
Control APD90 (ms) 293.85 10.41 23
Vrest -86.75 0.92
IK1 block 75% Variation in APD90 (%) +19.25 3.09 6Variation of Vrest (%) -4.56 1.95
IKr block 15% Variation in APD90 (%) +51.17 8.57 11Variation of Vrest (%) +0.67 1.11
IKr block 70% Variation in APD90 (%) +51.17 8.57 11Variation of Vrest (%) +0.67 1.11
IKs block 95% Variation in APD90 (%) +1.53 1.42 6Variation of Vrest (%) -0.19 1.59
Table 6.1: Evaluation of APD90 and Vrest in the TESZT dataset.
 CLVPET: AP traces from healthy human ventricular endocardial tissues
under variable CL stimulation were acquired at the University of Szeged.
After reaching steady-state following pacing at a CL of 1000 ms, stimulati at
CLs varying from 300 ms to 5000 ms were applied. For each CL, 25 pulses
were delivered and the AP corresponding to the last pulse was recorded. As
in the TESZT dataset, drugs were subsequently added to inhibit potassium
currents. The same drugs, and at the same concentrations, were supplied to
the tissues in this case.
For AP recordings under control conditions, the variation in the APD with
respect to steady-state APD at CL = 1000 ms was quantified. For AP record-
ings under potassium inhibitions, the variation in the APD with respect to the
APD at the same CL under control conditions was quantified. In Table 6.2,
evaluation of variations in APD90 are summarized.
The bath solution in the experiments of the CLVPET dataset is described
in [64]. Values of ion concentrations in the bath solution were as follows:
[Ca2+]o = 1:8 mM , [K+]o = 4:0 mM , [Na+]o = 135:0 mM , [Cl ]o =
124:6 mM .
 Drouin et al. (1995) [8]: APD90 values from epicardial and endocardial
cells of human ventricular tissues were measured. APD90 was quantified at
different CLs spanning from 1000 ms to 10000 ms. In Table 6.3, evaluation
of APD90 is summarized.
The bath solution used in this experiments is described in [8]. Values of
ion concentrations in the bath solution were as follows: [Ca2+]o = 2:7 mM ,
[K+]o = 4:0 mM , [Na+]o = 150:8 mM , [Cl ]o = 141:4 mM .
 Pieske et al. (2002) [9]: Intracellular sodium ([Na+]i) concentrations were
measured at the following CLs: 333, 500, 1000 and 4000 ms. In this study,
the absolute value of [Na+]i at CL = 1000 ms and the variations in [Na+]i
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Experiment Marker CL Mean SEM n
Control APD90 (%)
300 ms -24.98 1.38
21
400 ms -20.35 1.48
500 ms -14.57 1.05
700 ms -8.61 1.00
1000 ms -3.12 0.60
1500 ms +4.28 1.02
2000 ms +8.75 1.16
3000 ms +13.86 2.22
5000 ms +16.32 1.55
IK1 Blocked APD90 (%)
400 ms -9.68 5.35
6
500 ms -0.37 4.74
700 ms +10.93 3.75
1000 ms +20.55 3.66
1500 ms +29.32 4.33
2000 ms +32.56 4.96
3000 ms +37.49 6.09
5000 ms +41.93 7.17
IKr Blocked APD90 (%)
500 ms +19.51 5.45
9
700 ms +41.52 8.43
1000 ms +53.68 9.05
1500 ms +68.72 10.41
2000 ms +82.65 11.10
3000 ms +100.00 12.80
5000 ms +127.33 15.73
IKs Blocked APD90 (%)
300 ms -23.80 2.68
5
400 ms -17.94 2.52
500 ms -14.22 2.37
700 ms -8.22 1.81
1000 ms -2.62 1.59
1500 ms +2.82 1.52
2000 ms +6.59 2.02
3000 ms +9.13 2.71
5000 ms +11.96 3.79
Table 6.2: Evaluation of variations in APD90 in the CLVPET dataset.
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Experiment Marker CL Mean SEM n
ENDO APD90 (ms)
1000 ms 329.5 15.6
14
2000 ms 345.3 17.2
3000 ms 362.2 20.5
4000 ms 369.5 21.2
5000 ms 378.1 20.8
6000 ms 393.0 22.8
10000 ms 406.5 25.5
EPI APD90 (ms)
1000 ms 350.6 14.6
14
2000 ms 382.1 19.5
3000 ms 392.0 19.9
4000 ms 406.5 18.9
5000 ms 418.8 17.2
6000 ms 424.4 17.2
10000 ms 463.1 14.6
Table 6.3: Evaluation of APD90 in the study by Drouin et al. [8].
Experiment Marker Mean SEM n
CL = 1000 ms [Na+]i (mM) 18.58 3.91 7
CL = 4000 ms Variation in [Na+]i (%) -15.34 17.5 7
CL = 500 ms Variation in [Na+]i (%) +10.66 22.8 7
CL = 333 ms Variation in [Na+]i (%) +21.74 25.3 7
Table 6.4: Evaluation of [Na+]i and its variations in the study by Pieske et al.
[9].
for other CLs expressed as a percentage with respect to CL = 1000 ms were
quantified. In Table 6.4, evaluation of these markers is summarized.
Values of ion concentrations in the bath solution were as follows: [Ca2+]o =
1:0 mM , [K+]o = 5:4 mM , [Na+]o = 152:0 mM , [Cl ]o = 157:8 mM .
 Schmidt et al. (1998) [10]: Intracellular calcium ([Ca2+]i) concentrations
were measured at the following CLs: 333, 400, 500, 575, 666, 750, 1000, 1400,
2000, 3000 and 8000 ms. In this study, the absolute systolic and diastolic
values of [Ca2+]i for CL = 1000 ms and the variations in those values for
other CLs expressed as a percentage with respect to CL = 1000 ms were
quantified. In Table 6.5, evaluation of these markers is summarized.
The concentration of the main ions in the bath solution was: [Ca2+]o =
2:5 mM , [K+]o = 5:9 mM , [Na+]o = 126:2 mM , [Cl ]o = 133:3 mM .
 Coppini et al. (2013) [11]: Intracellular calcium ([Ca2+]i) concentrations
were measured at the following CLs: 1000, 2000, and 5000 ms. The following
markers were evaluated:
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Experiment Marker Mean SEM n
CL = 1000 ms
Diastolic [Ca2+]i (M) 1.798 0.0887 6Systolic [Ca2+]i (M) 0.256 0.0295
CL = 333 ms
Var. in Diastolic [Ca2+]i (%) +48.26 17.83 6Var. of Systolic [Ca2+]i (%) -2.22 5.22
CL = 400 ms
Var. in Diastolic [Ca2+]i (%) +34.45 13.23 6Var. of Systolic [Ca2+]i (%) +8.89 5.51
CL = 500 ms
Var. in Diastolic [Ca2+]i (%) +25.83 13.23 6Var. of Systolic [Ca2+]i (%) +14.11 5.61
CL = 575 ms
Var. in Diastolic [Ca2+]i (%) +18.96 12.06 6Var. of Systolic [Ca2+]i (%) +10.92 5.71
CL = 666 ms
Var. in Diastolic [Ca2+]i (%) +6.87 9.75 6Var. of Systolic [Ca2+]i (%) +8.41 5.22
CL = 750 ms
Var. in Diastolic [Ca2+]i (%) +6.32 9.21 6Var. of Systolic [Ca2+]i (%) +5.61 5.028
CL = 1400 ms
Var. in Diastolic [Ca2+]i (%) -4.60 10.93 6Var. of Systolic [Ca2+]i (%) -5.71 4.74
CL = 2000 ms
Var. of Diastolic [Ca2+]i (%) +2.85 11.51 6Var. of Systolic [Ca2+]i (%) -16.63 3.97
CL = 3000 ms
Var. in Diastolic [Ca2+]i (%) +1.09 9.21 6Var. of Systolic [Ca2+]i (%) -21.95 3.48
CL = 8000 ms
Var. in Diastolic [Ca2+]i (%) +3.43 12.06 6Var. of Systolic [Ca2+]i (%) -27.56 3.29
Table 6.5: Evaluation of [Ca2+]i and its variations in the study by Schmidt et al.
[10].
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Experiment Marker Mean SEM n
CL = 1000 ms
Diastolic [Ca2+]i (M) 0.139 0.00994
6[Ca
2+]i (M) 0.3528 0.0176
tCai;50% (ms) 170.27 26.37
tCai;90% (ms) 356.21 46.15
CL = 2000 ms Var. of Diastolic [Ca2+]i (%) -3.66 6.70 6
CL = 5000 ms
Var. of Diastolic [Ca2+]i (%) -7.82 5.83
6[Ca
2+]i (M) 0.343 0.0163
tCai;50% (ms) 239.33 35.16
tCai;90% (ms) 517.57 52.73
Table 6.6: Evaluation of [Ca2+]i characteristics in the study by Coppini et al. [11].
Marker Mean SEM n
t90%;1000!600 (ms) 119.5 21.57 2
t90%;600!1000 (ms) 243.0 59.40
Table 6.7: Evaluation of time for APD rate adaptation in the study by Pueyo
et al. [13].
– Diastolic [Ca2+]i: Absolute value for CL = 1000 ms and percentage of
variation at CL = 2000 and 5000 ms with respect to CL = 1000 ms.
– Difference between systolic and diastolic [Ca2+]i levels, denoted by[Ca2+]i:
Absolute values for CL 1000 and 5000 ms.
– Time constants: Time from the peak to 50% and 90% recovery of the
[Ca2+]i transient, denoted by tCai;50% and tCai;90%, respectively: Ab-
solute values for CL = 1000 and 5000 ms.
In Table 6.6, evaluation of these markers is summarized.
Values of ion concentrations in the bath solution were as follows: [Ca2+]o =
1:8 mM , [K+]o = 4:0 mM , [Na+]o = 132:0 mM , [Cl ]o = 142:0 mM .
 Pueyo et al. (2010) [13]: APD rate adaptation to abrupt CL changes when
varying CL from 1000 to 600 ms and from 600 to 1000 ms were measured.
In this study, following a period of steady-state pacing at a CL of 1000 ms,
stimuli were delivered at a CL of 600 ms for 10 minutes and, subsequently,
at a CL of 1000 ms for additional 10 minutes. In each transition, the time
to reach 90% of the final APD value was measured, denoted by t90%;1000!600
and t90%;600!1000, respectively. In Table 6.7, evaluation of this marker is
summarized.
Values of ion concentrations in the bath solution were as follows: [Ca2+]o =
1:0 mM , [K+]o = 4:0 mM , [Na+]o = 144:0 mM , [Cl ]o = 128:0 mM .
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Simulation of experimental protocols
The experimental protocols were simulated in isolated cells using a biphasic stim-
ulation current as described in [118]. While biphasic stimulation does not remove
differences between cell and tissue simulation results as discussed in chapter 4, it
provides a better approximation for the variations in [Na+]i and [K+]i with the
frequency of stimulation, owing the fact that the ionic load during each cycle is 0.
The amplitude of the biphasic stimulation current was set to twice the diastolic
threshold of the model. The duration of the positive square pulse of the biphasic
stimulation was set to 1 ms.
The model was first stabilized until steady-state conditions were reached. In
particular, the following stimulation protocols were applied when comparing with
the different experimental datasets:
 For the TESZT and CLVPET datasets, the model was first stimulated during
50 minutes at a CL of 1000 ms. The TESZT protocol involved evaluation
during the last cycle. The CLVPET protocol involved replication at different
CLs after this pre-stimulation.
 For the experiments of Drouin et al., Pieske et al., Schmidt et al. and Cop-
pini et al., the model was stimulated during 50 minutes at different CLs.
Electrophyisiological markers were evaluated during the last cycle.
 For the experiments published by Pueyo et al., the model was first stimulated
during 50 minutes at a CL of 1000 ms, CL was subsequently reduced to 600
ms and stimulation applied for 10 minutes and, finally, CL was increased to
1000 ms and stimulation applied for other 10 minutes.
Optimization algorithm
The optimization algorithm was as described in chapter 3. Design variables in-
cluded all the ionic conductances of the model as well as parameters related to
diffusion of intracellular calcium, namely:
 GNa: conductance of the fast sodium current (INa).
 GNa,bk: conductance of the background sodium current (INa,bk).
 GKr: conductance of the rapidly activating potassium current (IKr).
 GKs: conductance of the slowly activating potassium current (IKs).
 GKp: conductance of the plateau potassium current (IKp).
 Gto: conductance of the transient outward potassium current (Ito).
 GK1: conductance of the inward rectifier potassium current (IK1).
 GClCa: conductance of the calcium-activated chloride current (IClCa).
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 GCl,bk: conductance of the background chloride current (ICl,bk).
 GCaL: conductance of the L-type calcium current (ICaL).
 GCa,bk: conductance of the background calcium current (ICa,bk).
 INaK : maximum current carried through the sodium-potassium pump.
 Incx: maximum current carried through the sodium-calcium exchanger.
 IPMCA: maximum current carried through the sarcolemmal calcium pump.
 JCajunc,sl : diffusion of calcium from the junctional to the subsarcolemmal com-
partment.
 JCasl,myo : diffusion of calcium from the subsarcolemmal compartment to the
myoplasm.
 JSRleak : diffusion of calcium from the sarcoplasmatic reticulum to the my-
oplasm.
 JSRCarel : calcium release from the sarcoplasmatic reticulum to the junctionalcompartment.
 JserCa : calcium release from the sarcoplasmatic reticulum to the myoplasm.
As in chapter 3, all these variables were scaled to deal with their different orders
of magnitude:
xi = 20  log10

yi
y0i

; (6.3)
where y0i and yi are the initial and current values of the ith variable and xi is its
scaled value.
The initial radius for the trust region was selected as 2.5 for all the variables.
The minimum tolerance for the scaled variables, 1, was set to 0.01. The minimum
tolerance for the optimization function, 2, was set to 0.01. The minimum gradient,
3, was taken as 0.01. To create the database of markers in each iteration, 500
randomly-selected combinations of the design variables in the trust region were
simulated in each iteration of the optimization algorithm. For each marker, a
first-order response surface was calculated. To guarantee positivity of the response
surface of the objective function, a response surface of first order was created for
the error and later, it was squared.
Valid ranges for electrophysiological markers were defined based on experimen-
tal observations and simulated values of the electrophysiological markers under
control conditions. Specifically, the upper and lower limits were defined as follows:
mj;UL = max

mj ;exp + 2  mj ;exp; mj;control
	
mj;LL = min

mj ;exp   2  mj ;exp; mj;control
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where mj;UL is the upper limit for marker mj , mj;LL is the lower limit for marker
mj , mj ;exp is the mean of the experimental observations for marker mj , mj ;exp
is the standard deviation of the experimental observations for marker mj and
mj;control is the simulated value of the marker under control conditions.
All markers were considered as constraints for the optimization algorithm. As
in chapter 3, these constraints were defined to be consistent with the general for-
mulation of the inequality constraints:
gj(x) =
mj(x) mj;CRmj;RR
  1  0;
where mj;CR = (mj;UL +mj;LL)/2 is the central point of the valid range for the
electrophysiological marker j and mj;RR = (mj;UL  mj;LL)/2 is the distance between
mj;CR and each of the limits of the valid range.
Implementation
The model was implemented in CellML using the original CellML model pub-
lished in [120]. For the simulations, the model was exported to C++ and in-
cluded in the application of the DENIS project (http://denis.usj.es). The tool
to export the model can be found here: https://bitbucket.org/usj_bsicos/
denis-cellml2c/src/v0.1/. The original code of the DENIS application can be
found here: https://bitbucket.org/usj_bsicos/denis-myocyte/src/beta_v1.
0/. The equations of the model were solved using Fordward-Euler integrator with
a time step of 0.002 ms. Post-processing of simulation results and implementation
of the optimization algorithm were developed in MatLab® 2017a (The Mathworks
Inc.).
6.2.2 Model comparison
The behavior of the optimized model was compared against the original CRLP
model and other commonly employed human ventricular cell models (TP06, GPB,
ORd). Electrophysiological markers were computed in single cells for each of those
models.
6.2.3 Model validation
The optimized model was validated against experimental results by using a set of
electrophysiological markers different from the ones used for model development.
In chapter 4, markers like triangulation and upstroke or maximal potential were
shown to be highly different when evaluated in cells or tissues. These markers, not
having been used for model optimization, were used for validation. Evaluation was
performed by using a 3 cm-long homogeneous fiber model of endocardial ventricular
cells. The conditions of the experiments against which simulation results were
compared were reproduced by adjusting the external ionic concentrations. The
value of  was calculated to obtain a CV close to 65 cm/s [88] under control
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conditions. The cell capacitance was set to Cm = 1 F/cm2. Each marker was
evaluated at five positions within the fiber. Those positions were located at 1.00,
1.25, 1.50, 1.75 and 2.00 cm from the stimulation end of the cable. The mean value
of each marker over the five positions was calculated.
The same evaluation described for the optimized CRLP model was performed
for the initial CRLP model to assess the effect of the model optimization introduced
in this chapter.
Experimental dataset
The TESZT dataset described above provided experimental results on the following
AP markers:
 Triangulation: Difference between the APD90 and the APD50.
 Upstroke: Maximum of the temporal derivative of the membrane potential.
 Maximum potential: Maximum of the membrane potential.
On top of evaluating these markers under control conditions, the percentages of
variation in each marker following ionic current inhibitions (IK1, IKr or IKs blockades)
with respect to control conditions were measured. The bath solution in these
experiments is described in [64]: [Ca2+]o = 1:8 mM , [K+]o = 4:0 mM , [Na+]o =
135:0 mM , [Cl ]o = 124:6 mM .
For the steady-state simulations in fiber, we simulate 5 minutes of activity. We
reduced the simulation time for the fiber simulations in order to be able to obtain
the results in a reasonable time.
Implementation
Simulations were performed in a homogeneous 3-cm long fiber composed of endo-
cardial cells. A semi-implicit operator-splitting scheme [87] was used to solve the
model with a space discretization of x = 0:1 mm and a time step of t = 0:002
ms. The value of  was selected to get a maximum CV of 65 cm/s, which is in
agreement with experimentally reported CV values [88]. The cell capacitance was
set to Cm=1F/cm2. Fiber simulations were implemented in FORTRAN.
6.3 Results
6.3.1 Model optimization
Following model optimization, the variation in the ionic conductances of the op-
timized model with respect to the initial CRLP model varied between -23% and
30%. The original model had an error of 1783.4 (according to the formula defined
in section 6.2). After 13 iterations of the optimization algorithm, the error was
1360.5, thus representing a reduction in the error of 23.7%.
While in the initial CRLP model 77.2% of the markers were in physiological
range, this value increased to 81.2% after the optimization. Figure 6.1 shows the
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Blockage Marker Physiol. This CRLP ORd GPB TP06min mean max work
Control APD90 (ms) 194.0 293.8 393.6 328.6 334.2 279.6 283.0 285.4
Vmin (mV) -95.6 -86.8 -77.9 -87.4 -90.7 -96.2 -81.6 -93.8
75% IK1 APD90 (%) 4.1 19.3 34.4 13.3 34.1 10.1 26.1 6.3Vmin (%) -14.1 -4.6 5.0 -32.4 -25.0 1.0 -4.6 -3.9
15% IKr APD90 (%) 9.3 39.1 68.8 2.7 2.9 9.6 2.4 2.4Vmin (%) -5.1 -1.2 2.8 0.2 0.0 0.0 0.0 0.0
70% IKr APD90 (%) -5.5 58.1 121.7 15.2 15.9 71.6 13.1 13.0Vmin (%) -6.4 1.7 9.8 0.8 -0.1 0.0 0.0 0.0
95% IKs APD90 (%) -5.4 1.5 8.5 0.5 0.6 6.3 0.7 55.9Vmin (%) -8.0 -0.2 7.6 0.0 0.0 0.0 0.0 0.2
Table 6.8: Results of steady-state AP markers for a CL of 1000 ms computed with
the optimized CRLP model and other published human ventricular cell models.
AP of a single epicardial cell simulated under control conditions with the optimized
CRLP model and with other published human ventricular cell models. As can be
noted, the peak and dome features improved in chapter 5 for the CRLP model were
not modified following the model optimization introduced in this chapter.
The values of the optimized ionic conductances and the final description of the
model can be found in Appendix C.
Steady-state AP markers
Table 6.8 summarizes the results of steady-state AP markers for a CL of 1000 ms
under control conditions and following ionic current inhibitions. These results were
compared with experimental measurements from the University of Szeged and the
results of other recent human ventricular cell models, as described in 6.2. The
first version of the CRLP model, proposed in chapter 2, had only two steady-state
AP markers out of physiological range following inhibition of IK1 or IKr currents.
These two markers were still out of physiological range for the new CRLP model.
For IK1 inhibition, the variation in the resting membrane potential was slightly
larger for the optimized CRLP model than for the initial model version. The lack
of improvement for the new CRLP model can be explained by the modifications
introduced into the model prior to the optimization, namely the introduction of
[K+]i dynamics and the modification of the ICaL current, whereas subsequent opti-
mization tried to compensate the effect of such variations on the resting membrane
potential. Similar conclusions to those described above for IK1 block apply to the
case of IKr block.
APD dependence on CL
Figure 6.2 shows the variation in APD90 for different CLs under control conditions
as computed with the optimized CRLP model, the original CRLP model and other
UniversidadZaragoza
6. A Human Ventricular Electrophysiological Model with Improved
Description of Experimental Behavior 123
a) b)
0 100 200 300 400 500
t (ms)
-100
-50
0
50
V
 (m
V)
0 100 200 300 400 500
t (ms)
-100
-50
0
50
V
 (m
V)
c) d)
0 100 200 300 400 500
t (ms)
-100
-50
0
50
V
 (m
V)
0 100 200 300 400 500
t (ms)
-100
-50
0
50
V
 (m
V)
e)
0 100 200 300 400 500
t (ms)
-100
-50
0
50
V
 (m
V)
Figure 6.1: Action Potential of the different models under control conditions in
single epicardial cells: a) optimized CRLP model; b) initial CRLP model; c) GPB
model; d) ORd model; e) TP06 model.
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Figure 6.2: APD90 variation with CL under the same conditions of the CLVPET
dataset.
published human ventricular cell models. Experimental results evaluated for the
CLVPET dataset are presented for comparison. The APD90 value in cycle 25
of the CLVPET protocol expressed as a percentage of the APD90 value under
steady-state conditions for a CL of 1000 ms is presented. While the initial CRLP
model and the GPB model showed APD increases for decreasing CLs below 500 ms,
the optimized CRLP model already corrected this type of behavior, showing APD
decrases for decreasing CLs no matter the value of the CL. In fact, for long CLs,
the optimized CRLP model shows results very close to the experimental outcomes.
Figure 6.3 shows results of APD variations with CL changes, in this case fol-
lowing ionic current inhibitions. APD values are normalized with respect to those
corresponding to the same CL under control conditions. As can be observed, there
is very good agreement between the new version of the CRLP model and most
experimental results. Out of all the evaluated current inhibitions, the optimized
CRLP model renders results that are within experimental limits in all cases except
for the one corresponding to IKr inhibition.
Simulation results for APD90 variations with CL changes were also compared
with the experimental results published in [8]. Figure 6.4 illustrates the results for
endocardial and epicardial cells. The optimized CRLP model was within physi-
ological ranges for all CLs. Endocardial cells showed longer APs than epicardial
cells for the new CRLP model as well as for all other published human ventricular
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Figure 6.3: APD90 variation with CL under the same conditions of the CLVPET
dataset following ionic current inhibitions: A) 15% IKr block; B) 70% IKr block; C)
95% IKs block; D) Zoomed graphic for 15% IKs block; E) 75% IK1 block.
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Marker Physiol. This CRLP ORd GPB TP06min mean max work
[Na+]i (mM) [9] 0.00 18.58 39.27 9.04 10.06 6.92 8.10 8.06
Sys. [Ca2+]i (M) [10] 1.36 1.80 2.23 0.98 1.45 0.63 0.77 1.77
Dia. [Ca2+]i (M) [10] 0.11 0.26 0.40 0.11 0.12 0.09 0.10 0.13
Dia. [Ca2+]i (M) [11] 0.07 0.14 0.21 0.10 0.10 0.09 0.09 0.10
Table 6.9: Results of steady-state [Na+]i and [Ca2+]i for a CL of 1000 ms com-
puted with the optimized CRLP model and other published human ventricular cell
models.
cell models, including the initial CRLP model.
Intracellular sodium concentrations
In Table 6.9, steady-state [Na+]i for a CL of 1000 ms is presented as calculated
for different human ventricular cell models, including the optimized CRLP model
introduced in this chapter. Figure 6.9 shows the variation in [Na+]i for different
CLs, compared with the physiological ranges measured in the experiments of [9].
All the tested AP models are within experimental ranges.
Intracellular calcium concentrations
In Table 6.9, steady-state diastolic and systolic [Ca2+]i values for a CL of 1000 ms
are presented as calculated for different human ventricular cell models, including
the optimized CRLP model introduced in this chapter, while reproducing the con-
ditions of the experiments described in [10, 11]. Whereas the diastolic [Ca2+]i level
in the optimized model was within the physiological ranges of both experimental
studies, the systolic [Ca2+]i level was somewhat below experimentally reported
limits. Even if the optimization algorithm moved systolic [Ca2+]i towards the
physiological range, previous modifications introduced into the model had sepa-
rated the simulated systolic level to such an extent that it was not possible for the
optimization algorithm to completely move it into the expected range. Neverthe-
less, other commonly used human ventricular AP models present systolic [Ca2+]i
levels similar to those of the optimized CRLP model.
Figure 6.6 shows the variation in diastolic and systolic [Ca2+]i levels for different
CLs under the conditions of the experiments of [10]. Results are expressed as
percentages with respect to the case when the pacing frequency was 1 Hz. For the
comparison with the experimental data of [10], the optimized CRLP model is the
only one with all simulated values lying within the experimentally reported limits.
Figure 6.7 shows variations in [Ca2+]i characteristics for different CLs under the
conditions of the experiments of Coppini et al. [11]. The difference between systolic
and diastolic [Ca2+]i levels was within experimental limits when computed for the
optimized CRLP model (Figure 6.7.A), while all the other human ventricular cell
models rendered results out of those limits. Variations in systolic [Ca2+]i, as well
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Figure 6.4: Simulations of the experiments by Drouin et al. [8]: A) APD90
variation with CL for epicardial cells. B) Zoomed version of the figure shown
in A. C) APD90 variation with CL for endocardial cells. D) Zoomed version of the
figure shown in C.
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Piekse et al. [9] for endocardial cells.
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Figure 6.6: Variation in [Ca2+]i under the same conditions of the experiments by
Schmidt et al. [10]: A) Diastolic [Ca2+]i normalized by the value when the fre-
quency is 1Hz; B) Systolic [Ca2+]i normalized by the value when the the frequency
is 1Hz.
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Marker Physiol. This CRLP ORd GPB TP06min mean max work
t90%;1000!600 (s) 58.5 119.5 180.5 260.5 314.5 254.2 157.9 299.9
t90%;600!1000 (s) 75.0 243.0 411.0 265.3 346.4 352.2 184.4 350.1
Table 6.10: Results of APD adaptation to abrupt CL changes computed with all
tested human ventricular models under the same conditions as in [13].
as time from [Ca2+]i peak to 50% and 90% recovery, for different CLs was in very
good agreement with experimental behavior (Figure 6.7.B, C and D).
APD adaptation to abrupt changes in the CL
Table 6.10 presents the results corresponding to APD adaptation to abrupt CL
changes as calculated for all tested human ventricular cell models and the exper-
iments of [13]. Only the GPB model rendered values of time for 90% adaptation
lying within physiological ranges. The optimized CRLP model, despite being closer
to the experimental limits than the initial CRLP model, only provided physiolog-
ical results for CL increases, but not decreases, as happened with all other model
except for the GPB model.
6.3.2 Model validation
Table 6.11 summarizes validation results for the optimized and the initial CRLP
models. Under control conditions, both models rendered triangulation values out of
physiological range, but upstroke velocity and Vmax values within range. The effects
of ionic current inhibitions over triangulation were practically within physiological
range for both the new and the initial CRLP models. Only IK1 inhibition rendered
results out of physiological range, particularly for the upstroke velocity and Vmax.
Of note, when IK1 was blocked in the optimized model, the ERP increased over
1000 ms and only out of two consecutive stimulations was able to propagate an
AP.
6.4 Discussion
6.4.1 Model performance
The optimized CRLP model has been shown to produce a remarkably improved
behavior with respect to the initial CRLP model when comparing simulated data
with experimental evidences for a set of evaluated electrophysiological properties.
A detailed discussion on this is presented in the following paragraphs, together
with a comparison with other human ventricular cell models already published in
the literature.
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Figure 6.7: Variation in [Ca2+]i characteristics under the same conditions of the
experiments by Coppini et al. [11]: A) Difference between systolic and diastolic
[Ca2+]i levels as a function of CL; B) Systolic [Ca2+]i for different CLs normalized
by the value when CL is 1000 ms; C) Time from [Ca2+]i peak to 50% as a function
of CL; D) Time from [Ca2+]i peak to 90% as a function of CL.
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Blockage Marker Physiol. This CRLPmin mean max work
Control
Triangulation (ms) 44.6 65.2 85.8 137.9 111.1
Upstroke (mV/ms) 132.6 283.5 434.4 275.9 278.6
Vmax (mV) 15.7 28.0 40.3 25.1 27.4
75% IK1
Triangulation (%) 21.3 58.2 95.2 20.2 27.7
Upstroke (%) -21.6 -5.6 10.4 -98.6 0.8
Vmax (%) -7.3 6.4 20.0 -69.3 -0.1
15% IKr
Triangulation (%) -3.5 66.6 136.8 4.5 0.8
Upstroke (%) -37.0 -1.7 33.6 0.1 -0.7
Vmax (%) -44.8 -3.1 38.7 0.0 0.4
70% IKr
Triangulation (%) 3.1 138.7 274.4 24.7 8.3
Upstroke (%) -23.8 2.6 28.9 -1.5 1.9
Vmax (%) -25.7 -5.1 15.5 0.2 1.0
95% IKs
Triangulation (%) -9.6 2.4 14.4 0.2 2.3
Upstroke (%) -13.3 -5.2 2.8 -0.1 -0.6
Vmax (%) -31.1 12.1 55.2 0.0 -7.1
Table 6.11: Validation results. Steady-state AP markers for a CL of 1000 ms
calculated in tissue fibers simulated with the optimized and initial CRLP models.
Response to potassium current inhibitions
One of the limitations of the initial CRLP model was related to APD prolongation
following potassium current inhibitions. Specifically, when the initial CRLP model
was paced at low frequencies, IK1 inhibition prolonged the APD to a larger extent
than experimentally observed. The optimization algorithm reduced the amount of
APD prolongation induced by such inhibition and rendered percentages of APD
change well within physiological ranges. On the other hand, the optimized CRLP
model did not completely reproduce experimental evidences related to the effects
of IK1 inhibition on resting membrane potential. This is due to the fact that
the modifications introduced into the model before the optimization procedure
(i.e. incorporation of [K+]i dynamics and ICaL current refinement) led to resting
potentials further away from experimental data. While the optimization somewhat
improved that behavior, this was not enough to provide resting membrane potential
values lying within experimental limits. As a consequence, the ERP was extremely
large and not all stimulations were able to propagate an AP in a simulated tissue
fiber.
Following IKr inhibition, the optimized CRLP model led to APD prolongation
values of lower magnitude than experimentally reported. To reach an APD pro-
longation of the same extent as in the experiments, the optimization algorithm
employed to develop the new CRLP model was required to change some model
parameters to a remarkably large extent as compared with the trust region of the
algorithm. In the end, this effect was neglected by the algorithm. This can be
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considered as a limitation of how the algorithm was applied by using initially the
same trust region for all model conductances. More details on this limitation are
discussed below (section 6.4.2).
APD dependence on CL
One limitation of the initial CRLP model, inherited from the GPB model, was the
APD response to increasingly shorter CLs. Specifically, for increasingly shorter CLs
below 500 ms, the APD increased rather than decreasing. For the optimized CRLP
model, the APD decreased monotonically for increasingly shorter CLs, even if the
slope of such a relationship was slightly lower than experimentally observed. APD
dependence on CL was additionally investigated following ionic current inhbitions.
The behavior of the optimized model was generally consistent with experimental
data (see Figure 6.3). Nevertheless, there is still some room for improvement,
particularly in regards of the relationship between APD and CL following IK1 in-
hibition.
Also, differences in the APD between endocardial and epicardial cells for differ-
ent CLs were analyzed. The initial CRLP model proposed in this thesis was able
to adequately replicate the experimental APD results reported by Drouin et al. [8]
for epicardial cells, but it presented a significant error for endocardial cells. For the
optimized model, epicardial cells presented APD values shorter than the original
CRLP model while endocardial cells had APD values closer to the mean value of
the experiments. While for all tested human ventricular cell models, APD values
for endocardial cells were longer than for epicardial cells, Drouin et al. showed no
statistically differences in the APD values for both celly types, even being slightly
larger for epicardial cells. The optimized CRLP model rendered APD differences
between both cell types lower than the initial CRLP model and therefore closer to
experimental observations.
Intracellular sodium and calcium concentrations
[Na+]i values present a large variation when measured in different experiments [9].
This results in a very wide physiological range for [Na+]i, with any concentration
below 39.3 mM being considered as physiologically plausible. In the optimization
algorithm applied to develop the new CRLP model, when a given electrophysi-
ological marker presents large experimental variance, its weight in the objective
function is reduced. It is thus not surprising that [Na+]i values in the optimized
CRLP model are further away from mean experimentally reported value than the
initial CRLP model, but in any case of very similar magnitude than the values
reported for other human ventricular cell models of the literature.
Regarding [Ca2+]i values, calculated under the same conditions as in [10], the
optimized CRLP model presented systolic values lower than the first version of the
model and slightly out of physiological range. This can be attributed to the ICaL
current refinement proposed in chapter 5, which the optimization algorithm was
not completely able to compensate for. Nevertheless, similar results were obtained
with other common models, like the ORd and GPB models. On the other hand, the
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optimized CRLP model was the only model able to replicate experimental behav-
ior regarding changes in [Ca2+]i characteristics with the frequency of stimulation.
Specifically, when compared with the experimental data by Coppini et al. [11],
the new CRLP model showed physiological values for systolic and diastolic [Ca2+]i
markers as well as for time from [Ca2+]i peak to 90% recovery, with only time
from [Ca2+]i peak to 90% recovery presenting a less marked changed with pacing
frequency than the mean experimental value.
APD adaptation to abrupt CL changes
The adaptation of ventricular repolarization duration to abrupt changes in CL
has been proposed as an arrhythmic risk marker [81]. The adaptation time was
considered in the development of the new CRLP model. The main limitation of
including this marker in the optimization algorithm is that there are not systematic
studies analyzing it. In [95], ten different combinations of CLs were studied but
none of these combinations was used more than once in the experiments. Only
in [13], two experiments conducted under the same experimental conditions were
reported that served to define a physiological range for the adaptation time in
the process of model development. Large differences were found between results
simulated with the initial CRLP model and the experimental range. Although the
optimized CRLP model rendered results still out of the experimental limits, the
optimization algorithm allowed reducing the difference between the model and the
mean experimental value by more than 27%. The difference between simulated
and maximal experimental value of the adapation time was reduced by as much as
40.3% with respect to the initial CRLP model.
6.4.2 Optimization algorithm
The following paragraphs contain a discussion on a number of aspects of the opti-
mization algorithm used in the development of the CRLP model.
Initialization
In this work, we used an initial trust region with the same radius for each ionic con-
ductance aimed to be updated by the optimization algorithm. After optimization,
some currents were shown to contribute to AP changes to a lower extent than ex-
pected based on experimental evidences. In particular, the effect of IKr block on the
APD was remarkably lower than in available experimental data, and, while such
an effect was within physiological range, the dependence with pacing frequency
shown in the experiments was not reproduced by the model. Also, the increase in
IKs conductance required for this conductance to have notable effects on the AP
was far away from the range the algorithm considered. This could be explained by:
i) all the radius are reduced when one electrophysiological marker is out of range;
ii) the effect of variations in IKs conductance over the tested electrophysiological
markers was very small, so the algorithm did not consider updating this variable.
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A different strategy could be used to initialize the trust region. One possibility
could be to initialize the trust region with a different radius for each variable to
be updated by the optimization algorithm. The radius for each variable could, for
instance, be made inversely proportional to the greatest sensitivity of the evaluated
electrophysiological markers and directly proportional to the experimental variance
of the marker with the largest sensitivity. Based on this or other ideas, future
studies should address how to specifically define radius for each variable.
Objective function
In the optimization algorithm used in chapter 3 for incorporation of [K+]i dynam-
ics into the original CRLP model, the objective function was just defined by the
integral of the total potassium current during a cardiac cycle. In this chapter,
the objective function is defined as a sum of mulitple error functions reflecting
differences between simulated and experimental data in relation to a number of
electrophysiological properties. The weight assigned to each of the errors corre-
sponding to different properties is challenging and has a large impact in the results
obtained from the optimization procedure. In this chapter all errors were weighted
by the same amount. As a consequence, if a specific AP phase is represented
by several evaluated electrophysiological properties, the algorithm could be biased
to fit that phase. Future studies could address how to weight the different error
functions composing the objective function in such a way that the model renders
improved results according to the criteria of interest.
The use of electrophysiological markers as part of an objective function to be
optimized for cardiac AP model development has been explored in [123]. In that
study the authors defined the objective function to be zero when the distance
between the marker and the mean value is lower than the experimental standard
error of the mean and to increase linearly out of this region. Limitations of this
approach include the fact that several combinations of parameters could result in
the same value of the objective function or that improvements in one marker that
is close to physiological range could lead to a major deterioration in the value of
other markers completely out of physiological range, as the error increases linearly.
For this reason, in this chapter a minimization function was defined that assigns an
error value different from zero when the marker is within physiological range and
penalizes much more the fact of being out of range by using a quadratic function.
6.4.3 Validation
The main goal of the validation performed in this chapter was to evaluate that
the model did not show abnormal behavior for electrophysiological properties not
considered during the optimization phase. Future studies could extend validation
to incorporate other properties or to standardize a benchmark for the evaluation
of human ventricular models. This could help to improve our current understand-
ing on the benefits and limitations of any proposed model and to improve model
selection according to the specific problem to be investigated.
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6.5 Conclusions
In this chapter, an optimization algorithm was proposed to update the CRLP model
developed in previous chapters. The optimized CRLP model improved replication
of electrophysiological properties measured experimentally. Simulated results of
those properties were either within physiologically plausible ranges or at least closer
to them than before the optimization. A comparison with other published human
ventricular cell models was established.
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Chapter 7
Conclusions and Future
Work
7.1 Conclusions
In this thesis different techniques to improve the development and validation of
cardiac electrophysiological models have been proposed and analyzed. Based on the
increase in computational power, new strategies to reduce the number of hypothesis
and/or assumptions when building an electrophysiological model were considered.
The major conclusions of the thesis are summarized in the following.
7.1.1 Identification of major issues in electrophysiological model development
and validation
The development and validation of a computational electrophysiological model is a
complex process associated with a number of difficulties. Two main issues are: i) the
limited amount of experimental data the model can be based; ii) the way in which
information is extracted from experiments and used to build the models. Regarding
the former, a reduced number of experimental samples and the possibly limited
information available from those experimental samples may hamper the evaluation
of cell and tissue electrical activities for some range of parameters or under specific
conditions. In the case of human samples, this limitation is even more accentuated,
as there are really few available sets of data, and even more so from healthy human
hearts. Importantly, the experimental protocols applied over those data may not
always provide the information necessary for model development or validation.
Regarding the second limitation, the difficulty in obtaining valuable insights from
experimental studies may be due to the interaction between different elements
underlying cell or tissue electrical responses. For instance, it may be challenging to
investigate specific characteristics of a particular ionic current, as in some cases it
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may not be possible to completely isolate the effects of other currents. Or it may
happen that interactions between activation and/or inactivation gating processes
for a given ionic current hinders the evaluation of specific gating characteristics
necessary to theoretically formulate ionic current expressions in the models.
The above described issues make it complex to develop and validate a com-
putational electrophysiological model that can be used to reproduce experimental
evidences at different scales. In this thesis, a number of techniques were proposed
to minimize the impact of the above described issues and, when possible, to inte-
grate them in the process of development and validation of the model. Of note,
throughout the thesis the importance of considering the interactions between model
components and spatio-temporal scales has been pointed out when evaluating sim-
ulated data. This involves the possibility of considering processes covering from ion
channel characteristics and diffusion of ions in the cell up to the propagation of the
electric wave in excitable cardiac tissue. Since sometimes it may not be possible to
consider all model components at the same time due to computational restrictions,
in this thesis the focus has been on showing when specific elements should neces-
sarily be considered, when it is possible to simplify the model and when it may be
convenient to consider only part of the available information. In particular, this
thesis has highlighted the benefits of using in silico simulations of experimental
protocols to evaluate all those possibilities, as long as in silico simulations replicate
as closely as possible the conditions of the experiments against which the simulated
data is compared. This is further discussed in the next section.
7.1.2 New techniques for improved model development and validation
Throughout this thesis, the uncertainty associated with experimental data used
to build computational models has been analyzed and, when possible, integrated
into the process of model development. Such an uncertainty is in relation to the
large variance commonly observed over different experiments, the relatively low
number of conducted experiments or the limited amount of cells/tissues used for
characterization of the electrical properties of interest.
In some cases there is an additional intrinsic difficulty in obtaining experimental
measures of specific model parameters or in extracting such measures from the
recorded data. This would, for instance, apply to the evaluation of some gating
characteristics of ionic currents. In this thesis, in silico simulation of experimental
protocols is proposed to get indirect estimates of such characteristics. By using
in silico simulation of experimental protocols, together with the application of
other techniques, a model providing an improved representation of experimental
observations was built. Even if this technique turns out to be very useful for
identification of model ionic gating parameters, it becomes necessary to validate
the model with the new ionic expression as a whole so as to assess possible effects
at higher scales.
Another important challenge in computational model development and valida-
tion regards the identification of ionic current conductances. When investigating
cardiac diseases or assessing the effects of drugs, accurate evaluation of the contri-
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bution of each ionic current to the AP is very relevant. If a model with a highly
unbalanced representation of ionic currents is used, the simulation of the effects of
a drug or a disease that block one or several currents may provide totally mean-
ingless results. As discussed throughout this thesis, it is possible to accurately
estimate ionic current conductances by using techniques such as those proposed in
this study. In particular, formulation of an optimization problem that integrates a
number of relevant electrophysiological properties together with available experi-
mental data can to a great extent serve to the purpose of identifying physiologically
plausible conductance values that render the model suitable for investigation of car-
diac diseases or drug effects. Since optimization solving is highly computationally
demanding, approaches based on response surface approximations were proposed
in this thesis, which allowed model optimization in a reasonable computational
time. Also, such developed approaches are amenable to parallel computing, which
means the time required to solve the optimization problem can be reduced by us-
ing computational architectures specifically designed to parallel programs, such as
GPUs or high-throughput computer clusters.
Based on the above, one of the main conclusions of this thesis is the need
for considering as many model elements as possible in both the development and
validation processes. In some cases, the experimental data measured to study the
behavior of a given ionic current are affected by other ionic currents, intracellular
calcium handling or others factors, which may preclude investigation of certain cell
characteristics without accounting for those other influences. A good practice can
thus consist in developing/adjusting the model, or a part of it, by considering as
many involved elements as possible, while trying to replicate as faithfully as possible
the conditions underlying the experiments that are aimed to be reproduced.
In some cases the conditions or protocols of those experiments highly differ from
one to another study, yet more in the case of data recorded at different laboratories.
Although this might be seen as a limitation for model development and validation,
the techniques proposed in this thesis have shown the capacity to integrate all
those data no matter how different the experimental protocols underlying them
are. An important aspect in the description of an experimental protocol is the
value of the ion concentrations in the bath solution. Sometimes this aspect has
been overlooked, but it can be relevant when accounting for data recorded under
various conditions and a single in silico AP model is expected to reproduce different
available evidences.
7.2 Future work
Some future research lines identified during the development of this thesis are:
 Extend the proposed methodologies to populations of models representing
electrophysiological variability: In this thesis, an average computational AP
model was considered. This average model is representative of the mean ex-
perimentally observed behavior in human ventricular cells, but, by definition,
it does not aim to represent the well known cell-to-cell variability present in
biological data, in general, and electrophysiological data, in particiular. All
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the approaches proposed in this thesis for the development and validation of
a computational electrophysiological model could be extended to consider a
population of models aimed at covering the variability reported for different
cells in experiemntal studies.
 Application of the proposed methodologies to other human ventricular electro-
physiological models: Published human ventricular AP models present widely
varied formulations of ionic currents, calcium handling and others. Whereas
those models faithfully reproduce experimental observations regarding some
electrophysiological properties, they fail to represent other properties, as high-
lighted in this thesis. The optimization methodologies presented in this thesis,
and in particular those described in chapter 6, could be applied onto those
other human ventricular AP models to improve their overall performance.
Also, if the definition of a specific model component wants to be adjusted for
one of those models, the optimization methodology could be as well applied
to guarantee accurate representation of the corresponding experimental data
following model adjustment.
 Definition of a benchmark for validation of electrophysiological models: Based
on the developments presented in this thesis, a benchmark could be estab-
lished to evaluate human ventricular AP models and identify those satisfying
the criteria of interest. This benchmark could incorporate tests from the ionic
to the tissue level, involving different stimulation protocols and considering
different measurement conditions. This could be applied not only to average
AP models, like the TP06, GPB, ORd or CRLP models, but also to models
being part of populations generated based on those other AP models. For
each research question to be investigated, the use of a set of selected models
defined based on such a developed benchmark could be of major help.
 Improved optimization solving by adapting the trust region radius to each esti-
mated variable: As indicated in chapter 6, the radius of the trust region would
benefit from a definition adapted to the individual characteristics of each vari-
able. Without such an adapted definition, some model variables end up being
barely modified during the optimization solving due to the way the impact on
the considered electrophysiological markers is accounted for. Future strate-
gies could be investigated that allowed including variable normalization in
the optimization to improve overall efficiency of the optimization algorithm.
 Further update of model components: In this thesis a response-surface-based
algorithm was used for optimization of ionic current conductances. Also, im-
proved definition of ICaL voltage-dependent inactivation gates was addressed.
The methodologies presented in this thesis could be extended to update other
model components.
 Development of new stimulation pulse: In chapter 4, a comparison of a num-
ber of electrophysiological properties measured in simulated cells and tissues
was provided. As described in that chapter, some properties presented highly
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different values depending on the evaluated spatial scales. Since in some stud-
ies the computational cost of conducting tissue simulations may be a limiting
factor, definition of stimulation protocols that rendered simulated results
similar to those measured in tissue while in fact simulating single cells would
be of major advantage. Those stimulation protocols could, for instance, be
based on the stimulation that one cell receives from its neighbors in the tissue
(electrotonic coupling). In addition, the influence of different ionic currents
on the propagation of the electric wave should could be accounted for in the
definition of those stimulation protocols.
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Description of the First
Model
B.1 Model Parameters
B.1.1 Physical Constants
Name Value Units
R 8314 J/(mol K)
Frdy 96485 C/mol
T 310 K
FoRT Frdy/(R  T ) mV  1
Cmem 1:381  10 10 F
B.1.2 Enviromental Parameters
Name Value Units
Lengthcell 100  10 5 dm
Radiuscell 10:25  10 5 dm
Vcell  Radius2cell  Lengthcell L
Vmyo 0:65  Vcell L
Vsr 0:035  Vcell L
Vsl 0:02  Vcell L
Vjunc 5:39  10 4  Vcell L
JCajunc,sl 8:2413  10 13 L/ms
JCasl,myo 3:7243  10 12 L/ms
JNajunc,sl 1:8313  10 14 L/ms
JNasl,myo 1:6386  10 12 L/ms
147
148 New Methodologies for the Developmentand Validation of Electrophysiological Models
B.1.3 Fractional Currents
Name Value Units
Fjunc 0:11 [ ]
Fsl 1  Fjunc [ ]
FjuncCaL 0:9 [ ]
FslCaL 1  FjuncCaL [ ]
B.1.4 Ion Concentrations
Name Value Units
Ki 138 mM
Ko 5:4 mM
Cli 15 mM
Clo 150 mM
Cao 1:8 mM
Mgi 1 mM
Nao 140 mM
B.1.5 Sodium Transport
Name Value Units
GNa 18:86 mS/F
GNa,bk 0:597  10 3 mS/F
INaK 0:99 pA/pF
KmKo 1:5 mM
KmNaip 11 mM
B.1.6 Potassium Currents
Name Value Units
pNaK 1:833  10 2 [ ]
GK1 5:7153  10 1 mS/F
GKp 2  10 3 mS/F
GKr 3:5  10 2 mS/F
GKsjunc 3:5  10 3 mS/F
GKssl 3:5  10 3 mS/F
Gtof ;EPI 1:144  10 1 mS/F
Gtos;EPI 1:56  10 2 mS/F
Gtof ;ENDO 1:404  10 3 mS/F
Gtos;ENDO 3:7596  10 2 mS/F
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B.1.7 Chlorine currents
Name Value Units
GClCa 0:054813 mS/F
GCl,bk 9  10 3 mS/F
KdClCa 100  10 3 mM
B.1.8 Calcium Transport
Name Value Units
pCa 1:9887  10 4 L/(F ms)
pK 5:4675  10 8 L/(F ms)
pNa 3:0375  10 9 L/(F ms)
Incx 4:5 pA/pF
KmCai 3:59  10 3 mM
KmCao 1:3 mM
KmNai 12:29 mM
KmNao 87:5 mM
ksat 0:32 [ ]
nu 0:27 [ ]
Kdact 0:15  10 3 mM
IPMCA 0:0673 pA/pF
KmpCa 0:5  10 3 mM
GCa,bk 5:513  10 4 mS/F
B.1.9 SR Calcium Fluxes
Name Value Units
VmaxSRCaP 5:3114  10 3 mM/ms
ec50SR 0:45 mM
hillSRCaP 1:787 [ ]
kiCa 0:5 mM
 1 mS 1
kim 0:005 mS
 1
koCa 10 mM
 2 ms 1
kom 0:06 mS
 1
ks 25 mS 1
Kmf 0:246  10 3 mM
Kmr 1:7 mM
MaxSR 15 [ ]
MinSR 1 [ ]
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B.1.10 Buffering
Name Value Units
BmaxCaM 24  10 3 mM
BmaxSR 17:1  10 3 mM
BmaxTnChigh 140  10 3 mM
BmaxTnClow 70  10 3 mM
Bmaxmyosin 140  10 3 mM
BmaxNaj 7:561 mM
BmaxNasl 1:65 mM
BmaxSLlowsl
37:4  10 3  Vmyo/Vsl mM
BmaxSLlowj
4:6  10 4  Vmyo/Vjunc mM
BmaxSLhighsl
13:4  10 3  Vmyo/Vsl mM
BmaxSLhighj
1:65  10 4  Vmyo/Vjunc mM
Bmaxcsqn 140  10 3  Vmyo/Vsr mM
koffcsqn 65 mS
 1
koffCaM 238  10 3 mS 1
koffSR 60  10 3 mS 1
koffTnChCa
0:032  10 3 mS 1
koffTnChMg
3:33  10 3 mS 1
koffTnCl 19:6  10 3 mS 1
koffmyoCa 0:46  10 3 mS 1
koffmyoMg 0:057  10 3 mS 1
koffslh 30  10 3 mS 1
koffsll 1:3 mS
 1
koffNa 1  10 3 mS 1
koncsqn 100 mM
 1 mS 1
konCaM 34 mM
 1 mS 1
konSR 100 mM
 1 mS 1
konTnChCa
2:37 mM 1 mS 1
konTnChMg
3  10 3 mM 1 mS 1
konTnCl 32:7 mM
 1 mS 1
konmyoCa 13:8 mM
 1 mS 1
konmyoMg 0:0157 mM
 1 mS 1
konslh 100 mM
 1 mS 1
konsll 100 mM
 1 mS 1
konNa 0:1  10 3 mM 1 mS 1
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B.2 Model Equations
B.2.1 Nerst Potentials
ENajunc =
1
FoRT
 ln Nao
Naj
ENasl =
1
FoRT
 ln Nao
Nasl
EKs =
1
FoRT
 ln Ko + pNaK Nao
Ki + pNaK Nai
EK =
1
FoRT
 ln Ko
Ki
ECajunc =
1
2  FoRT  ln
Cao
Caj
ECasl =
1
2  FoRT  ln
Cao
Casl
ECl =
1
FoRT
 ln Cli
Clo
B.2.2 INa:Fast Sodium Current
mss =
1
1 + e
 (56:86+V )
9:03
2
m =0:1292  e (
V+45:79
15:54 )
2
+ 0:06487  e (V 4:82351:12 )2
dm
dt =
mss  m
m
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ah =

0 if V   40
0:057  e (V+80)6:8 otherwise
bh =
(
5:9231
1+e
 (V+10:66)
11:1
if V   40
2:7  e0:079V + 3:1  105  e0:3485V otherwise
h =
1
ah + bh
hss =
1
1 + e
V+71:55
7:43
2
dh
dt =
hss   h
h
aj =
(
0 if V   40
( 2:5428104e0:2444V  6:94810 6e 0:04391V )(V+37:78)
1+e0:311(V+79:23) otherwise
bj =
(
0:6e0:057V
1+e 0:1(V+32) if V   40
0:02424e 0:01052V
1+e 0:1378(V+40:14) otherwise
j =
1
aj + bj
jss =
1
1 + e
V+71:55
7:43
2
dj
dt =
jss   j
j
INajunc =Fjunc GNa m3  h  j 
 
V   ENajunc

INasl =Fsl GNa m3  h  j  (V   ENasl)
INa =INajunc + INasl
B.2.3 INa,bk: Background Sodium Current
INa,bkjunc =Fjunc GNa,bk 
 
V   ENajunc

INa,bksl =Fsl GNa,bk  (V   ENasl)
INa,bk =INa,bkjunc + INa,bksl
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B.2.4 INaK: Na-K Pump Current
 =
e
Nao
67:3   1
7
fNaK =
1
1 + 0:1245  e 0:1V FoRT + 0:0365    e V FoRT
INaKjunc =
Fjunc  INaK  fNaK Ko
1 +

KmNaip
Naj
4
 (Ko +KmKo)
INaKsl =
Fsl  INaK  fNaK Ko
1 +

KmNaip
Nasl
4
 (Ko +KmKo)
INaK =INaKjunc + INaKsl
B.2.5 IKr: Rapidly Activating Potassium Current
xrss =
1
1 + e
 (V+10)
5
xr =
3300
1 + e
 22 V
9



1 + e
V+11
9
 + 230
1 + e
V+40
20
dxKr
dt =
xrss   xKr
xr
rKr =
1
1 + e
V+74
24
IKr =GKr 
r
Ko
5:4
 xKr  rKr  (V   EK)
B.2.6 IKs: Slowly Activating Potassium Current
xsss =
1
1 + e
 (V+3:8)
14:25
xs =
990:1
1 + e
 (V+2:436)
14:12
dxKs
dt =
xsss   xKs
xs
IKsjunc = Fjunc GKsjunc  x2Ks  (V   EKs)
IKssl =Fsl GKssl  x2Ks  (V   EKs)
IKs =IKsjunc + IKssl
JesúsCarro
154 New Methodologies for the Developmentand Validation of Electrophysiological Models
B.2.7 IKp: Plateau Potassium Current
kpKp =
1
1 + e7:488 
V
5:98
IKp =GKp  kpKp  (V   EK)
B.2.8 Ito: Transient Outward Potassium Current
xtoss =
1
1 + e
 (V 19)
13
xtos =
9
1 + e
V+3
15
+ 0:5
dxtos
dt =
xtoss   xtos
xtos
ytoss =
1
1 + e
V+19:5
5
ytos =
800
1 + e
V+60
10
+ 30
dytos
dt =
ytoss   ytos
ytos
xtof =8:5  e (
V+45
50 )
2
+ 0:5
dxtof
dt =
xtoss   xtof
xtof
ytof =85  e
 (V+40)2
220 + 7
dytof
dt =
ytoss   ytof
ytof
Itos =Gtos  xtos  ytos  (V   EK)
Itof =Gtof  xtof  ytof  (V   EK)
Ito =Itos + Itof
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B.2.9 IK1:Inward Rectifier Potassium Current
aK1 =
4:0938
1 + e0:12165(V EK 49:9344)
bK1 =
15:7197  e0:06739(V EK 3:2571) + e0:06175(V EK 594:31)
1 + e 0:16285(V EK+14:2067)
K1ss =
aK1
aK1 + bK1
IK1 =GK1 
r
Ko
5:4
K1ss  (V   EK)
B.2.10 IClCa: Calcium-Activated Chlorine Current
IClCajunc =
Fjunc GClCa
1 + KdClCaCaj
 (V   ECl)
IClCasl =
Fsl GClCa
1 + KdClCaCasl
 (V   ECl)
IClCa =IClCajunc + IClCasl
B.2.11 ICl,bk: Background Chlorine Current
ICl,bk =GCl,bk  (V   ECl)
B.2.12 ICaL: L-type Calcium Current
Voltage-Dependent Activation Gate
dss =
1
1 + e
 (V+5)
6
d =
1:4
1 + e
 35 V
13
+ 0:25
d =
1:4
1 + e
V+5
5
d =
1
1 + e
50 V
20
d =d  d + d
dd
dt =
dss   d
d
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Voltage-Dependent Inactivation Gates
fss =
1
1 + e
V+20
7
f =1102:5  e (
V+27
15 )
2
f =
200
1 + e
13 V
10
f =
180
1 + e
V+30
10
+ 20
f =f + f + f
df
dt =
fss   f
f
f2ss =
0:67
1 + e
V+35
7
+ 0:33
f2 =300  e
 (V+25)2
170
f2 =
31
1 + e
25 V
10
f2 =
16
1 + e
V+30
10
f2 =f2 + f2 + f2
df2
dt =
f2ss   f2
f2
Calcium-Dependent Inactivation Gates
dfCaBj
dt =1:7  Caj 
 
1  fCaBj
  11:9  10 3  fCaBj
dfCaBsl
dt =1:7  Casl  (1  fCaBsl)  11:9  10
 3  fCaBsl
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Currents
ICaj =
pCa  V  Frdy  FoRT 
 
Caj  e2V FoRT   Cao

e2V FoRT   1
ICasl =
pCa  V  Frdy  FoRT 
 
Casl  e2V FoRT   Cao

e2V FoRT   1
INaj =
pNa  V  Frdy  FoRT 
 
Naj  eV FoRT  Nao

eV FoRT   1
INasl =
pNa  V  Frdy  FoRT 
 
Nasl  eV FoRT  Nao

eV FoRT   1
IK =
pK  V  Frdy  FoRT 
 
Ki  eV FoRT  Ko

eV FoRT   1
ICajunc =FjuncCaL  ICaj  d  f  f2 
 
1  fCaBj

ICasl =FslCaL  ICasl  d  f  f2  (1  fCaBsl)
ICaNajunc =FjuncCaL  INaj  d  f  f2 
 
1  fCaBj

ICaNasl =FslCaL  INasl  d  f  f2  (1  fCaBsl)
ICaK =
IK  d  f  f2 

FjuncCaL 
 
1  fCaBj

+ FslCaL  (1  fCaBsl)

ICa =ICajunc + ICasl
ICaNa =ICaNajunc + ICaNasl
ICaL =ICa + ICaK + ICaNa
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B.2.13 Incx: Na-Ca Exchanger Current
Kajunc =
1
1 +

Kdact
Caj
2
Kasl =
1
1 +

Kdact
Casl
2
s1junc =e
nuV FoRT Na3j  Cao
s1sl =e
nuV FoRT Na3sl  Cao
s2junc =e
(nu 1)V FoRT Na3o  Caj
s2sl =e
(nu 1)V FoRT Na3o  Casl
s3junc =KmCai Na3o 
 
1 +

Naj
KmNai
3!
+Km3Nao  Caj 

1 +
Caj
KmCai

+KmCao Na3j +Na3j  Cao +Na3o  Caj
s3sl =KmCai Na3o 
 
1 +

Nasl
KmNai
3!
+Km3Nao  Casl 

1 +
Casl
KmCai

+KmCao Na3sl +Na3sl  Cao +Na3o  Casl
Incxjunc =
Fjunc  Incx Kajunc  (s1junc   s2junc)
s3junc 
 
1 + ksat  e(nu 1)V FoRT

Incxsl =
Fsl  Incx Kasl  (s1sl   s2sl)
s3sl 
 
1 + ksat  e(nu 1)V FoRT

Incx =Incxjunc + Incxsl
B.2.14 IpCa: Sarcolemmal Calcium Pump Current
IpCajunc =
Fjunc  IPMCA  Ca1:6j
Km1:6pCa + Ca
1:6
j
IpCasl =
Fsl  IPMCA  Ca1:6sl
Km1:6pCa + Ca
1:6
sl
IpCa =IpCajunc + IpCasl
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B.2.15 ICa,bk: Background Calcium Current
ICa,bkjunc =Fjunc GCa,bk 
 
V   ECajunc

ICa,bksl =Fsl GCa,bk  (V   ECasl)
ICa,bk =ICa,bkjunc + ICa,bksl
B.2.16 SR Fluxes: Calcium Release, SR Calcium Pump, SR Calcium Leak
kCaSR =MaxSR  
MaxSR  MinSR
1 +

ec50SR
CaSR
2:5
koSRCa =
koCa
kCaSR
kiSRCa =kiCa  kCaSR
RI =1 RyRr  RyRo  RyRi
dRyRr
dt =kim RI   kiSRCa  Caj RyRr  
 
koSRCa  Ca2j RyRr   kom RyRo

dRyRo
dt =koSRCa  Ca
2
j RyRr   kom RyRo   (kiSRCa  Caj RyRo   kim RyRi)
dRyRi
dt =kiSRCa  Caj RyRo   kim RyRi  
 
kom RyRi   koSRCa  Ca2j RI

JSRCarel =ks RyRo  (CaSR   Caj)
JserCa =
VmaxSRCaP 

Cai
Kmf
hillSRCaP   CaSRKmr hillSRCaP
1 +

Cai
Kmf
hillSRCaP
+

CaSR
Kmr
hillSRCaP
JSRleak =5:348  10 6  (CaSR   Caj)
B.2.17 Ion Homeostasis
Sodium Buffers
dNaBj
dt =konNa Naj 

BmaxNaj  NaBj

  koffNa NaBj
dNaBsl
dt =konNa Nasl 

BmaxNasl  NaBsl

  koffNa NaBsl
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Cytosolic Calcium Buffers
dTnCl
dt =konTnCl  Cai 

BmaxTnClow   TnCl

  koffTnCl  TnCl
dTnChc
dt =konTnChCa  Cai 

BmaxTnChigh   TnChc   TnChm

  koffTnChCa  TnChc
dTnChm
dt =konTnChMg Mgi 

BmaxTnChigh   TnChc   TnChm

  koffTnChMg  TnChm
dCaM
dt =konCaM  Cai  (BmaxCaM   CaM)  koffCaM  CaM
dMyoc
dt =konmyoCa  Cai 
 
Bmaxmyosin  Myoc  Myom

  koffmyoCa Myoc
dMyom
dt =konmyoMg Mgi 
 
Bmaxmyosin  Myoc  Myom

  koffmyoMg Myom
dSRB
dt =konSR  Cai  (BmaxSR   SRB)  koffSR  SRB
JCaBcytosol =
dTnCl
dt +
dTnChc
dt +
dTnChm
dt +
dCaM
dt
+
dMyoc
dt +
dMyom
dt +
dSRB
dt
Junctional and SL Calcium Buffers
dSLLj
dt =konsll  Caj 

BmaxSLlowj
  SLLj

  koffsll  SLLj
dSLLsl
dt =konsll  Casl 

BmaxSLlowsl
  SLLsl

  koffsll  SLLsl
dSLHj
dt =konslh  Caj 

BmaxSLhighj
  SLHj

  koffslh  SLHj
dSLHsl
dt =konslh  Casl 

BmaxSLhighsl
  SLHsl

  koffslh  SLHsl
JCaBjunction =
dSLLj
dt +
dSLHj
dt
JCaBsk =
dSLLsl
dt +
dSLHsl
dt
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Sodium Concentrations
dNaj
dt =
 INatotjunc  Cmem
Vjunc  Frdy +
JNajunc,sl
Vjunc
 (Nasl  Naj)  dNaBjdt
dNasl
dt =
 INatotsl  Cmem
Vsl  Frdy +
JNajunc,sl
Vsl
 (Naj  Nasl)
+
JNasl,myo
Vsl
 (Nai  Nasl)  dNaBsldt
dNai
dt =
JNasl,myo
Vmyo
 (Nasl  Nai)
Calcium Concentrations
dCsqnb
dt =koncsqn  CaSR 
 
Bmaxcsqn   Csqnb
  koffcsqn  Csqnb
dCaj
dt =
 ICatotjunc  Cmem
Vjunc  2  Frdy +
JCajunc,sl
Vjunc
 (Casl   Caj)  JCaBjunction
+
JSRCarel  Vsr
Vjunc
+
JSRleak  Vmyo
Vjunc
dCasl
dt =
 ICatotsl  Cmem
Vsl  2  Frdy +
JCajunc,sl
Vsl
 (Caj   Casl)
+
JCasl,myo
Vsl
 (Cai   Casl)  JCaBsk
dCai
dt =
 JserCa  Vsr
Vmyo
  JCaBcytosol +
JCasl,myo
Vmyo
 (Casl   Cai)
dCaSR
dt =JserCa  

JSRleak  Vmyo
Vsr
+ JSRCarel

  dCsqnbdt
B.2.18 Membrane Potential
ICatotjunc =ICajunc + ICa,bkjunc + IpCajunc   2  Incxjunc
ICatotsl =ICasl + ICa,bksl + IpCasl   2  Incxsl
ICatot =ICatotjunc + ICatotsl
IKtot =Ito + IKr + IKs + IK1   2  INaK + ICaK + IKp
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INatotjunc = INajunc + INa,bkjunc + 3  Incxjunc + 3  INaKjunc + ICaNajunc
INatotsl =INasl + INa,bksl + 3  Incxsl + 3  INaKsl + ICaNasl
INatot =INatotjunc + INatotsl
ICltot =IClCa + ICl,bk
Itot =INatot + ICltot + ICatot + IKtot
dV
dt =  (Itot   Istim)
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Appendix C
Description of the Final
Model
This appendix includes only the parameters or equations that were modified with
respect to the version described in Appendix B.
C.1 Model Parameters
C.1.1 Enviromental Parameters
Name Value Units
JCajunc,sl 7:861586  10 13 L/ms
JCasl,myo 3:734497  10 12 L/ms
C.1.2 Fractional Currents
Name Value Units
Fjunc 0:11 [ ]
Fsl 1  Fjunc [ ]
FjuncCaL 0:9 [ ]
FslCaL 1  FjuncCaL [ ]
Fto;s 0:12 [ ]
Fto;f 1  Fto;f [ ]
C.1.3 Sodium Transport
Name Value Units
GNa 18:9024 mS/F
GNa,bk 0:5181448  10 3 mS/F
INaK 1:140666 pA/pF
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C.1.4 Potassium Currents
Name Value Units
GK1 4:253697  10 1 mS/F
GKp 2:173516  10 3 mS/F
GKr 3:507879  10 2 mS/F
GKs 0:0034 mS/F
GtoEPI 1:558487  10 1 mS/F
GtoENDO 4:674482  10 2 mS/F
C.1.5 Chlorine currents
Name Value Units
GClCa 4:757296  10 2 mS/F
GCl,bk 9:417983  10 3 mS/F
C.1.6 Calcium Transport
Name Value Units
GCaL 4:7628  10 4 mS/F
pCa 1 L  
/s
pK 1:3746417  10 4 L  
/s
pNa 7:63689  10 6 L  
/s
Incx 2:747111 pA/pF
IPMCA 5:84106  10 2 pA/pF
GCa,bk 4:820643  10 4 mS/F
C.1.7 SR Calcium Fluxes
Name Value Units
VmaxSRCaP 4:609837  10 3 mM/ms
ks 24:7507 mS 1
kSR;leak 5:483405  10 6 mS 1
C.2 Model Equations
C.2.1 Ito: Transient Outward Potassium Current
Itos =Gto  Fto;s  xtos  ytos  (V   EK)
Itof =Gto  Fto;f  xtof  ytof  (V   EK)
Ito =Itos + Itof
C.2.2 ICaL: L-type Calcium Current
Voltage-Dependent Activation Gate
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Voltage-Dependent Inactivation Gates
fss =
1
1 + e
V+24:63
5:87
f =1102:5  e (
V+27
15 )
2
f =
200
1 + e
20:6 V
10
f =
180
1 + e
V+30
10
+ 20
f =f + f + f
df
dt =
fss   f
f
f2ss =
0:67
1 + e
V+24:63
5:87
+ 0:33
f2 =300  e
 (V+25)2
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f2 =
16
1 + e
V+30
10
f2 =f2 + f2
df2
dt =
f2ss   f2
f2
Currents
ICaj =GCaL  pCa 
V  Frdy  FoRT
2

 
Caj  e2V FoRT   Cao

e2V FoRT   1
ICasl =GCaL  pCa 
V  Frdy  FoRT
2

 
Casl  e2V FoRT   Cao

e2V FoRT   1
INaj =GCaL  pNa  V  Frdy  FoRT 
 
Naj  eV FoRT  Nao

eV FoRT   1
INasl =GCaL  pNa  V  Frdy  FoRT 
 
Nasl  eV FoRT  Nao

eV FoRT   1
IK =GCaL  pK  V  Frdy  FoRT 
 
Ki  eV FoRT  Ko

eV FoRT   1
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ICajunc =FjuncCaL  ICaj  d  f  f2 
 
1  fCaBj

ICasl =FslCaL  ICasl  d  f  f2  (1  fCaBsl)
ICaNajunc =FjuncCaL  INaj  d  f  f2 
 
1  fCaBj

ICaNasl =FslCaL  INasl  d  f  f2  (1  fCaBsl)
ICaK =
IK  d  f  f2 

FjuncCaL 
 
1  fCaBj

+ FslCaL  (1  fCaBsl)

ICa =ICajunc + ICasl
ICaNa =ICaNajunc + ICaNasl
ICaL =ICa + ICaK + ICaNa
C.2.3 SR Fluxes: Calcium Release, SR Calcium Pump, SR Calcium Leak
JSRleak =kSRleak  10 6  (CaSR   Caj)
C.2.4 Ion Homeostasis
Potassium Concentrations
dKi
dt =  IKtot 
Cmem
Vmyo  Frdy
C.2.5 Membrane Potential
IKtot =Ito + IKr + IKs + IK1   2  INaK + ICaK + IKp   Istim
Itot =INatot + ICltot + ICatot + IKtot
dV
dt =  Itot
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Appendix D
Acronyms
 1D: one-dimensional.
 AP: action potential.
 APA: action potential amplitude.
 APD: action potential duration.
 APDR: action potential duration restitution.
 AV : atrioventricular.
 BZ : border zone.
 CI : coupling interval.
 CL: cycle length.
 CRLP: Carro-Rodríguez-Laguna-Pueyo human ventricular cell model [120].
 CRN : Courtemanche-Ramirez-Nattel model [47].
 CV : conduction velocity.
 CVDs: cardiovascular diseases.
 CZ : central zone.
 DI : diastolic interval.
 ECC : excitation-contraction coupling.
 ECG: electrocardiogram.
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 ERP: effective refractive period.
 GPB: Grandi-Pascualini-Bers human ventricular model [15].
 HH : Hodgkin-Huxley model [26].
 IMW04: Iyer et al. human ventricular cell model [45].
 LR: Luo-Rudy model [107].
 NCD: noncommunicable disease.
 NZ : normal zone.
 ORd:O’Hara-Rudy-dynamic human ventricular cell model [64].
 RSA: response surface approximations.
 S1: basic stimulus.
 S2: extra stimulus.
 SA: sinoatrial.
 SEM : standard error of the mean.
 SR: sarcoplasmic reticulum.
 TNNP04: tenTusscher-Noble-Noble-Panfilov human ventricular cell model
[46].
 TP06: tenTusscher-Panfilov human ventricular cell model [51].
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JesúsCarro


The development and validation of a computational electrophysiological
model is a complex process associated with a number of difficulties. Two
main issues are: i) the limited amount of experimental data the model can
be based; ii) the way in which information is extracted from experiments
and used to build the models. Based on the increase in computational
power, new strategies to reduce the number of hypothesis and/or assump-
tions when building an electrophysiological model were considered. In
particular, the application of an optimization algorithm together with the
simulation of in silico simulation of experimental protocols, helped to find
a model that better represents the experimental results.
This thesis highlighted the benefits of using in silico simulations of ex-
perimental protocols to evaluate all those possibilities, as long as in silico
simulations replicate as closely as possible the conditions of the experi-
ments against which the simulated data is compared.
